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Summary
Androgen steroids are an important group in the hormone family. As they play 
significant roles in the human body, identification and determination of these compounds 
have been of great interest in many fields. In this thesis, systematic studies of the 
compounds in the androgen group by liquid chromatography / mass spectrometry have 
been undertaken.
The first chapter gives a brief introduction to the structure, function and 
classification of the steroid family, and is followed by a review of different analytical 
techniques applied in this family. The theory behind the chromatographic and mass 
spectrometric techniques used has also been introduced.
Structural information about the androgenic steroids and their conjugates has been 
obtained in chapters 2 and 3 respectively by both ESI and APCI mass spectrometry. The 
effect of different solvent systems was studied in detail in both the positive and negative 
ionization modes and the collision induced dissociation of these compounds was also 
investigated by tandem mass spectrometry.
In chapter 4, LC/MS methods have been optimized in terms of columns, solvent 
systems, flow rate and mass spectrometer parameters to quantify some of the androgens 
and their conjugates respectively. The linearity, precision and limits of detection were 
estimated for these compounds.
A derivatization method was developed to enhance the sensitivities for detection 
of the androgens and their conjugates by LC/MS in the final chapter. A TMPP reagent 
was used as a derivatizing reagent, and the spectra of these TMPP-derivatives of 
androgens were studied by ESI mass spectrometry. A LC/MS method was also set up 
with the aim of quantitation of five TMPP-derivatives of androgens.
IV
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A G androsterone glucuronide
ANOVA analysis of variance
APCI atmospheric pressure chemical ionization
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Cl chemical ionization
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dc direct current
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ECD electron capture detector
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RIA radioimmunoassay
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RSD relative standard deviation
Rs column resolution
SFC supercritical fluid
SIM selected ion monitoring
SPE solid phase extraction
SRM selected reaction monitoring
T testosterone
TG testosterone glucuronide
TIC total ion chromatography
TLC thin layer chromatography
TMS trimethylsilyl
TMPP tris (2,4,6-trimethoxyphenyl) phosphonium bromide
TOF time of flight
TS testosterone sulfate
tM dead time
tR retention time
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UV ultraviolet
Vm dead volume
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Chapter 1 
Introduction
1.1 Introduction to the steroid hormones
1.1.1 Structures o f steroids
All the structures of the steroid hormones are related to the 
cyclopentanoperhydro-phenanthrene nucleus. The numbering of the 
cyclopentanoperhydrophenanthrene ring system and the lettering of the ring are presented 
in Figure 1.1 The ring system of steroids is stable and is not catabolized by mammalian 
cells. Biological activities of steroids vary by alteration of the ring substituents rather 
than alteration of the ring structure itself.
Figure 1.1 Structure and numbering system of cyclopentanoperhydrophenanthrene
11^  13 ^ 1 6
I c  I D I
^ 1^  ^ 9 — --------^ 1 4 --------------- 15
2 ^ i ( r  ^ 8 ^
I A I B |
Figure 1.2 Structure of cholesterol
HO
2
The parental precursor of the steroid is cholesterol (shown in Figure 1.2), which 
is a white crystaline compound originally isolated from gallstones. Cholesterol is a 
constituent of every animal tissue and occurs partly as the free alcohol and partly 
esterified with the higher fatty acids.
1.1.2 Classification and function
Steroid hormones are derived in specific tissues in the body and are more often 
classified by their biological activities, into adrenal hormones, progestogens, estrogens 
and androgens.
1.1.2.1 Adrenal hormones
This group of steroids are formed in the adrenal cortex, and usually classified into 
glucocorticoids and mineralocorticoids according to their different physiological 
functions. The structures of these two groups are similar, and the difference depends on 
the presence or absence of a 17-hydroxy group. The 17-hydroxylated compounds are 
glucocorticoids, while the 17-deoxy compounds are mineralocorticoids. But there is some 
overlap of function between the two groups.
Glucocorticosteroids promote the deposition of glycogen in the liver, produce 
glucose from amino acids, retard the oxidation of glucose and kill certain T cells in high 
doses. They are essential for the maintenance of life and important in resistance to shock 
and infection. The principal steroid of this group is cortisol.
3
Mineralocorticosteroids control the balance of salt and water. Their actions retain 
sodium and prevent the retention of excess potassium. Aldosterone is the most potent 
adrenal steroid of this type.
1.1.2.2 Progestogens
Progesterone is the most important steroid of this group. It is secreted by the 
corpus luteum of the ovary and is responsible for preparing the endometrium for 
pregnancy. It maintains the uterine endometrium for implantation (with estradiol) and is 
a differentiation factor for mammary glands. Progesterone is an intermediate in the 
biosyntheses of the corticosteroids, the estrogens and the androgens.
1.1.2.3 Estrogens
Naturally occurring estrogens have a basic C l8 structure with an oxygen 
substituent at C (17) and a characteristic aromatic A ring. The hydroxyl group at C (3) 
gives them phenolic and therefore weakly acidic properties.
Estrogens are produced in the gonads, the placenta and the andrenal cortex. In 
combination with other hormones, estrogens are responsible for the development and 
maintenance of the female sexual organs and characteristics, and are important in the 
anterior pituitary. Estrogen formed by the placenta gradually increases and in late 
pregnancy the production may exceed one thousand times that of the ovary. They also 
have some effects on oral structures, such as influence the growth of the oral epithelium 
and increase the activity of cells in the buccal epithelium.
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1.1.2.4 Androgens
All the androgens comprise a group of C19 steroids, but differences occur in the 
type and position of the moieties, which are attached to the basic C l9 unit. The major 
naturally occurring androgens are testosterone, 5a-dihydrotestosterone (5a-DHT) and 
5a-androstane-3a, 17(3-diol, with A4-androstenedione and dehydroepiandresterone 
(DHA) having only weak biological activity (Fig. 1.3).
The androgens are secreted to a large extent by the Leydig cells of the interstitial 
tissues of the testes and to a lesser extent by the adrenals and ovaries. There is some 
evidence that the Sertoli cells of the seminiferous tubules can also synthesize and secrete 
testosterone. Androgens exert numerous diverse effects; they develop and maintain the 
male reproductive organ’s characteristics, involve the normal functioning and structure of 
the prostate gland and seminal vesicles. Moreover, there is an increase in the size of the 
testes, scrotum, penis, seminal vesicles, prostate, vas deferens and epididymis at puberty. 
The anabolic effects of androgens are also noted at this time when there is an increase in 
muscle protein, reflected urinary creatinine, a decrease in urinary nitrogen excretion 
without an increase in blood urea. These effects, including those on bone, give rise to the 
dramatic increases in height and weight noted in boys at puberty. Effects of androgens on 
non-sexual organs include those on the length of the vocal chords, resulting in deepening 
of the voice, and on the kidneys. These are larger in men than in women and numerous 
enzymes are increased in quantity. A further well-known increased activity of the 
sebaceous glands occasionally leading to the troublesome problem of acne. Sexual,
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auxiliary and facial hair-growth is also androgen-dependent. The androgen steroids are 
chiefly metabolized by the liver and excreted in the urine.
Figure 1.3 Some important metabolic pathways of androgens 127
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Figure 1.3. Summarizes some of the more important metabolic pathways of the 
androgens, with the exception of conversion to estrogens. These pathways include: the 
reduction of the double bond at C4, leading to 5a/5p isomers; the reduction of the 3-oxo 
group to 3a/3P-hydroxy steroids; the oxidation of the 17p-hydroxy group to 17-carbonyl 
group if a 17-methyl group is absent; hydroxylation (eg: at C6, C l2, C l6) and
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epimerization (eg: 17(3-hydroxy group to 17a-hydroxy group); conjugation, mainly as 
glucuronide and to a lesser extend as sulphate, occurs at C3 or C l7.
1.1.3 Analytical techniques o f steroids
There are many different analytical techniques involved in the biological or 
clinical analysis of steroids, such as traditionally bioassays, colorimetric, fluorimetric, 
and most widely used immunoassay and chromatographic methods. However, the 
incidence of bioassays, colorimetric, and fluorimetric methods has declined sharply in 
recent years whereas commercial assay kits have become available for most important 
steroids. Several types of immunoassays including radioimmunoassay 1'2, enzyme- 
immunoassay 3-4 and fluoroimmunoassay 5 are currently used for most of routine 
determinations and still used in research of the measurements of steroid concentrations. 
However, immunoassay is restricted to determination of a single steroid whereas the 
study of broad steroid profile, requiring the simultaneous determination of various 
steroids not appropriately to be carried out with conventional methodologies.
1.1.3.1 Radioimmunoassay
In radioimmunoassay (RIA), a fixed concentration of labeled tracer antigen is 
incubated with a constant amount of antiserum, such that the concentration of antigen 
binding sites on the antibody is limiting; for example, only 50% of the total tracer 
concentration may be bound by antibody. If unlabeled antigen is added to this system, 
there is competition between labeled tracer and unlabeled antigen for the limited and
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constant number of binding sites on the antibody, and thus the amount of tracer bound to 
antibody will decrease as the concentration of unlabeled antigen increases. This can be 
measured after separating antibody-bound from free tracer and count either the bound 
fraction, the free fraction or both. A calibration curve is set up with known amount of 
androgen, from which unknown samples can be calculated. Thus the four basic 
necessities for a RIA system are an antiserum to the compound to be measured, the 
availability of a radioactively labeled form of the compound, a method whereby 
antibody-bound tracer can be separated from unbound tracer, and a standard unlabeled 
material.
RIA has long been established and involved for the analysis of steroids 6'9. As 
steroids are typically in very low concentrations in biological extract, it has the added 
advantage of concentrating the analyte in addition to removing unwanted cross-reactants 
from the sample. Although selective extraction of the analyte is possible, it is becoming 
common practice to perform multiple determinations on a single extract requiring the use 
of less selective extracting media 10'12. A common problem with RIA techniques is 
specific and nonspecific interference with the antibody-analyte binding. Antibodies to 
steroids are usually made by immunizing animals to the steroid, which has been 
conjugated to an antigenic protein (e.g., bovine serum albumin) as a hapten 13. Such 
antisera, typically, have some degree of cross-reactivity with structurally similar steroids 
which is usually reported as the amount of cross-reacting steroid needed to displace 50% 
of bound labeled ligand in the absence of the steroid being analyzed. This is often 
expressed as a percentage of the analyte required achieving the same displacement. 
Although low cross-reactivities are frequently regarded as insignificant, the concentration 
of different steroids varies over a wide range. Hence, apparently small cross-reactivities 
can become significant. Nonspecific interference can be attributed to compounds in the
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incubation mixture, which interfere with the antibody-analyte binding. This is a problem 
with all RIA procedures, but more particularly with those incorporating an extraction step 
where the analyte and interfering species have both been concentrated.
1.1.3.2 Gas chromatography
Homing and coworkers 14'18 pioneered the gas chromatography (GC) of steroids 
emphasizing aspects of stationary phase selectivity and the development of non- 
adsorptive, thermal stable steroid derivatives. Most studies with steroids have relied on 
the formation of suitable derivatives to enhance the chromatographic separation due to 
their poor thermal stability. Steroids undergo all of the reactions expected of molecules 
containing double bonds, keto-groups, and hydroxyl groups. Many of these reactions 
have been exploited to convert the polar oxo- and hydroxyl functions of steroids to non­
polar derivatives for GC. The formation of methoxime-trimethylsilyl (MO-TMS) ethers 
is one of the most satisfactory procedures. In certain circumstances, other derivatives 
have been more useful, as in the determination of isomeric urinary estrogens where 
resolution of the ethoxime (EO)-TMS derivatives was superior to that of the 
corresponding MO-TMS ethers 19. Related derivatives include n-butyloxime-TMS ethers 
20, trimethylsilyloxime (TMSO)-TMS ethers 21*22, benzyloxime-TMS ethers 23, and 
persilyloxime-TMS ethers 24. In addition to improve chromatographic behavior, 
halogenated derivatives significantly increase sensitivity when used with electron capture 
detector (ECD) . Fluorinated derivatives have been used with mass spectrometric 
detection presumably because of intense ions of high mass in the mass spectrum and 
enhanced volatility allowing lower column temperatures or reduced analysis times .
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There are generally two categories of stationary phases used for the GC of 
steroids: non-selective phases in which separation is based on volatility effects; and 
selective phases in which the separation based on volatility is modified by the presence or 
absence of characteristic groups in the steroid molecule. Before 1965, Homing et al 14 
relied on selectivity effects based on the use of selective phases and derivatization to 
effect separations. However, a fundamental change occurred in their approach, in which 
they emphasized column efficiency rather than selectivity to obtain a urinary metabolic 
profile in 1971 16. One of the most important developments for improving the separation
97 9Qof steroids was the application of fused silica columns to steroid analysis ‘ . Excellent 
separations of the free underivatized steroids have been achieved on these columns, 
which have been used successfully to establish comprehensive urinary steroid profiles 30. 
However, adsorption-related problems were reported for steroids with underivatized oxo- 
functions 19.
Three major detectors have been used in the GC analysis of steroids. Flame 
ionization detector (FID) has been used particularly in combination with TMS ethers 
permitting detection down to the nanogram level in relatively impure biological extracts. 
The ECD has been less used compared to the others because of its extreme sensitivity to 
nonspecific background substances. The most popular and widely used detection system 
is a mass spectrometer (MS) coupled with GC. Determinations of steroids in biological 
samples such as urine, plasma and cell cultures have been intensively studied with this 
system and its applications have been reviewed by Gaskel in 1983 31, Wolthers and Kraan 
32 in 1999 and Shimada et a l.33 in 2001.
1.1.3.3 Thin layer chromatography
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Thin layer chromatography (TLC) has been widely used in routine clinical 
analysis for steroids. Many types of phases 34-37 have been studied including silica gel, 
alumina, celite, and cellulose. The reversed phase generated by silanizing silica gel was 
described by Corti et a l . Furthermore, silica gel is also well suited as a support for 
partition chromatography with various mobile phases but is more commonly used as an 
adsorbent. Indeed, most TLC work with steroids has been carried out on silica gel or 
alumina 39-43. The mobile phases were chosen based on the nature of stationary phase and 
the polarity of steroid. For example, an ether, ester or ketone in the mobile phase often 
effects useful modification in relative retentions 44. Many separations are achieved by 
simple development on more or less activated layers 45. For difficult separations, multiple 
developments in the same or different mobile phases or 2-dimensional development can 
be used 46. Detection methods for steroids in TLC include UV absorption, fluorescence, 
iodine vapour and enzymatic detection 47-48.
1.1.3.4 High performance liquid chromatography
The investigation of steroids by high performance liquid chromatography (HPLC)
began in the early 1970’s with the evaluation of several coated phases for steroid
separation by Siggia and Dishman 49. Since then, it has become one of the most important
techniques in steroid research because of its advantages, which include: (i) offering a
simple and effective technique for rapidly separating and quantitating small
concentrations in the presence of large contaminants; (ii) not normally requiring a
complicated sampling procedure, such as preparing antisera or labeling the antigen in
immunoassay methods; (iii) being suitable for nonvolatile- and thermally labile steroids,
50-51 which are not possible to analyze by GC without derivatization. The application of
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HPLC to steroids has been reviewed by Heftmann and Hunter in 1979 and Kautsky in 
1981 53.
The most widely used stationary phases for steroids are C18 or C8 ligands bonded
to the silica support 56'59. This silica-based reversed-phase possess the desirable
characteristics of well-controlled particle size, pore structure and mechanical strength as
well as a rich repertoire of bonding chemistry. Many successful separations of steroids
have been reported by these kinds of columns. Purdon et al. reported the separation of 15
different testosterone metabolites on a Supelcosil LC-18 column with a one-step linear
gradient of methanol in water (10%-60% methanol) 60. Navajas et al. described an
alternative HPLC method for the determination of testosterone and epitestosterone on a
Hypersil BDS-C18 reversed-phase column with gradient elution and UV absorbance
detection 61. Some urinary glucuronide conjugates were separated on a C l8 column and
62were detected spectrofluorimetrically at 445nm with excitation at 367nm by Iwata et al . 
Reversed phase chromatography on Partisil 10 ODS was recommended for the 
simultaneous determination of estriol, estradiol and estrone . Similarly, reversed phase 
chromatography was preferred for the determination of corticosteroids 64 in plasma. 
Radial compression columns containing C18 and C8 reversed phases (10 pm) have been 
utilized65 as complementary packing to effect the separation of up to 21 progesterone and 
pregneonlone metabolites in 20-40min using high flow rates of 2-3 ml/min. However, the 
silica-based reversed phase becomes undesirable because of the pH stability and residual 
chemical activity of the unprotected silica support, although manufacturers use various 
methods to reduce the unreacted-silanol content. Apart from the reversed phase materials 
with alkyl or phenyl functionality, bonded phase silica with 1, 2-dehydroxypropyl ether 
(DIOL) has been popular for the HPLC of steroids. The advantage of DIOL phases is the 
reversal in elution pattern relative to reversed phase packing . Most routine analyses
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can be performed on a reversed phase column such as Lichrosorb PR-18 with a DIOL 
column being used for more difficult separations 66.
A novel reversed phase-porous graphitic carbon (PGC) provided unique 
selectivities in addition to improve chemical stability and surface homogeneity . PGC is 
produced by the graphitization of a phenol-formaldehyde resin-impregnated silica gel and 
exhibits the inherent pH stability and the chemical homogeneity that a bonded silica 
phase does not. Wade and Haegele 69 described an HPLC-UV method for simultaneous 
measurement of cortisone and cortisol in human saliva with sample preparation by solid- 
phase extraction on cyclodextrin (CD) media. However, compared to silica particles, 
PGC is limited by its lower efficiency and higher fragility. Moreover column of this 
material are available only in short lengths and are expensive. A variety of pore sizes are 
not available at this time.
7(1A few optimization procedures have been described, such as solvent triangle , 
window diagram 71, factorial design techniques 72 and multi-criteria decision-making 
methods 73. Valko and Siegel74 used molecular modeling for mobile-phase optimization 
in RP-HPLC. Chong et al. 75 achieved the optimization of the solvent composition by 
making use of the overlapping resolution.
The correct combination of stationary and mobile phase is essential. This is 
demonstrated by the reversed-phase chromatography of adrenal steroids on various ODS 
materials differing in the number of free silanol groups 76. Many useful steroid 
separations have been achieved using isocratic elution with a binary solvent as mobile 
phase. In some cases, phosphate buffer is incorporated in the mobile phase. With these 
systems, the buffer anion and pH exert a significant effect on the separation. For a 
complex biological sample containing many hormones, the use of a ternary mobile phase
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77has permitted high selectivity . In the case of normal-phase HPLC, the elution of highly 
polar steroids takes a long time, and therefore, a gradient system needs to be employed as 
the mobile phase. The success of a separation, particularly for late eluting steroids, often 
depends on the gradient shape. Non-linear, linear and stepped gradients have been used.
Shalahy and Shahjahan 59 tested the selectivity of different organic solvents: 
methanol, acetonitrile and tetrahydrofuran separately after mixing with phosphate buffer 
at different pH and with different ratios. All the tested analytes (dexamethasone, 
hydrocortisone, hydrocortisone acetate, prednisolone and prednisolone acetate) gave 
highly resolved, sharp peaks with acetonitrile-phosphate buffer (6:4) at pH 8 as mobile
78phases. Saisho et al. separated several adrenal steroids without the use of any gradient 
system by using a mixture of methanol-acetonitrile-water (55:3:42, v/v/v). While 
separation of androstenedione and its stereospecific hydroxyandromatic derivatives were 
achieved by using a linear gradient of acetonitrile and water in increasing amounts from 
30%-60% of the first solvent 79. Elisabetta Venturelli et al. 80 measured urinary 
testosterone with a mobile phase of acetonitrile-water (1:9 v:v), and acetonitrile content 
was increased to 100% in 25min and maintained at 100% for 5min.
HPLC has proved a versatile technique for the quantitative determination of 
steroids by using ultraviolet (UV) 66,81,82, fluorescence 83-85, electrochemical 86-88 and 
mass spectrometry (MS) as detectors.
The choice of detection system is governed largely by the expected concentration 
range of steroids and sample type. The low levels of steroids normally encountered in 
biological samples required a detector of maximal sensitivity. UV and fluorescence 
detection are usually part of HPLC analyses for steroid hormones. However, the limit of a
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quantitative determination of these methods is thought to be 0.5-1.0ng. Simultaneous 
measurement with two complementary detectors offers considerable potential for the 
quantification of a steroid. For example, UV and fluorescence make a powerful 
combination. Further developments in coupled HPLC-mass spectrometric systems will 
undoubtedly enhance the role of HPLC in the determination of steroids.
Historically, UV absorption has occupied a pre-eminent position as a detection 
system in HPLC. Whereas isolated carbonyl groups absorb UV with a maximum around 
275-285nm, the 1,3-unsaturated ketones in the A-ring of steroids absorbs with a
89maximum around 240 nm. Thus, steroid metabolites of progesterone and testosterone 
have been quantified at 240 nm 90'91. Measurements in the 210-220nm region required 
highest purity solvents to avoid excessive baseline noise 92. For those steroids absorbing 
in the UV below 200nm, it is difficult to obtain a signal free from noise, particularly 
when gradient elution is used. Whilst baseline correction is also necessary at higher 
wavelength with some gradients.
Mass spectrometry (MS) affords specificity and sensitivity for steroid detection. 
Since the mass spectrometer only detects ionizable components in the mass range 
selected, much interference could be avoided by choosing a mass range or “window” 
applicable to the compounds of interest but still above the majority of ionizable 
endogenous material. The greatest disadvantage to HPLC is the difficulty of interfacing 
with MS. However, the development of interface techniques including thermospray (TS) 
93, atmospheric pressure chemical ionization (APCI) 113 and electrospray (ESI) 118 make 
the combination of HPLC separations with specific MS identification a practical 
technique. With the improvement of techniques, LC-MS has increasingly been applied to 
the analysis of steroids, giving molecular mass information and limited fragmentation.
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Prough et al. have studied the metabolism of DHEA in rat and human liver microsomal 
fractions using LC-APCI-MS. Metabolites identified in both species included 16a- 
hydroxy-DHEA, 7a-hydroxy-DHEA and 7-oxo-DHEA 55. The use of the isotope-labeled 
internal standards has proved to be useful in LC-MS to compensate for the substantial
OA
variations in ionization conditions . The technique developed by Esteban and Yeergey 
94 for measurement of plasma cortisol using stable isotope dilution MS is accurate and 
reliable. A thermospray-HPLC/MS method for determination of serum 
dehydroepiandrosterone sulfate has been described by Shackleton et al. 95, using [7,7-
2 96H2 ] dehydroepiandrosterone (DHEA) sulfate as internal standard. Chung et al. 
synthesized deuterium labeled 5a-androstane-3a, 17p-diol and its 17p-glucuronide, and 
the products were identified by TS-MS and ESI-MS. The analysis of natural steroids 
using LC-MS has been reviewed by Shimada et al. 54 in 2001.
1.2. Introduction to high performance liquid 
chromatography/mass spectrometry
1.2.1 Introduction to chromatography
97The Russian botanist Mikhail Tswett first introduced chromatography in 1906. 
He used a column of powdered calcium carbonate to separate green leaf pigments into a 
series of colored bands by allowing a solvent to percolate through the column bed. He
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described this technique as chromatography, from the Greek words of “ chroma ” 
meaning color and “ graphein “ meaning writing. The generic terminology now 
encompasses a wide range of separation sciences.
Essentially, chromatography is a physical method of separation in which the 
components to be separated are distributed between two phases, one is held static which 
is termed as the stationary phase, the other travels past the stationary phase under gravity, 
pressure or by capillary action which is termed as the mobile phase. The stationary phase 
is a dispersed medium with a large surface area and it can be either a solid or a liquid 
spread over an inert support or spread as a thin film on the walls of the column. The 
mobile phase can be a gas (GC), a liquid (LC) or a supercritical fluid (SFC). Based on the 
nature of the mobile phase, chromatography can be categorized as gas chromatography, 
liquid chromatography and supercritical fluid chromatography. In this thesis, liquid 
chromatography coupled with mass spectrometry was applied for the study of androgenic 
steroids.
1.2.1.1 Terms used in chromatography
The chromatographic theory was first proposed by Nobel Prize winners Martin 
and Synge 98 and developed by Craig 99 and Glueckauf100 as the plate theory. Later, van 
Deemter 101 and Giddings 102 established the rate theory. The terms introduced here can 
be used for all chromatographic techniques not only for liquid chromatography.
Partition coefficients
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The equilibrium constant K of an analyte for the equilibrium between mobile 
phase and stationary phase is defined as
K = Cs/C m (1.2.1)
Where Cs is the molar concentration of analyte in the stationary phase and Cm is its molar 
concentration in the mobile phase. Components with a high distribution in the stationary 
phase will move slowly through the column and hence be separated from components 
with a lower distribution in the stationary phase. A separation can’t be achieved without a 
difference in distribution between the components.
Retention time
The time it takes after sample injection for the analyte peak to reach the detector 
is called the retention time (tR). The time for the unretained components to reach the 
detector is called the dead time (tM).
Capacity factor
Capacity factor (k) is used to describe the migration rates of analytes on the 
column. The relation between capacity factor and retention time is:
k  =  ( t R  -  t M )  /  t M  ( 1 . 2 . 2 )
When k is much less than unity, the analytes are eluted so rapidly that accurate 
determination of the retention times is difficult. When the capacity is more than 20, 
elution time is too long and peak is very wide. The ideal separations are performed under 
the conditions, which the capacity factor of the components in a mixture is 1 to 5.
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Selectivity factor
The selectivity factor (a) of a column for the two components A and B is defined
as:
a = KB/KA (1.2.3)
Where Kb is the partition ratio for the more strongly retained components B and Ka is the 
partition ratio for the less strongly held components A.
Resolution
The resolution (Rs) is the ability of the chromatographic column to separate two
components and is derived from the separation of the peak maxima, At, and the baseline
peak widths Wi and W2 (see figure 1.4) where:
Rs = 2At / ( W i + W 2) (1.2.4)
Base line resolution corresponds to Rs > 1.5 is desirable for peaks of similar size.
Figure 1.4 Resolution of the chromatographic separation of two components
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Column efficiency
Column efficiency is described in terms of a plate number, originating from
QO
distillation theory and first applied to chromatography by Martin and Synge . At each 
plate, equilibrium of the solute between the stationary and mobile phase is assumed to 
take place. The efficiency of a chromatographic system improves as the number of 
equilibrations increases, that is, the number of theoretical plates increases. The plate 
number, N, of a chromatographic system is given by:
N = 16 (tR / Wb )2 (1.2.5)
Where tR is the retention time of peak and the Wb is the baseline peak width.
The efficiency of a column is, however, usually determined as the height 
equivalent to a theoretical plate (HETP), defined as the number of theoretical plates per 
unit length of column (L):
HETP = L /N ( 1.2.6 )
1.2.1.2 High performance liquid chromatography
Classical liquid chromatography (LC) employed wide bore glass tubes (10-
50mm) ranging from 50-500 mm in length containing large diameter (150-200 pm)
particles of stationary phase. However, column efficiencies using these systems were
poor but they are still used considerably for preparative purpose, this context technique
has since been superseded. Early in the history of LC, it was realized that large increases
in column efficiency could be achieved by decreasing particle-packing sizes. In the late
1960s, a number of workers effectively produced the technology to create and utilize
small particle diameters of 10 pm with impressive speed and resolution 103. The term high
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performance liquid chromatography (HPLC) has since been coined to differentiate the 
newer procedures incorporating small diameter packing in stainless steel tubes, 
necessitating sophisticated instrumentation, from the classical techniques.
1.2.1.2.1 HPLC instrument
An HPLC instrument has at least the elements which are shown in Figure 1.5: 
solvent reservoir, transfer line with frit, high-pressure pump, sample injection device, 
column, detector and data recorder, usually together with data evaluation. For 
temperature-controlled separations, a thermostat is enclosed around the column, and it is 
also quite common to work with more than one solvent, thus a mixer and controller are 
needed. If data acquisition is done by a computer, it can also be used for the control of the 
whole system.
Figure 1.5 Schematic diagram of an HPLC system
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Mobile phase
The mobile phase is chosen for its chromatographic properties: it interacts with a 
suitable stationary phase to separate a mixture as fast and as efficiently as possible. 
Generally, a range of solvents is potentially able to solve any particular problem based on 
different criteria, such as viscosity, boiling point, purity and detector character.
For separation of a complex mixture, several solvents are normally used. In this 
case, solvent miscibility must be considered. It is always best to use solvents which are 
fully miscible with each other; acetone, glacial acetic acid, absolute ethanol, isopropanol 
and tetrahydrofuran are normally miscible with almost all other solvents. The usual 
eluents for reversed phase chromatography (RPC) are mixtures of an aqueous buffer or 
water, as the weaker component, and an organic solvent, either methanol, acetonitrile or 
tetrahydrofuran (THF) as the stronger component. Buffered solutions are usually used if 
the analyte can ionize and pH control is required.
Stationary phases and columns
Several different materials are usually used to synthesize stationary phases for 
different purpose, including silica, chemically modified silica, styrene-divinylbenzene, 
alumina and porous graphitic carbon.
Silica is an adsorbent with outstanding properties. It consists of silicon atoms 
bridged three-dimensionally by oxygen atoms and the lattice is saturated at the surface 
with OH groups, the so-called silanol groups. All these functional groups at the surface
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could act as adsorptive centers, and the different properties of these functional groups 
could be used for the separation of different compounds.
The silanol groups on the surface of silica usually are chemically modified to give 
stationary phases with specific properties. The silanol group can be derivatised with an 
alcohol, ROH, where R may be an alkyl or an other functional group. Octadecylsilane 
(ODS), in which R = -(CH2 )i?CH3 , is the most widely used in this way. It is extremely 
non-polar and is the preferred choice for use in reversed-phase chromatography.
Cross-linked polystyrene is a versatile stationary phase resulting from 
copolymerization of styrene and divinylbenzene. Styrene-divinylbenzene can be used as a 
reversed-phase material in combination with aqueous mobile phase, and is stable in the 
pH range 1 to 13, as opposed to pH 2 to 8 for bonded silicas. The excellent pH resistance 
allows a good deal of scope for selecting the best eluent composition, this being a distinct 
advantage over stationary phases derived from silica.
Most HPLC columns are made of 316-grade stainless steel, which is austenitic 
chromium-nickel-molybdenum steel, resistant to the usual HPLC pressure and also 
relative inert to chemical corrosion. The inside of the column should have no rough 
surfaces, grooves or microporous structures, so the steel tubes must be either precision 
drilled or polished or electropolished after common manufacturing.
Columns of i.d. 2-5 mm are generally used for analytical purposes. Wider columns 
of i.d. between 10 mm and 25.4 mm may be used for preparative work. Columns 5, 10, 
15 or 25 cm long are common if microparticulate stationary phases of 10 pm or less are 
used. If higher plate numbers are needed it is usually better to use a packing with smaller 
particles than to lengthen the column. A longer column increases the retention volume, 
thus decreasing the concentration of the peak in the eluate and impairing the detection 
limit.
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Detectors
Several detectors can be coupled to HPLC, e.g. ultraviolet (UV) detectors, 
refractive index detectors, fluorescence detectors, electrochemical detectors as well as the 
very powerful mass spectrometer.
UV is the most commonly used type of detector as it can be rather sensitive, has a 
wide linear range, is relatively unaffected by temperature fluctuations and is also suitable 
for gradient elution. The principal of a UV detector is shown in Figure 1.6 Light travels 
in a longitudinal direction through the cells, and the same lamp transmits light through 
the measurement and reference cells. Two photodiodes measure the light intensity in both 
cells; the electronic system compares these signals and fluctuations in illumination 
intensity are balanced accordingly. Low-pressure mercury vapor lamps or cadmium, zinc, 
deuterium and tungsten lamps are suitable light sources.
Figure 1.6 Principle of UV detector used in HPLC
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1.2.2 Introduction of mass spectrometry
The history of mass spectrometry can be traced back to 1897, when Nobel Prize
winner J.J. Thompson 104 measured the ratio of charge-to-mass of the electron using
magnetic and electric deflection. He later constructed the first mass spectrometer (then
called a parabola spectrograph) and obtained mass spectra of O2 , N2 , CO, CO2 and
COCI2 . He also observed negative and multiple charged ions and discovered the isotopes
20 and 22 of neon 105. After that, Dempster 106 developed the electron ionization source
and the first spectrometer with a sector shaped magnet (180°) and direction focusing. A
year later, Aston 107 developed the first mass spectrometer with velocity focusing and
won Nobel Prize in 1922. Since then, mass spectrometry has undergone tremendous
improvements. In 1948, Cameron and Eggers 108 published a design for a linear time-of-
flight (TOF) mass spectrometer after the concept of this analyzer first proposed by
Stephens l09. In 1950’s, the quadrupole analyzer and the ion trap or quistor was described
in a patent by Paul and Steinwedel no, and then the quadrupole mass spectrometer was
developed by Paul and other cooperators Ul. At the same period, the first spectrometer
coupled with a gas chromatograph was developed by McLafferty et a l 112. In the 1970’s,
the most important advances in mass spectrometry were the discovery of atmospheric
pressure chemical ionization (APCI) by Homing et al 113 and the coupling of HPLC to
MS by Arpino et a l 114. Many other important techniques have been invented in recently
years, which include the fast atom bombardment (FAB) source115, thermospray (TI) 116,
matrix-assisted laser desorption ionization (MALDI) 117, electrospray (ESI) 118'120} and
121nanoelectrospray source .
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1.2.2.1 Diagram of a mass spectrometer
A mass spectrometer always contains the five components as shown in Figure 1.7, 
namely (i) an inlet device to introduce the compound that is analyzed, e.g. a gas or liquid 
chromatograph or a direct syringe pump, (ii) a source to produce ions from the sample, 
(iii) one or several analyzers to separate the various ions according to their mass-to- 
charge ratios, (iv) a detector to count ions emerging from the last analyzer and to measure 
their abundance, (v) a computer to process the data, which produces the mass spectrum in 
a suitable form and controls the instrument feedback.
Figure 1.7 Schematic diagram o f  a mass spectrometer
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1.2.2.2 Ion sources
In the ion source, the analyzed samples are ionized for analysis in the mass 
spectrometer. A variety o f ionization techniques are used for mass spectrometry such as:
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electron ionization (El) and chemical ionization (Cl) for gas-phase ionizations; 
electrospray, thermospray and APCI for liquid-phase ion sources; MALDI, secondary ion 
mass spectrometry, field desorption and plasma desorption for solid-phase ion sources. 
The ion sources produce ions mainly by ionizing a neutral molecule through electron 
ejection, electron capture, protonation, deprotonation, adduct formation or transfer of a 
charged species from a condensed phase to the gas phase. Ion production often implies 
gas-phase ion-molecule reactions. A brief description of the most commonly used ESI 
and APCI sources is given below.
Electrospray
Electrospray ionization (ESI) is a soft ionization method that proceeds at 
atmospheric pressure and then transfers the ions into the mass spectrometer. ESI is the 
most unique interface in LC/MS because the ion generation process imparts very little 
internal energy into the analyte. The energy driving the thermodynamic change-of-state is 
electrostatic potential energy from a high voltage applied between the electrospray needle 
and collector (Figure 1.8). When the analyte solution flows constantly through a capillary 
with small diameter or a needle tip to which is applied a high voltage (3~5 kV), ions in 
solution migrate from the bulk to the surface of the liquid under the influence of the high 
field strength near the tip of the needle. Counter-ions are depleted from the surface of the 
liquid leaving a net charge. The characteristic “ Taylor cone” is the result of the liquid 
accelerating toward the collection electrode. When the electrostatic forces exceed the 
inward forces from the surface tension a cone-jet is created. The highly charged surface 
of the liquid jet immediately disrupts into droplets toward the collector electrode.
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Figure 1.8 Taylor cone formed at the capillary tip in ESI
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Figure 1.9 The mechanism of the formations of ions in ESI; (a) representation of the 
process of the shrinkage of the charged droplets; (b) representation of the process of the
generation of gas phase ions.
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At a sufficiently high electric field, liquid filament is emitted from the Taylor 
cone tip. At some distance downstream, the liquid filament becomes unstable and forms 
separate charged droplets 122. While in flight, the charged droplets release organic 
solvents and modifiers and are reduced in size. This reduction in the volume of the 
droplets results in the generation of excess charged droplets. As the coulombic forces 
prevail over the surface-tension forces, the droplets are broken into smaller droplets 
(Figure 1.9 (a)). The charged droplets become progressively smaller by a serial repetition 
of this process, and finally the charge is transferred to analyte molecules in the gas-phase 
(Figure 1.9 (b))123.
Unlike most ionization processes in mass spectrometry which occur in the gas 
phase, ESI involves the transfer of ions present in a liquid phase into the gas phase. If a 
species exists in solution with more than one ionizable site, then ESI will also produce 
more than one charge in the gas phase. In this way we can observe multiple-charged 
species in the mass spectrum. This effectively folds the mass spectrum of a high 
molecular weight species into the mass range of a typical mass analyzer.
Atmospheric pressure chemical ionization
APCI is an ionization technique analogous to chemical ionization (Cl) that uses 
gas-phase ion-molecule reactions at atmospheric pressure, and in which primary ions are 
produced by corona discharges on a solvent spray. The principle governing APCI is 
shown in Figure 1.10.
The analyte in solution from a direct inlet probe or a liquid chromatography 
eluting at a flow rate of between 0.2 and 2 ml/min is introduced directly into a pneumatic
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nebulizer where it is converted into a thin fog by a high-speed nitrogen beam. Droplets 
then are displaced by the gas flow through a heated quartz tube called a 
desolvation/vaporizer chamber. The heat transferred to the spray droplets allows 
vaporization o f the mobile phase and o f the sample in the gas flow. The temperature o f 
chamber is controlled, which makes the vaporization conditions independent o f the flow 
and the nature o f the mobile phase. The hot gas and the compounds leave this tube. After 
desolvation, they are carried to a corona discharge electrode where ionization occurs. In 
the positive ion mode, either proton transfer or adduction o f reactant gas ion can occur to 
produce ions o f the molecular species, depending on the relative proton affinities o f the 
reactant ions and the gaseous analyte molecules. In the negative mode, the ions o f the 
molecular species are produced either by proton abstraction or adduct formation.
Figure 1.10 Principle o f APCI
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Generally, the evaporated mobile phase acts as the ionizing gas and reactant ions 
are produced from the effect of a corona discharge on the nebulized solvent. Typically, 
the corona discharge forms primary ions such as N2 *+ or (V + by electron ionization. 
These ions then collide with vaporized solvent molecules to form secondary reactant gas 
ions. Because the ionization of the substrate occurs at atmospheric pressure and thus with 
a high collision frequency, it is very efficient. Furthermore, the high frequency of the 
collisions serves to thermalize the reactant species. In the same way, the rapid 
desolvation and vaporization of the droplets reduces considerably the thermal 
decomposition of the analyte. The result is ionization producing predominantly ions of 
molecular species with few fragmentations.
1.2.2.3 Mass analyzer
Once the ions have been produced, they need to be separated according to their 
masses, which must be determined. There are many different analyzers, such as the 
magnetic or electromagnetic analyzer, the time-of -flight mass analyzer, the quadrupole 
or ion trap, and the Fourier transform ion cyclotron resonance mass spectrometry.
The time-of-flight mass analyzer requires the ions to be produced in bundles and 
thus is especially well suited for pulsed laser sources. The ion trap, previously used as a 
gas chromatography/mass spectrometry (GC/MS) analyzer, is now also used as a high- 
performance mass spectrometer. Ion cyclotron resonance mass spectrometers using 
Fourier transform have shown impressive possibilities particularly for high resolution and 
collision-induced dissociation.
Instruments combing several analyzers in sequence, known as tandem mass
spectrometry (MS/MS), are becoming increasingly common. They allow one to obtain a
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mass spectrum resulting from the decomposition o f  an ion selected in the first analyzer. 
The tim e-dependent decomposition o f a selected ion can also be observed in cyclotron or 
ion trap instruments.
Quadrupole mass analyzer
The principle o f the quadrupole was described by Paul and Steinwegen 110 at the 
Bonn University in 1953. The quadrupole has since been developed for commercially 
available instruments by the work o f Shoulders, Finnigan and Story 124.
As the name implies, the quadrupole consists o f four precisely engineered parallel 
rods equally spaced around a central axis. Ions are introduced along the axis o f the poles. 
There are four electrodes applied onto the quadrupole, with either a circular or hyperbolic 
cross section. Opposing sets o f rods have both a direct current (dc) and an alternating 
current or a radio frequency (ac) voltage component; one set positive, one set negative as 
shown in Figure 1.11.
Figure 1.11 Schematic o f quadrupole mass analyzer
For mass analysis, a continuous beam of ions enters one end of this assembly 
from the ion source, and exits the opposite end to be detected by a high voltage detector. 
Ions are filtered on the basis of their mass-to-charge ratio. Ions below and above a certain 
m/z value will be filtered out of the beam depending on the ratio of the dc and ac voltage. 
The motion of an ion through a quadrupole analyzer is described by the following two 
equations:
d^x ' 
d 2t
d 2y
z \  2x(Vdc + Vac cosQf) _ Q 
m j  r 2
d 2t
+ 2x(Vdc+Vac cosQ/)_=  0
\mj
(1.2.7)
(1.2.8)
Where x and y represent x-axis and y-axis respectively, VdC and Vac are dc voltage and ac 
voltage, r is the distance between the inner edge of the rod and the center of the space 
between rods and Q is the frequency of the applied alternating voltage.
In practice, the highest detectable m/z ratio of quadrupole is about 4000 Th and 
the resolution hovers at around 3000 (resolving power). Thus, beyond 3000 u the isotope 
clusters are no longer clearly resolved. The resolution normally obtained is not sufficient 
to deduce the elementary analysis. Usually, quadrupole mass spectrometers are operated 
at “ unit resolution”, i.e. a resolution that is sufficient to separate two peaks one mass unit 
apart. Quadrupoles are low-resolution instruments.
Tandem mass spectrometry in quadrupoles
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Figure 1.12 shows the general diagram of an instrument with three quadrupoles. A 
collision gas can be introduced into the central quadrupole at a pressure such that an ion 
entering the quadrupole undergoes one or several collisions.
Figure 1.12 Diagram of a triple quadrupole instrument. The first and last (Q1 and Q3) are 
mass spectrometers. The center quadrupole q2 is a collision cell made up of a quadrupole
using RF only
Q1 q2 Q3
When a gas is inert, internal energy is transferred to the ion by converting a 
fraction of the kinetic energy into internal energy. The ion then fragments and the 
products are analyzed by quadrupole Q3. The collisions in these instruments occur at low 
energy. When the gas is reactive, ion-molecule reactions can be induced. The reaction 
products then are analyzed by Q3. These instruments with several analyzers in series can 
be scanned in several ways, such as product ion scan, precursor ion scan and neutral loss 
scan.
The product ion scan mode consists of selecting an ion with a chosen mass-to- 
charge ratio using the first Ql. This ion collides inside the central quadrupole and reacts 
or fragments. The reaction products are analyzer by Q3.
The precursor ion scan mode consists of focusing the Q3 on a selected ion while 
scanning the masses using Ql. All of the ions that produce the ion with the selected mass 
through reaction or fragmentation are thus detected.
34
In the neutral loss scan mode both Ql and Q3 are scanned together, but with a 
constant mass offset between the two. Thus for a mass difference a, when an ion of mass 
m goes through the Ql, detection occurs if this ion has yielded a fragment ion of mass 
(m-a) when it leaves the collision cell.
Ion trap mass analyzer
125The ion trap has been modified to a useful mass analyzer by Stafford et al of 
the Finnigan Company. Conceptually, an ion trap can be imagined as a quadrupole bent 
on itself in order to form a closed loop. The inner rod is reduced to a point at the center of 
the trap, the outer rod is the circular electrode and the top and bottom rods make up the 
caps. The principle of the ion-trap mass analyzer is introduced below.
Figure 1.13 Section of a quadruple ion trap and the potentials applied.
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Ions outlet
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The ion trap mass analyzer consists of three electrodes: two end-cap electrodes 
and one ring electrode. The end-caps are applied with a DC potential (U) and the ring 
electrode is applied with a RF potential (Vcos (cot)) as shown in Figure 1.13. If
8 zU (1.2.9)
AzV (1.2.10)
where:
m = the mass of ion detected, 
z = the charges that the ion is carrying, 
ro = internal radius of the ring electrode,
U = DC potential applied to the end-cap electrodes,
V = the amplitude of the RF potential applied to the ring electrode, 
co = angular frequency of the applied RF waveform,
the ion motion in the trap could be described by an a-q stability diagram (Figure 1.14).
Ions with different masses can be trapped at different points in the stability zone when U
and V are adjusted properly. When U and co are fixed, the RF amplitude (V) increases
gradually, some ions will move out of the stable zone and have unstable motions and get
out of the trap to the detector, through which mass-selective instability scan is achieved.
From equation (1.2.9) and (1.2.10), we can obtain an equation of
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m /  - AV
z rlco2qz
(1.2.11)
For a given ion trap instrument, there is an instability boundary that is defined by the 
value of qz (equation (1.2.10)). In a commercial Finnigan ion trap, qz = 0.908 is the point 
of instability boundary. Depending upon the amplitude of RF voltage (V) placed on the 
ring electrode, an ion of a given m/z will have a qz value that will fall within the 
boundaries of the stability diagram, and the ion will be trapped. If the qz value at the 
voltage falls outside of the boundaries of the stability diagram, the ion will move out of 
the trap.
Figure 1.14 a-q stability diagram of a quadruple ion-trap mass spectrometer.
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As the voltage (V) is increased, the qz value for the ion also increases. When V is
high enough and the qz value falls out of the stability boundary, the ion will be ejected
out of the trap. However, The amplitude of the RF cannot be increased too high due to
practical difficulties encountered when interfacing high voltages to electronic circuits.
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Ions oscillate with a frequency, known as the secular frequency, that is determined by the 
values for az and qz and by the frequency of the RF potential. An applied oscillating 
signal, an AC voltage, may be applied across the end-cap electrodes to increase ion 
kinetic energies and excite ion trajectories . If the amplitude of the signal is large 
enough, ions will be ejected from the trap rather than undergo fragmentation. This 
technique, termed resonance ejection, allows ejection to occur at voltages lower than 
those required for ejection at qz of 0.908, extending the nominal mass range of the ion 
trap.
Tandem mass spectrometry in ion trap
For the performance of tandem MS, parent ions are selected by choosing DC 
voltage (U) and the amplitude of RF voltage (V). An AC voltage is applied to match the 
secular frequency of parent ion, from which the parent ions gain kinetic energy. Since 
ion traps are operated in a helium gas bath (lmTorr), parent ions will collide with the gas 
molecules and gain internal energy, resulting in fragmentation. The fragment ions then 
can be analyzed as described above. There are several ways to perform tandem mass 
spectrometry in an ion trap. Time-dependent rather than space-dependent tandem mass 
spectrometry occurs in the trap. The general sequence of operations is as follows:
1. Select ions of given mass-to-charge ratio by expelling all the others from 
the ion trap. This can be performed either by selecting the precursor ion at the 
apex of the stability diagram or by resonant expulsion of all ions except for the 
selected precursor.
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2. Let these ions fragment. Energy is provided by collisions with the helium 
gas, which is always present. This fragmentation can be improved by excitation of 
the selected ions by irradiation at secular frequency.
3. Analysis of the ions by the scanning methods using stability or resonant 
ejection.
4. Alternatively, select a fragment in the trap and let it fragment further. This 
step can be repeated to provide M Sn spectra.
1.2.2.4 Ion Detectors
The ion beam passes through the mass analyzer and then can be detected by two 
kinds of detectors: one is like a photographic plate or Faraday cage which allows a direct 
measurement of the charges; the other is an electron or photon multiplier which increases 
the intensity of the signal.
Electron multiplier
The electron multiplier is the most commonly used detector in mass spectrometers 
because of its low cost and good linear dynamic response range. When a positive or 
negative ion reaches the conversion dynode, it causes the emission of several secondary 
particles. These secondary particles can include positive ions, negative ions, electrons and 
neutrals. When positive ions strike the negative high-voltage conversion dynode, the 
secondary particles of interest are negative ions and electrons. When negative ions strike 
the positive high-voltage conversion dynode, the secondary particles of interest are 
positive ions. These secondary particles are accelerated into the continuous-dynode
39
electron multiplier. They strike the cathode with sufficient energy to dislodge electrons as 
they collide with its curving inner walls. These electrons pass further into the electron 
multiplier, again striking the walls, causing the emission of more and more electrons as 
they travel towards the ground potential. Thus a cascade of electrons is created that 
finally results in a measurable current at the end of the electron multiplier. The 
amplifying power is the product of the conversion factor (number of secondary particles 
emitted by the conversion dynode for one incoming ion) and the multiplying factor of the 
continuous-dynode electron multiplier. It may reach 107. Their lifetime is limited to 1 or 
2 years because of surface contamination from the ions or from a relatively poor vacuum. 
The conversion factor depends on the nature (mass, charge and structure) and on the 
energy of the detected ions, so these detectors are not as precise as Faraday cylinders. 
However, their sensitivity is such that they allow rapid scanning. The principle of 
electron multiplier is shown in Figure 1.15.
Figure 1.15 Diagram of the principle of electron multiplier
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Chapter 2 
Tandem Mass Spectrometry of Free 
Androgenic Steroids
2.1 Introduction
To help identification and determination of androgen steroids in biological 
samples, the mass spectrometric (MS) properties for the free androgens shown in Figure
2.1 are described in this chapter. The effect of different solvent system on the spectra of 
these compounds using electrospray (ESI) and atmospheric pressure chemical ionization 
(APCI) were studied in details, and their collision induced dissociation (CID) spectra 
were also investigated by tandem mass spectrometry.
2.2 Experimental
2.2.1 Materials
Testosterone, epitestosterone, androstendione, adrenosterone, androsterone, 
epiandrosteone, 5a-dihydrotestosteone, 5p-dihydrotestosterone, etiocholan-3p-ol-17-one, 
eticholan-3a-ol-17-one, 5a-androstan-3p-ol-17-one, 5a-androstane-3, 17-dione, 
dehydroepiandrosteone, 5-androstane-3P, 17P-diol, androstanediol, 11-ketoandrosterone, 
11 p-hydroxyandrosterone were purchased from Sigma-Aldrich Ltd (Poole, Dorset, UK). 
The standards were dissolved in methanol, and further diluted to the concentrations 
ranging from 1-1 Ong/pl with methanol/water (1:1) for the experiments. The structures of 
the investigated androgens are present in Figure 2.1.
The HPLC grade methanol, acetonitrile and water were purchased from Fisher 
Scientific (Loughborough, Leicester, UK).
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Figure 2.1 Structures of 17 free androgenic steroids
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2.2.2 HPLC
The chromatographic system consisted of a Hewlett-Packard 1100 HPLC system 
comprised of a binary gradient pump, auto sampler, column oven, and diode-array 
detector (Hewlett-Packard, Waldbom, Germany). Sample introduction into the mass 
spectrometer with methanol/ water (1:1, v/v) was delivered by HPLC system. The flow 
rate was 200pl/min for ESI-MS, and 400pl/min for APCI-MS.
2.2.3 Mass spectrometry
2.2.3.1 ESI-MS
The ESI-MS and ESI-CID experiments were performed on a LCQ ion trap mass
spectrometer (Finnigan, Hemel Hempstead, UK) equipped with an ESI source. Standard
solutions were loop (5pi) injected into the mass spectrometer by the HPLC system.
Typical ESI-MS conditions were:
Parameter Positive-ion mode
Sheath gas flow (arbitrary units) 80
Auxiliary gas flow (arbitrary units) 20
Spray voltage 4.5 kV
Capillary temperature 250°C
Capillary voltage 20 V
Tube lens offset 10 V
2.2.3.2 APCI-MS
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The APCI-MS and APCI-CID experiments were also performed on a LCQ ion 
trap mass spectrometer using an APCI source. The APCI-MS conditions were:
Parameter
Vaporizer temperature
Sheath gas flow (arbitrary units)
Auxiliary gas flow (arbitrary units)
Discharge current
Capillary temperature
Capillary voltage
Tube lens offset
Positive-ion mode
550°C
70
20
5 pA 
175°C 
10 V 
30 V
Methanol / water (1:1) and acetonitrile / water (1:1) were used as carrier solvent.
2.3 ESI-MS o f  androgenic steroids
2.3.1 Solvent effect for the spectra of representative androgenic steroids
In order to optimize the best solvent system for determining the spectra of 
androgens by ESI-MS, standards were prepared by dilution in either methanol/water (1:1) 
or acetonitrile/water (1:1) respectively, and loop injected into the flow of 
acetonitrile/water (1:1) delivered into the mass spectrometer by the HPLC system. The 
comparison between this two dilution solvents is shown in Figure 2.2.
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Figure 2.2 Intensities of [MH]+ of androgens with different 
dilution solvents in ESI-MS
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The two figures (2.2 and 2.3) show that the intensity of the androgens is optimal 
when samples are diluted in methanol/water and also delivered to the mass spectrometer 
with a methanol/water solvent system.
2.3.2 ESI-MS spectra of androgenic steroids
Both positive and negative ionization models were evaluated for investigation of 
the androgenic steroids, but no significant ions were observed in the negative ion mode, 
and therefore only positive ion mode spectra with ESI-MS are reported in Table 2.1.
The protonated molecular ion [MH]+ was dominant in the elecrospray mass 
spectra of all of the investigated steroids with the single exception of llp - 
hydroxyandrosterone, for which the ion ([MNa]+ + H2 O) was most abundant. Relatively 
weak ions corresponding to adducts of the molecular ion with sodium were observed in 
all the spectra of the steroids. The orientation (a  or p) of 17-OH or 3-OH group 
influenced the abundance of ([MNa]+ + H2 O) rather than [MNa]+, and the abundances of 
[MNa+ H20]+ were apparently higher for the a-OH than for P-OH groups. The presence 
of a ketone or hydroxy group on the 11 position of the steroids resulted in a significant 
increase of [MNa]+ and ([MNa]+ + H2 O), and a large decrease of [MH]+ for 11P- 
hydroxyandrosterone (Table 2.1). Adducts with methanol and water were not present in 
the spectra of 4-ene-3-one steroids, 11-keto-androsterone, and llp-hydroxyandrosterone, 
but were observed for the rest of steroids investigated. The intensities of ([MH]+ +H2 O) 
and ([MH]+ +MeOH) ions seemed slightly higher for 17-OH groups than for those of 3- 
OH groups, but their orientation did not make any difference.
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There were no fragment ions for dehydration observed for the steroids with 4-ene- 
3-one in the A ring. However, for those steroids without a A4-double bound in the A ring, 
the spectra showed a peak of high relative intensity corresponding to water loss from 
their protonated molecular ions. It was suggested by Williams’ group1 and Bouchoux’s 
group2 that the protonation may probably start at the 3-one functional group for 4-ene-3- 
one steroids, due to the strong proton affinity of the conjugated double bonds in the 
structure of 4-ene-3-one steroids, and this structure makes the protonated ions very stable 
for these compounds. However, protonation may be initialed at the C-17 or the C-3 
hydroxy group for those steroids without a A4-double bond in the A ring, and their 
protonated ions easily lose of water due to the unstable structures of these compounds. 
([MH]+ -H2 O) and ([MH]+ -2 H2 O) were present at quite high intensities in the mass 
spectra of these compounds. This result is in a good agreement with the previous studies1'
2. In addition, ratios of [MH-H20]+ /[MH]+ were much lower of C-17 hydroxy steroids 
(5-17%) than those of C-3 hydroxy steroids (65-96%). Introduction of ketone or hydroxy 
group on the 11-position also decreased these ratios.
2.4 APCI-MS of androgenic steroids
2.4.1 Solvent effect of androgenic steroids for APCI-MS
The effects of the solvent system used for sample prepare from and HPLC were 
also studied for APCI-MS. As was the case in ESI-MS, methanol/water gave
56
substantially stronger signals for the androgens in APCI-M S than acetonitrile as shown 
Figure 2.4 and 2.5.
Figure 2.4 Intensities o f [MH] o f androgens with different 
dilution solvents in APCI-M S
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2.4.2 APCI-M S o f androgenic steroids
2.4.2.1 Positive ion mode
As shown in Table 2.2, the protonated ion [M+H]+ was the most intense peak for 
the androgenic steroids with 4-ene-3-one structures, e.g. 5a-dihydrotestosterone, 5(3- 
dihydrotestosterone and 5a-androstane-3, 17-dione. In contrast, the dehydration ion of 
[M+H]+ was dominant in the spectra of steroids without A4  bond in the A ring. For 
steroids with 4-ene-3-one structure, there was either absent or of very low abundance the 
ion corresponding to ([MH]+-H2 0 ) or ([MH]+ -2 H2 O), whilst, high intensity ions of 
([MH]+ -H2 O) or ([MH]+ -2 H2 O) were present in the spectra of the steroids without 4-
n
ene-3-one structure. Similar spectra were also obtained by a Japanese research group for 
11 (3-hydroxyandrostenedione (m/z 303), A4 -androstenedione (m/z 287) and 
dehydroepiandrosterone (m/z 271). There were no sodium adducts observed for the APCI 
spectra in contrast to the ESI-spectra. Some methanol adduct ions were also observed for 
these kinds of steroids. A peak corresponding to ([MH]+-H2 ) was found in all the spectra 
of the steroids. Honing’s research group6 investigated adduct formation by three groups 
of steroids using an APCI source, and they also found that the group of 4-ene-3-one 
steroids showed a very good response for the protonated molecule in the positive mode, 
but no significant signals in the negative mode; however, the group of 3-OH aliphatic A 
ring steroids did not generate any abundant ions in either mode. Steroids lacking keto- 
groups show a low tendency to the formation of protonated molecules. Our observations 
were consistent with these fundings.
As in the ESI-MS spectra, the orientation of 17-OH group (a  or (3) did not result 
in any significant difference between the spectrum of testosterone and epitestosterone. 
For those steroids without a A4-double bond in the A the ring, the spectra showed
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apparent differences between 3-OH group and 17-OH group; whereas, ([MH]+ -H2 O) 
was dominant for the former, [MH]+ was the most abundant for the latter. In addition, the 
ratio of ([MH]+-H20) / [MH]+ or ([MH]+-2H20) / [MH]+ was increased by the 16-one 
group compared to 17-one group. An increased ratio of adduct ions was observed with 
11-one or 11-OH steroids, and moreover, the 11-OH androgens showed the most 
intensive peak of ([MH]+-2H20). There was also higher ratio of ([MH]+-H20) / [MH]+ or 
([MH]+-2H20) / [MH]+ present in the spectrum of dehydroepiandrosterone, assigned to 
the presence of the A5-double bond in the B ring. There was no [MH]+ observed for the 
spectra of androstanediol and 5a-androstane-3p, 17p-diol, with ([MH]+-2H20) was most 
abundant in the spectrum of the former and ([MH]+-H20) was dominant for the latter. 
The major ions and their relative abundances were summarized in Table 2.2.
2.4.2.2 Negative ion mode
Whereas no significant ions were observed for most of androgen steroids in 
negative ion mode. Androgen steroids containing a 4-ene-3-one system and 11- 
ketoandrosterone were found to yield significant ions in negative ion mode APCI, as 
shown in Table 2.3.
The deprotonated molecular ion [M-H]' dominated in the mass spectra of the 
steroids in Table 2.3 except for adrenosterone. An ion corresponding to loss of water 
from the deprotonated molecule, ([M-H]' -H2 O), was also observed in the spectra of 
adrenosterone and 11-ketoandrosterone, and an ion corresponding to further loss of water 
was observed in the spectrum of 11-ketoandrosterone. The loss of hydrogen from the 
pseudo-molecular ions was observed in all the spectra of the above steroids and strong
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tandem loss of hydrogen were observed in the spectra of androstendione, adrenosterone 
and 11 -ketoandrosterone which has more than one keto-group on their structures
Table 2.3 APCI-MS of androgen steroids: m/z and relative abundances of major ions
(negative mode)
Androgen steroid T* ET* Androstendione Adrenosterone 11-Ketoandrosterone
[M-H]' 287(100) 287(100) 285 (100) 299 (98) 303 (100)
[M-H]--H2 285 (14) 285 (15) 283 (61) 297(100)
[M-H]' -2H2 281 (32) 295 (12)
[M-H]' -3H2 279 (9)
[M-H]' -4H2 277 (8)
[M-H]' -H20 281 ~(29) 285(13)
[M-H]' -H20-H2 279 (14) 283 (53)
[M-H]' -H20-2H2 277 (5) 281 (35)
[M-H]' -H20-3H2 275 (5) 279 (20)
[M-H]' -H20-4H2 277 (30)
[M-H]' -2H20 267 (5)
[M-H]' -2H20-H2 
[M-H]' -2H20-2H2
- - - - 265 (15) 
263 (19)
*T, testosterone; ET, epitestosterone.
2.5 Comparison of the sensitivity between ESI and APCI
The same concentration (lOpg/ml) of each steroid was injected into the ESI 
source and the APCI source respectively, and the different intensities of their extracted 
base peak were compared in Figure 2.6.
The extracted peak intensities of most steroids were more than twenty times 
higher using the APCI source than using the ESI source, except for lip -  
hydroxyandrosterone which was only two times higher using the APCI source than using 
the ESI source. The APCI source has showed the much better sensitivity than the ESI 
source for the detection of the investigated androgen steroids, due to the low polarity of 
the group compounds, and was selected for the subsequent collision induced dissociation 
(CID) studies.
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Figure 2.6 Comparison of sensitivities using the APCI and 
the ESI source
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Androgen steroid
1 .Testosterone (m/z 289), 2. Epitestosterone (m/z 289), 3. Androstenedione (m/z 287),
4. Epiandrosterone (m/z 273), 5. Dehydroepiandrosterone (m/z 271), 6. 5a-Dihydrotestosteone 
(m/z 291), 7. 5a-Androstane-3, 17-dione (m/z 289), 8. 11-Ketoandrosterone (m/z 287),
9. 11 P-Hydroxyandrosterone (m/z 271).
2.6 Collision induced dissociation (CID) of APCI-MS
2.6.1 CID o f  4-ene-3-one steroids
2.6.1.1 M S2 o f 4-ene-3-one steroids
There were two fragments ([M H]+ -H2O) and ([M H]+ -2 H 2O) observed in the high 
mass range o f the MS spectra yielded by the protonated m olecule o f all 4-ene-3one 
steroids, whilist m ajor fragment ions at m/z 97, 109, 121, 123 were characteristically 
present in the low mass ions. Draisci and his co workers 9 observed similar fragment ions 
o f m/z 97 and 109 in the spectra o f testosterone and epitestosterone using APCI-M S. 
O ther researchers 3’4 have obtained sim ilar CID spectra using ESI-MS. Curcuruto et. al 5
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observed fragment ions of m/z 97, 109 and 123 of testosterone by thermospray tandem 
mass spectrometry. The fragment ion of m/z 97 was clearly presented in all the 4-ene-3- 
one steroids except adrenosterone, which had oxygen substitution in the C-l 1 position. It 
has been proposed that this fragment was related to the A ring fission by T.M. Williams 
et. a l l, but the mechanism is still unclear.
Figure 2.7 Possible mechanism for the formation of the m/z 109 ion in the 
CID mass spectrum of testosterone by Williams et al.
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The fragment ion at m/z 109 were observed in all the spectra for this group
steroids, and it has been suggested by Zaretskii 6  and Shackleton 3 that the formation of
this fragment was due to the fission of the C9-C10 and C5-C6 bonds. However, Williams 
1 1 ^and his co-workers examined the C- and deuterium-labeled testosterone analogs, and
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they suggested that the formation of the m/z 109 was related the cleavages of Cl-CIO, 
C7-C8 and C5-C10 bonds. They also proposed a possible mechanism for formation of 
m/z 109 (Figure 2.7). Our studies were consistent with Williams’ proposal, because a 
keto-group at the C -ll position would inhibit the reactions of structure c to structure d 
and d’, so there would be much reduction of m/z 109 ion expected for adrenosterone., as 
observed in the CID spectrum of adrenosterone in the present sudy.
1 3  5It has been proposed by previous investigators ’ ’ that the ion at m/z 123 was generated 
by the cleavage of the C6-C7 and C9-C10 bonds. Our studies however showed no 
significant peak at m/z 123 in the spectra of epitestosterone and adrenosterone, but these 
CID spectra did contain a significant peak at m/z 121. It seemed that the formation of this 
ion was somehow related to substitution at C -ll and C-17, but further study is still 
needed to investigate its mechanism. The MS spectra of 4-ene-3-one steroids are shown 
in Figure 2.8.1-4.
Figure 2.8.1 MS2 of testosterone from parent ion of m/z 289; collision energy 23%
23% steroid 1 10ug #22-30 RT: 0.77-0.88 AV: 9 SB: 34 0.06-0.63,1.22-1.96 NL: 2.91E5
T: + c Full ms2 289.00@23.00 [ 75.00-290.00)
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Figure 2.8.2 MS2 of epitestosterone from parent ion of m/z 289; collision energy 23%
23% steroidl2 10ug_011108130031 #22-30 RT: 0.75-0.85 AV: 9 SB: 36 0.03-0.55,1.13-1.99 NL:5.50E5
T: + c Full ms2 289.00@23.00 [ 75.00-290.00]
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Figure 2.8.3 MS2 of androstendione from parent ion of m/z 287; collision energy 25%
2 5 % 4 - d i o n e 1 u g _ 0 1 0 3 2 7 1 5 0 9 3 2 # 9 - 1 1 RT: 0 . 1 8 - 0 . 2 2  AV: 3 SB:  6 3  0 . 0 1 - 0 . 1 6 ,  0 . 3 3 - 1 . 4 8  NL: 9 . 4 0 E 4  
T: + c Full m s 2 2 8 7 . 5 0 @ 2 5 . 0 0  [ 7 5 . 0 0 - 3 5 0 . 0 0 ]
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Figure 2.8.4 MS of adrenosterone from parent ion of m/z 301; collision energy 25%
25%MS2steroid30 10ug#166-177 RT: 3.45-3.68 AV: 12 SB: 207 0.36-3.41, 4 .00-5.23 NL: 2.69E5 
T: + c Full m s2  3 0 1 .50@25.00 [80.00-302.00]
1 0 0 - 1
9 0 - 283.1
80-
7 0 -
60-
<  5 0 -
40-
30- 255.1
225.22 0 -
243.2175.1121.1 2 2 3 2
1 0 -
187.1 219,1163.1 282,491.2 109.2 301.3
280 300260140 160 180 200 220 2401 0 0 120
m/z
2 .6 .1.2 MS3 of 4-ene-3-one steroids
Ions of m/z 253, 251 and 265 corresponding to further loss of water from their 
precursor ions ([MH]+ -H2 O) derived from 4-ene-3one steroids, were observed in the 
MS3 spectrum of any of these compounds but no ions of m/z 97 and 109 were present. 
There was an abundant ion of m/z 105 present in the MS3 spectrum of testosterone, but 
not in the spectrum of epitestosterone. This apparent difference may be useful for the 
distinguishing the two isomers, compared to the strong similarity of their MS spectra. 
The MS3 spectra of 4-ene-3one steroids were shown in Figure 2.9.1-4.
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Figure 2.9.1 MS3 o f testosterone from ion of m/z 289-271; collision energy 23%-30%
[MH]+ (m/z 289) -> ([MH]+ - H20 )  (m/z 271)
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Figure 2.9.2 MS3 of epitestosterone from ion of m/z 289-271; collision energy 23%-30% 
[MH]+ (m/z 289) -> ([MH]+ - H2 0) (m/z 271)
23% 30% s t ero i d  1 2 1 0 u g # 1 9 - 3 0  RT: 0 . 7 5 - 0 . 9 4  AV: 1 2 SB :  3 3  0 . 0 9 - 0 . 6 0 ,  1.1 8 - 1 . 9 9  NL: 7 . 0 0 E 3  
T: + c Full m s 3  2 8 9 . 0 0 @ 2 3 . 0 0  2 7 1 . 0 0 @ 3 0 . 0 0  [ 7 0 . 0 0 - 2 9 0 . 0 0 ]
25 3 . 1
9 0 -
8 0 -
7 0 -
8
c3
s 5 0 -
.5 =
i  4 0 -  Q£ 2 1 3 . 3
3 0 -
1 9 7 . 2
2 0 - 171 . 1
1X5. 0
1 8 5 . 1
163,3 20 . 1.1
1 35 . 21 0 - 2 2 5 . 0  2 4 3 . 21 2 ].Q 3 0 9 5 . 3
| |  107 . 1 1 4 5 . 2
160 260 2 8 080 100 120 140 1 8 0 20 0 22 0 240
m Iz
67
Figure 2.9.3 MS3 of androstendione from ion of m/z 287-269; collision energy 25%-30%
[MH]+ (m/z 287) ([MH]+ - H20 )  (m/z 269)
3 0 % 4 - d i o n e 1 u g _ # 1 4 - 1 5  RT: 0 . 3 4 - 0 . 3 7  AV: 2 SB:  5 4  0 . 0 2 - 0 . 2 9 ,  0 . 4 9 - 1 . 4 9  N L : 5 . 6 6 E 3  
T: + c Full m s 3 2 8 7 . 5 0 @ 2 5 . 0 0  2 6 9 . 5 0 @ 3 0 . 0 0  [ 7 0 . 0 0 - 3 5 0 . 0 0 ]
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Figure 2.9.4 MS3 of androstendione from ion of m/z 301-283; collision energy 25%-30% 
[MH]+ (m/z 301) -> ([MH]+ - H20 ) (m/z 283)
2 5 % -3 0 % s te ro id 3 0 # 1 7 -3 0 RT: 0 . 3 8 - 0 . 5 7  AV: 1 4 SB:  1 3 0 . 0 5 -0 . 3 4  N L : 2 . 2 1 E 6  
T: + c Full m s 3 3 0 1 . 5  0 @ 2 5 . 0  0 2 8 3 . 5  0 @ 3 0 . 0  0 [ 7 5 . 0  0-3  0 2 . 0  0]
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2.6.2 CID spectra of 5a-dihydrotestosterone and its isomers
2.6.2.1 CID spectra of 5a-dihydrotesterone and its isomers from parent ion of m/z 291
The CID spectrum from the ion of m/z 291 in the APCI-MS was only available 
for 5a-dihydrotestosterone due to the poor sensitivity for its other isomers. Two fragment 
ions, m/z 273 and 255 were dominant in the CID spectrum, corresponding to consecutive 
loss of water from [MH]+. Relative to their abundance in the CID spectra of 4-ene-3-one 
steroids, there were significant reductions in the intensity of the ions at m/z 97, 109 and 
123, so it appears that the presence of A4-double bond at the A-ring of the steroid is very 
important to generate these fragments. The MS2 spectrum of 5a-dihydrotestosterone from 
parent ion of m/z 291 was shown in Figure 2.10.
Figure 2.10 MS2 of 5a-dihydrotestosterone from parent ion of m/z 291; collision energy 
30%
3 0 % s t e r o i d 5  1 0 u g # 2 4 - 2 7  RT:  0 . 9 4 - 1 . 0 6  AV: 4 S B : 3 8 0.0 4-0 .8 5 . 1 .3 5-2 .0 0 N L : 1 . 2 5 E 4
T: + c F u II m s 2 2 9 1 . 0  0 @ 3 0 . 0  0 [ 8 0 . 0  0-2 92 . 0  0]
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2.6.2.2 CID spectra of 5a-dihydrotesterone and its isomers from fragment ion of m/z 273
A fragment ion at m/z 255 was dominant in the CID spectra of 5a- 
dihydrotestosterone and its isomers generated from parent ion of m/z 273 in the APCI- 
MS. Fragment ions at m/z 97, 109 and 123 ions were present in a very low relative 
abundance for 5a- and 50- dihydrotestosterone, but no fragment ions of m/z 97 and 109 
were observed for the other isomers. The MS2 spectrum of 5a-dihydrotestosterone from 
ion of m/z 273 was present in Figure 2.11, and the spectra of its other isomers were 
present in Appendix 1-5.
Figure 2.11: MS2 of 5a-dihydrotestosterone from fragment ion of m/z 273; collision 
energy 28%
2 8% s t e r o l d 5  1 0 u g # 1 4 - 2 1  RT: 0 . 5 5 - 0 . 8 3  AV: 8 SB:  3 8  0 . 0 1 - 0 . 4 6 ,  0 . 9 5 - 1 . 9 8  NL: 5 . 7 2 E 3  
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2.6.2.3 CID spectra of dihydrotesterone and its isomers from fragment ion of m/z 255
There were very similar CID spectra from m/z 255 for 5a-dihydrotestosterone 
and its isomers, and no m/z 97, 109 and 123 ions could be detected for these compounds. 
The MS spectrum of 5a-Dihydrotestosterone from ion of m/z 255 was shown in Figure 
2.12 and the spectra of its other isomers were present in Appendix 6-10.
Figure 2.12: MS2 of 5a-dihydrotestosterone from fragment ion of m/z 255; collision 
energy 30%
3 0 %  s t e r o i d 5  1 0 u g _ 0 1  1 1 071  81 3 4 8 # 1  8 - 2 2  RT:  0 . 7 3 - 0 . 8 9  AV: 5 S B :  13  0 . 1 2 - 0 . 6 1  N L : 4 . 2 6 E 4
T: + c Fu II m s 2 2 5 5 . 0  0 @ 3 0 . 0  0 [ 7 0 . 0  0-2  5 6 . 0  0]
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2.6.3 CID spectra for the other steroids
2.6.3.1 MS2 of 5a-androstan-3P-ol-16-one
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In a similar manner to the 17-one steroid, no MS spectrum could be obtained 
from the parent ion of m/z 291 for 5a-androstan-3p-ol-16-one, but CID spectra from m/z 
273 and 255 were observed. The spectra generated from m/z 255 for the 17-one and 16- 
one steroid were very similar. However, there was apparent fragment ion of m/z 109 that 
were absent from the spectra for 17-one steroids observed in the spectra of the 16-one 
steroids from the parent ion at m/z 273. The MS2 spectra from ion of m/z 273 and 255 
were shown in Figure 2.13.1-2.
Figure 2.13.1 MS2 of 5a-androstan-3P-ol-16-one from ion of m/z 273; collision energy
30%
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Figure 2.13.2 MS2 of 5a-androstan-3P-ol-16-one from ion of m/z 255; collision energy
30%
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2.6.3.2 MS2 of dehydroepiandrosterone
Fragment ions at m/z 97, 109 and 123 were observed in the low mass range of the 
spectrum for dehydroepiandrosterone generated from the parent ion at m/z 289, but no 
such ions were observed in the CID spectrum from the parent ion at m/z 271. In addition, 
the fragment ion at m/z 97 was quite abundant in the spectrum. Compared with the 
fragmentation pattern proposal to account for the CID spectra of 4-ene-3-one steroids and 
dihydrotestosterone, the mechanism to generate the fragment ion at m/z 97 may be the 
result of the fission at both A-ring and B-ring. For the spectrum from the ion at m/z 253, 
the fragment at m/z 197 was the most abundant ion presented, corresponding to loss of 
the fragment of butene (C4 H8). The MS spectra of dehydroepiandrosterone from ion of 
m/z 289,271 and 253 were present in Figure 2.14.1-3.
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Figure 2.14.1 MS2 of dehydroepiandrosterone from parent ion of m/z 289; collision 
energy 25%
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Figure 2.14.2 MS of dehydroepiandrosterone from ion of m/z 271; collision energy 30%
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Figure 2.14.3 MS of dehydroepiandrosterone from ion of m/z 253; collision energy 32%
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2.6.3.3 MS2 spectra of 11-ketoandrosterone
The m/z 287, 269 and 251 ions were presented the spectrum of 11- 
ketoandrosterone from parent ion of m/z 305, and were assigned to loss of water 
involving the oxygen atoms at the position of C3, C ll and C l7. Compared to 
adrenosterone, loss the keto-group at the position of Cl 1 appeared to occur more readily. 
A fragment of m/z 247 was also present, corresponding to further loss of hydrogen. There 
were no fragment ions observed at m/z 97, 109 and 123 in this spectrum. The spectrum of 
11-ketoandrosterone from ion of m/z 305 was shown in Figure 2.15, and other spectra 
from ion of m/z 287 and 269 are shown in Appendix 11-12.
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Figure 2.15 MS2 of 11-ketoandrosterone from parent ion of m/z 305; collision energy
25%
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2.6.3.4 MS spectrum of 11 p-hydroxyandrosterone
There was no protonated molecular ion of m/z 307 observed in the MS spectrum 
for 11 P-hydroxyandrosterone. Consequently dehydration ions of m/z 271 and 253 were 
observed in the spectrum from the parent ion at m/z 289. The MS spectrum of l lp -  
hydroxyandrosterone from ion of m/z 289 was shown in Figure 2.16, and other spectra 
from ion of m/z 271 and 253 were present in Appendix 13-14.
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Figure 2.16 MS2 of 11 p-hydroxyandrosterone from ion of m/z 289; collision energy 30%
30% ste ro id29  10ug_01 1 108180630#20-25  RT: 0 .80-1.00 AV: 6 SB: 1 3 0.1 0-0.59 NL: 9.52E3 
T: + c Full m s2  289.00@ 30.00  [75.00-290.00]
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2.6.3.5 MS2 of 5a-Androstan-3, 17-dione
There were no ions of m/z 97, 109 or 123 observed in the CUD spectrum of 5a- 
androstane-3, 17-dione, in contrast to its biological precursor androstendione, again 
demonstrating the importance of the A4 -double bond for the formation of these ions. The 
MS2 spectrum of 5a-androstan-3, 17-dione from ion of m/z 289 was shown in Figure 
2.17, and other spectra from ion of m/z 271 and 253 were present in Appendix 15-16.
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Figure 2.17 MS2 of 5a-Androstan-3, 17-dione from ion of m/z 289; collision energy 25%
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2.6.3.6 MS2 of two diol-steroids
No CID spectra are obtained from the protonated parent ions of m/z 293 for 
androstanediol and of m/z 291 for As-androstene-3p, 17p-diol, but there were CID 
spectra from ion of m/z 257 for androstanediol, ion of m/z 273 and 255 for A5 - 
androstene-3p, 17P-diol present in Appendix 17-19.
2.7 Conclusions
Androgenic steroids were ionized with both ESI and APCI source, and two
solvent systems (methanol/water and acetonitrile/water) were also studied for the effects
of the two ionization methods. Solvent system of methanol/water proved better than
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acetonitrile/water as a dilution and injection solvent for the ionization efficiency of both 
sources, therefore, methanol/water was adopted as the solvent system in the development 
of LC-MS on-line analysis.
Androgenic steroids were studied in both positive and negative mode, and 
significant spectra were obtained in positive mode for both ESI and APCI source. 
However, no significant ions were obtained in the negative mode using the ESI source, 
and only spectra of 11-ketoandrosterone and 4-ene-3-one steroids were obtained in 
negative mode using the APCI source. In positive mode, similar ions of [MH]+, ([MH-]+- 
H2 O) and ([MH]+-2 H2 0 ) were present in quite high abundances; ([MH]+-H2 ) and ([MH]+ 
+MeOH) were present in relative low abundances in the spectra of both ESI-MS and 
APCI-MS. However, sodium adduct ions [M+Na]+ were observed in only ESI-MS 
spectra. In negative mode of APCI-MS, very abundant deprotonated molecular ion of [M- 
H]’ was observed in the spectra of 11-ketoandrosterone and 4-ene-3-one steroids, and 
also ion of ([M-H]'-H2 ) or ([M-H]'-H2 0 ) was presented in low abundances.
The collision induced dissociation of androgenic steroids was performed using 
positive APCI-MS, because the APCI source showed much better sensitivities and less 
chemical noise than using the ESI source. The CID spectra showed product ions formed 
by loss of water for all the investigated androgenic steroids, and structural specific ions of 
m/z 97, 109, 121 and 123 were characteristic for the 4-ene-3-one steroids and DHEA, but 
there were either much reduced in relative abundance or absent these ions in the CID 
spectra of the other steroids.
As a conclusion, positive CID of precursor ions generated by APCI provides good 
sensitivities and abundant diagnostic product ions and is therefore the preferred choice of
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identification of androgenic steroids, as well as the possible efficient screening method 
the future analysis in LC-MS.
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Chapter 3
Tandem Mass Spectrometry of Androgenic 
Steroid Conjugates
3.1 Introduction
Conjugated androgenic steroids mainly as glucuronides or sulfates are phase II 
metabolites of androgens \  Usually these conjugates are hydrolyzed, yielding the free 
androgens which are derivatized and then identified by means of gas chromatography / 
mass spectrometry (GC/MS) . The improvements in interfacing liquid chromatography 
(LC) with mass spectrometry (MS) allow the direct detection of these compounds without 
hydrolysis 3’4. To help to identify and determine the steroid conjugates shown in Figure
3.1 by LC/MS, a series of studies of electrospray ionization (ESI), atmospheric pressure 
chemical ionization (APCI) together with tandem mass spectrometry of these compounds 
were described in this chapter.
3.2 Experimental
3.2.1 Materials
Testosterone glucuronide, testosterone sulfate sodium salt and androstanediol 
glucuronide sodium salt were purchased from Steraloids (USA). All the other steroid 
conjugates presented in Figure 3.1 were from Sigma-Aldrich Ltd (Poole, Dorset, UK). 
The standards were dissolved in methanol, and further diluted to concentrations ranging 
from l - 1 0 ng/pl with methanol/water ( 1 :1 ) for the experiments.
HPLC grade methanol, acetonitrile and water were purchased from Fisher 
Scientific (Loughborough, Leicester, UK).
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Figure 3.1 Structures of the ten androgenic steroid conjugates included in
the current study
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3.2.2 HPLC and mass spectrometry
The HPLC instrument and conditions were the same as those described in Chapter
2 .
The same LCQ ion trap mass spectrometer (Finnigan, Hemel Hempstead, UK) 
was used for the experiments of steroid conjugates; the conditions for ESI-MS and APCI- 
MS were summarized as follow:
ESI-MS
Parameter
Sheath gas flow (arbitrary units) 
Auxiliary gas flow (arbitrary units) 
Spray voltage 
Capillary temperature 
Capillary voltage 
Tube lens offset
Positive-ion mode
80 
2 0  
4.5 kV 
220 °C 
+20 V 
+5 V
Negative-ion mode
70 
2 0  
4.5kV 
220 °C 
-45 V 
-40 V
APCI-MS
Parameter
Vaporizer temperature
Sheath gas flow (arbitrary units)
Auxiliary gas flow (arbitrary units)
Discharge current
Capillary temperature
Capillary voltage
Tube lens offset
Positive-ion mode
500°C
70
2 0
5 pA 
175°C 
+12 V 
+30 V
Negative-ion mode
500°C
70
2 0
5 pA 
175°C 
-30 V 
-50 V
3.3 ESI-MS of androgenic steroid conjugates
3.3.1 ESI-MS of androgenic steroid conjugates in positive mode
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The solvent system was also studied for conjugated steroids. Unlike free steroids, 
there was little difference in the peak intensity whether the sample was diluted in 
methanol/water ( 1 :1 ) or acetonitrile /water ( 1 :1 ), however, the mass spectra of conjugated 
steroids were very different when they were eluted with these two different solvent 
systems (Table 3.1 and 3.2). M is corresponding to the molecular weight of each 
compound.
3.3.1.1 ESI-MS of androgenic steroid conjugates eluted with acetonitrile/water
Peaks corresponding to the sodium ion adduct of the conjugated dimer [2M+Na]+ 
were dominant for steroid glucuronides in the spectra of positive ESI/MS, and also 
consecutive sodium adducts of M, 2M or 3M were presented in the spectra of these 
compounds (Table 3.1). Only testosterone glucuronide was observed to yield a 
protonated molecule, whilst 5P-androstane-ll, 17-dione-3a-ol glucuronide yield a 
protonated dimer [2M+H]+ in the ESI/MS spectra. The ions of [2M+Na]+ were dominant, 
and also the ions of [3M+Na]+ and [4M+Na]+ were observed in the spectra of steroid 
sulfates.
3.3.1.2 ESI-MS of androgenic steroid conjugates eluted with methanol/water
The protonated ion [M+H]+ was dominant for testosterone glucuronide, 5p- 
Androstane-11, 17-dione-3a-ol glucuronide sodium salt and 5a-Androstan-3a, 17 P-diol 
glucuronide sodium salt (Table 3.2), whilst the sodium adduct ion [M+Na]+ was 
dominant for the other 3-O-conjugated steroid glucuronides, for which no [M+H]+ was
c  o
observed. These results were in good agreement with the earlier studies ‘ , and have been
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Table 
3.1 ESI-M
S 
of steroid 
conjugates eluted 
with 
acetonitrile/water (
1:
1) m/z and 
relative
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sulfate 
sodium 
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Table 
3.2 
ESI-M
S 
of steroid 
conjugates eluted 
with 
m
ethanol/w
ater (1:1) m/z and 
relative abundances of major ions (positive m
ode)
explained by Harrison 9 in terms of the differences in proton affinities: proton affinity of 
the 4-ene-3-one in the steroid ring structure is significantly higher than that of a hydroxy 
or carbonyl group not in conjugation with a double bond.
There were also ions containing dimers observed for steroid glucuronides. 
Fragmentation of steroid glucuronides by loss of the glucuronide moiety and further loss 
of water were observed. The ion corresponding to [2M+Na]+ was dominant for most 
steroid sulfates but for testosterone sulfate spectrum, which was dominant by the ion 
corresponding to [2M+H]+. Quite intensive peaks of [M+Na]+ and [3M+Na]+ were also 
observed for steroid sulfates, similar to steroid glucuronides; ions corresponding to 
fragmentation of steroid sulfates involving loss of the sulfate moiety or further loss of 
water were also present in the ESI/MS spectra.
3.3.1.3 Comparison of the sensitivities obtained using the two eluting solvent systems
The most abundant peak in the spectra of each steroid conjugate using 
acetonitrile/water and methanol/water as HPLC eluting solvent was compared by its 
absolute intensity of the most abundant peak in the spectrum of each compound (Figure 
3.2). When methanol/water was used, peak intensity was about 2 to 4 times higher than 
that using acetonitrile/water.
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Figure 3.2 Comparison of peak intensities of conjugated 
steroids using different eluting solvent system
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* Concentration o f each sample was 10 ng/pl.
1. Testosterone glucuronide (m/z 995, 465) 2. Testosterone sulfate (m/z 803, 781)
2. Androsterone glucuronide (m/z 977, 489) 4. Androsterone sulfate (m/z 807, 807)
5. Etiocholan-3a-ol-l 7-one glucuronide (m/z 977, 489) 6. E tiocholan-3a-ol-l7-one sulfate 
(m/z 807, 807) 7. DHEA glucuronide (m/z 995, 487) 8. DHEA sulfate (m/z 803, 803)
9. 5p*Androstane-l l,17-dione-3a-ol glucuronide (m/z 1027, 503)
10. 5a-Androstan-3a,17P-diol glucuronide (m/z 1003, 491)
3.3.2 ESI-M S o f androgenic steroid conjugates in negative mode
The effect o f the solvent system on ESI-MS was also studied in negative mode, 
but unlike positive mode, there were m uch smaller differences between the resulting 
spectra for the acetonitrile/water and m ethanol/water systems in negative mode (Table
3.3 and 3.4).
3.3.2.1 ESI-MS o f androgenic steroid conjugates eluted with acetonitrile/water
For the negative ESI-MS spectra using acetonitrile/water elution (Table 3.3), [M- 
H]' was dominant for most o f steroid glucuronides except 5p-androstane-l 1, 17-dione-
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3a-ol glucuronide sodium salt and 5a-androstan-3a, 17p-diol glucuronide sodium salt, 
which were dominanted by [M-Na]\ There was also a series of sodium adduct peaks 
formed by consecutive addition of sodium to dimers and trimers of steroid glucuronides 
in low intensities. Compared to the spectra of steroid glucuronides, the spectra of steroid 
sulfates were quite simple, as only ions of [M-Na]' and [2M-Na]‘ were observed.
3.3.2.2 ESI-MS of androgenic steroid conjugates eluted with methanol/water
Similar spectra were observed in negative ion mode for the steroid conjugates 
eluted with methanol/water. The deprotonated molecule of [M-H]' was the base peak for 
testosterone glucuronide, androsterone glucuronide and etiocholan-3a-ol-l 7-one 
glucuronide; whereas, the de-sodiated ion [M-Na]', was dominant for the 5p-androstane- 
11, 17-dione-3a-ol glucuronide sodium salt, 5a-androstan-3a, 17P-diol glucuronide 
sodium salt and the steroid conjugate sulfates. It seemed that the methanol/water solvent 
system inhibits the formation of the dimers or trimers, because only relative low 
abundance ions corresponding to [2M-Na]' or [2M-2H+Na]' were observed in their 
spectra. The major ions and their abundance were present in Table 3.4.
3.3.2.3 Comparison of sensitivities obtained using the two eluting solvent system
The same base peak either [M-H]' or [M-Na]', was chosen for the comparison 
between the above solvent systems, due to the very similar spectra of the androgenic 
steroid conjugates using both solvents. Unlike positive mode, the sensitivities of these 
steroids were not greatly affected by the different solvent systems. There were however
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slightly higher intensities consequent on elution with methanol/water compared with 
acetonitrile/water for most o f steroid conjugates (Figure 3.3).
es
a.
-aa>■<->(jau-*->XW
Figure 3.3 Comparison of the peak intensities of androgenic 
streroid conjugates using different eluted solvents
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n  r i l l  1
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Andrgenic steroid conjugate
10
* Concentration o f each sample was lOng/pl.
1 .Testosterone glucuronide (m/z 463) 2. Testosterone sulfate (m/z 367) 3.Androsterone glucuronide 
(m/z 465) 4. Androsterone sulfate (m/z 369) 5. E tiocholan-3a-ol-l 7-one glucuronide (m/z 465)
6. E tiocholan-3a-ol-l 7-one sulfate (m/z 369) 7. DHEA glucuronide (m/z 463)
8. DHEA sulfate (m/z 367) 9. 5(3-Androstane-l 1,17-dione-3a-ol glucuronid (m/z 479)
10. 5a-Androstan-3a,17(5-diol glucuronide (m/z 467).
3.3.3 Com parison o f sensitivity betw een positive and negative mode
For the steroid sulfates, peak intensities were apparently higher in negative mode 
than in positive mode, but similar intensities in the spectra o f steroid glucuronides were 
observed in positive mode and negative mode. The spectra in negative mode were quite 
simple, and this may benefit the quantitative analysis, however, the spectra in positive 
mode gave more structural information and would benefit the compound identification.
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Figure 3.4 Comparison of peak intensities of conjugated 
steroids between positive mode and negative mode
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Concentration of each sample was lOng/pl.
1. Testosterone glucuronide (m/z 489, 463) 2. Testosterone sulfate (m/z 781, 367)
3.Androsterone glucuronide (m/z 489, 465) 4. Androsterone sulfate (m/z 807, 369) 5. 
Etiocholan-3a-ol-l 7-one glucuronide (m/z 489, 465) 6. Etiocholan-3a-ol-l 7-one sulfate 
(m/z 807, 369) 7. DHEA glucuronide (m/z 487, 463) 8. DHEA sulfate (m/z 803, 367) 9. 
5(3-Androstane-l l,17-dione-3a-ol glucuronide (m/z 503, 479) 10. 5a-Androstan-3a,17(3- 
diol glucuronide (m/z 491, 467).
3.4 APCI-MS of androgenic steroid conjugates
3.4.1 APCI-M S spectra in positive mode
3.4.1.1 APCI-M S o f androgenic steroid conjugates eluted with acetonitrile/water
Unlike ESI-MS spectra o f androgenic steroid conjugates, there was no protonated 
m olecule [MH]+ or sodium adduct [M +Na]+ observed in the APCI-M S spectra except 
testosterone glucuronide, for which the protonated m olecule [MH]+ was observed in a 
very low abundance. For steroid glucuronides, the most abundant ion either
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corresponding to ([MH]+-Glu) or ([MH]+-G1u-H2 0 ) was present in the spectra by loss of 
their glucuronide moiety or further loss of water from their protonated molecules. In the 
case of steroid sulfates, peak corresponding to ([MH-Na]+-SC>3 -H2 0 ) or ([MH-Na]+-SC>3 - 
H2 O) was dominant in the spectra. Similar to the ESI-MS spectra, there were still some 
dimerions observed in the spectra of several of the conjugates eluted with 
acetoniltrile/water. The major ions and the abundances were present in Table 3.5.
3.4.1.2 APCI-MS of androgenic steroid conjugates eluted with methanol/water
APCI-MS spectra (Table 3.6) of conjugated steroids eluted with methanol/water 
were very similar to the spectra of their free steroids. It seemed that the conjugated 
steroids readily lost their glucuronide or sulfate moieties in the APCI source under the 
conditions. The similar spectra were also observed by the research group of Kuuranne 
for testosterone glucuronide and epitestosterone glucuronide. Moreover, they observed 
the protonated ion of [MH]+ for these two compounds, but we did not observe this ion in 
our spectra. Most significant difference between the spectra of steroid glucuronides and 
steroid sulfates is that the fragmentations of steroid glucuronides corresponding to loss of 
the glucuronide moiety ([MH]+-Glu) were observed in the former spectra, but no 
fragmentations of steroid sulfates corresponding to loss of sulfate moiety ([MH]+-Sulf) 
were observed in the latter spectra.
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3.4.2 APCI-MS of androgenic steroid conjugates in negative mode
Negative mode APCI was also studied using both two solvent systems (Table 3.7 
and 3.8), and very similar spectra between each other were obtained. In the spectra eluted 
with methanol/water, ions of [M-Na]’ were dominant for steroid sulfates and 5(3- 
Androstane-11, 17-dione-3a-ol glucuronide, and ions of [M-H]' were dominant for the 
other steroid glucuronides. In contrast in the spectra of acetonitrile/water eluted 
conjugates, deprotonated molecular ions of [M-H]' or de-sodiated ions of [M-Na]' were 
dominant most of investigated steroid conjugates, and very abundant ions of [2M- 
2H+Na]* or [2M-Na]' were also observed. Compared with the two solvent systems, it was 
easier to get the multi-conjugates when the investigated steroids were injected with 
acetonitrile/water.
3.4.3 Sensitivities of androgenic steroid conjugate by APCI-MS
The polarity of the analyte increases when the free steroid is conjugated with a 
glucuronide or sulfate moiety, the sensitivity should be better by ESI-MS than by APCI- 
MS, as the ESI source is designed for more polar compounds. This was found to be the 
case in these experiments. The peak intensities in the ESI-MS spectra were more than 
thirty times higher than those in the APCI-MS spectra for steroid glucuronides in the 
negative mode, and more than a hundred times higher for steroid sulfates. The 
comparison of the sensitivities by ESI-MS and APCI-MS in negative mode is presented 
in Figure 3.5.
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Table 3.7 
APCI-M
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Figure 3.5 comparison of the extracted peak intensities
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Note: Samples (lOng/pl) were injected with acetonitrile/water. The labeled value is for APCI-MS.
1. Testosterone glucuronide (m/z 463) 2. Testosterone sulfate (m/z 367) 3. Androsterone 
glucuronide (m/z 465) 4. Androsterone sulfate (m/z 369) 5. Etiocholan-3a-ol-17-one glucuronide 
(m/z 465) 6. Etiocholan-3a-ol-17-one sulfate (m/z 369) 7. DHEA glucuronide (m/z 463) 8. 
DHEA sulfate (m/z 367) 9. 5p-Androstane-l l,17-dione-3a-ol glucuronide (m/z 479) 10. 5a- 
Androstan-3a,17p*diol glucuronide (m/z 467).
3.5 Collision induced dissociation of steroid conjugates by ESI-MS
The ESI source was chosen for collision induced dissociation (CID) studies for 
the androgenic steroid conjugates due to its good sensitivity.
3.5.1 CID o f  steroid conjugates in positive mode
The CID spectra o f the selected androgenic steroid conjugates were studied using 
both acetonitrile/water and m ethanol/water as delivered solvent for loop injection.
3.5.1.1 Injected with acetonitrile/water
Many abundant ions were studied for generation of MS spectra, such as [M- 
H+2Na]+, [M-2H+3Naf, ([M-2H+3Na]++H2 0), [2M-H+2Na]+ and [2M-2H+3Na]+. 
However, significant CID spectra were obtained only from the parent ions [M-H+2Na]+ 
and [2M-2H+3Na]+ for steroid glucuronides. No significant CID spectra were obtained 
for steroid sulfates in the positive mode.
CID spectra from parent ion of [2M-2H+3Na]+
Fragment ions of m/z 509, 531 and 549 were present in the CID spectra of 
testosterone glucuronide and DHEA glucuronide from parent ion [2M-2H+3Na]+ (m/z 
995), which corresponded to loss of [M-H+Na], M and [M-H2 O]. Fragment ions of m/z 
511, 551 and 981 were observed in the CID spectra of androsterone glucuronide and 
etiocholan-3a-ol-17-one glucuronide, corresponding to loss of [M-H+Na], [M-H2 O] and 
H2 O. Fragment ion of m/z 525 were observed in the spectrum of 5p-androstane-ll, 17- 
dione-3a-ol glucuronide, corresponding to loss of M. For the CID spectrum of 5a- 
androstan-3a, 17p-diol glucuronide, m/z 513, 553 and 985 were present in corresponding 
to loss of M, [M-H2 0 -Na+H] and H2 O. The CID spectra from ion of [2M-2H+3Na]+ 
were shown in Figure 3.6.1-4 for testosterone, androsterone, 5p-androstane-ll, 17- 
dione-3a-ol, and 5a-androstan-3a, 17P-diol glucuronide; Appendix 20-21 for DHEA 
and etiocholan-3a-ol-17-one glucuronide.
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Figure 3.6.1 CID of testosterone glucuronide from ion of m/z 995; collision energy 31%
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Figure 3.6.2 CID of androsterone glucuronide from ion of m/z 999; collision energy 31%
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Figure 3.6.3 CID of 5p-Androstane-l 1, 17-dione-3a-ol glucuronide from ion of m/z
1027; collision energy 32%
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Figure 3.6.4 CID of 5a-Androstan-3a, 17p-diol glucuronide from ion of m/z 1003; 
collision energy 32%
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CID spectra from parent ion of [M-H+2Na]+
Similar CID spectra were observed for testosterone glucuronide, DHEA 
glucuronide, androsterone glucuronide and etiocholan-3a-ol-17-one glucuronide from 
their respective parent ion [M-H+2Na]+. Fragment ions at m/z 491 or 493 corresponding 
to the loss of water from parent ion, together with fragment ions at m/z 449 or 451 were 
observed, corresponding to the loss of CH3 COOH. There was also a fragment ion at m/z 
179 observed in the low mass range of all the spectra, corresponding to the protonated 
glucuronic acid. The CID spectrum of testosterone glucuronide was shown in Figure 
3.7.1, and the spectra of DHEA, androsterone, and etiocholan-3a-ol-17-one glucuronide 
were present in Appendix 22-24.
A fragment ion at m/z 366 was most abundant in the CID spectrum of 5p- 
androstane-11, 17-dione-3a-ol glucuronide, but its origin was not clear. There were also 
fragment ions of m/z 507 and 179 observed in its spectrum. The spectrum was shown in 
Figure 3.7.2.
The most abundant fragment ion m/z 495 was present in the CID spectrum of 
5a-androstan-3a, 17p-diol glucuronide, corresponded to loss of water from the parent ion 
[M+Na]+, the fragment ion at m/z 453 was again observed, corresponding to loss of 
CH3 COOH from the parent. There was also an ion observed at m/z 354 (m/z 513-159), 
that could arise in the same way as the ion at m/z 366 formed from 5p-androstane-l 1, 17- 
dione-3a-ol glucuronide, but the mechanism is not clear. The spectrum was shown in 
Figure 3.7.3.
1
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Figure 3.7.1 CID of testosterone glucuronide from ion of m/z 509; collision energy 35%
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Figure 3.7.2. CID of 5p-androstane-ll, 17-dione-3a-ol glucuronide from ion of m/z 525; 
collision energy 35%
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Figure 3.7.3. CID of 5a-androstan-3a, 17p-diol glucuronide from ion of m/z 513;
collision energy 35%
3 5 % 51 3 s te ro id 2 5 #2  5 -4 8 RT: 0 . 5 5 - 1 . 0 6  AV: 24  SB : 1 3 0 . 06-0 .32 N L : 1 . 4 1 E 4
T: + c Full m s 2 5 1 3 . 5  0 @ 3 5 . 0  0 [ 1 4 0 . 0  0 - 5 1 4 . 0  0)
4 9 5 . 3
1 0 0 —1
90  —
8 0  —
7 0 -
£ 6 0 -
o) 4 0 —
3 5 4 . 6
4 5 3 . 33 0 -
2 0  —
1 0 — 3 9 5 . 4 4 93  A2 2 0 . 5 3 5 1 , 331 5.4 394 . 12 6 0 . 7
4 5 0 50 02 0 0 2 5 0 3 0 0 3 5 0 4 0 0
m Iz
3.5.1.2 Injected with methanol/water
The base peak of [M+Na]+ or [M+H]+ was chosen as the parent ion for 
generation of CID spectra of the steroid glucuronides using methanol/water. As the case 
in the spectra using acetonitrile/water, no significant spectra obtained for the steroid 
sulfates.
CID spectra from the parent ion [M+Na]+
The fragment ions corresponding to the sodium adduct of glucuronic acid 
([Glu+Na]*) and [Glu+Na+H2 0 ]+ derived from glucuronide moiety at m/z 199 and 217 
repectively, were presented in all the CID spectra generated from the parent ion of
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[M+Na]+. The CID spectra for testosterone, androsterone, etiocholan-3a-ol-17-one, and 
DHEA glucuronide were present in Appendix 25-28.
CID spectra from the parent ion [M+H]+
A fragment ion of m/z 289 was the base peak in this CID spectrum of 
testosterone glucuronide, corresponding to the loss of glucuronide moiety. Fragment ions 
of m/z 271 and 253 were also observed for the further loss of water. Borts and his co­
workers 10 using a methanol, NH4 OAC and glacial HO Ac buffer, also observed a 
fragment ion at m/z 289 from parent ion m/z 465 for testosterone and epitestosterone 
glucuronide. However, they also observed a fragment ion at m/z 271 from parent ion m/z 
369 for testosterone sulfate, could not be obtained under the conditions used in the 
present study. The CID spectrum of testosterone was shown in Figure 3.8.1.
Figure 3.8.1. CID of testosterone glucuronide from ion of m/z 465; collision energy 26%
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3.5.2 CID of androgenic steroid conjugates in negative mode
3.5.2.1 Androgenic steroid glucuronides
There were style peaks of [2M+Na-2H]', [2M-Na]', [M-H]' and [M-Na]' present 
in the ESI spectra of the androgenic steroid glucuronides, and the fragmentation of these 
ions were studied by the CID-MS.
CID spectra from parent ion of [2M+Na-2H]‘
There was very abundant fragment ion of [M-H]' present in all the CID spectra 
produced from the parent ion [2M+Na-2H]', and a peak at m/z 935 was also observed in 
the spectra of androsterone glucuronide and etiocholan-3a-ol-17-one glucuronide, 
corresponding to an ion formed by loss of water from the parent, but this ion was absent 
from the spectra of testosterone glucuronide and DHEA glucuronide. Whilst a fragment 
ion at m/z 601 was the base peak in the spectrum of etiocholan-3a-ol-17-one 
glucuronide, no such an ion was observed in the spectrum of its isomer androsterone 
glucuronide. The CID spectra of these compounds were present in Appendix 31-34.
CID spectra from parent ion of [2M-Na]‘
A fragment ion at m/z 501 was the base peak in the CID spectrum of 5p- 
androstane-11, 17-dione-3a-ol glucuronide sodium salt, corresponding to [M+Na-2H]', 
and there was also fragment ion of high abundance at m/z 963, formed by loss of water 
from the parent, together with a fragment ion at m/z 479, corresponding to [M-Na]' of
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low abundance. In contrast, a fragment ion at m/z 467 was dominant in the CID spectrum 
of 5p-androstane-l 1, 17-dione-3a-ol glucuronide sodium salt, but no fragment ions 
corresponding to [M+Na-2H]' and ([2M-Na]' -H2 O) were present. The CID spectra of 5(3- 
androstane-ll,17-dione-3a-ol and 5p-androstane-ll, 17-dione-3a-ol glucuronide sodium 
salt were present in Appendix 35-36.
CID spectra from the parent ion [M-H]'
The CID spectra showed a very intense peak corresponding to ([M-H]*-H2 0 ), and 
weak peaks assigned to ([M-H]'-CH3 COOH), [M-H-80]' and [M-H-118]', which are 
probably due to charge induced fragmentation of the glucuronide moiety. Peaks 
corresponding to loss of glucuronide moiety ([M-H]'-Glu) and further loss of two 
hydrogens ([M-H]'-G1u-H2 ) were observed in relative high abundance in the CID 
spectrum of testosterone glucuronide, but in very low abundance in the spectra of the 
other glucuronides. Glucuronide fragment ion (m/z 175) and [GIU-H-H2 O]' (m/z 157) 
were observed in all the CID spectra of steroid glucuronides. Similar spectra were also 
observed by Kuuranne and M. Vahermo8, and they suggested that the fragment ion ([M- 
H]'-Glu-H2) was formed by the loss of glucuronide group, with the transfer of two 
hydrogens from the aglycone to the glucuronide group resulting in the a, P-unsaturated 
structure of the aglycone fragment ion and allowing delocalization of the negative charge 
at the glucuronide group. Our result is consistent with this suggestion.
Although the CID spectra of the 5a/5p-iomeric steroid glucuronides 
(androsteome glucuronide and etiocholan-3a-ol-17-one glucuronide) are quite similar, 
there is however, an ion of m/z 307 present in the spectrum of androsterone glucuronide;
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whereas, no such ion is observed in the spectrum of etiocholan-3a-ol-17-one 
glucuronide. The CID spectra of these compounds were shown in Figure 3.9.1-4.
Figure 3.9.1 CID of testosterone glucuronide from ion of m/z 463; collision energy 32%
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Figure 3.9.2. CID of androsterone glucuronide from ion of m/z 465; collision energy 32%
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Figure 3.9.3 CID of etiocholan-3a-ol-17-one glucuronide from ion of m/z 465; collision
energy 32%
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Figure 3.9.4 CID of DHEA glucuronide from ion of m/z 463; collision energy 32%
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CID spectra from parent ion of [M-Na]
The CID spectra of 5p-androstane-ll, 17-dione-3a-ol glucuronide and 5a- 
androstan-3a, 17p-diol glucuronide generated from the parent ion [M-Na]' show the 
same types of fragment ions as from parent ion of [M-H]', that is ions formed by the 
losses of water and acetic acid ([M-Na]'-H2 0 ) and [M-Na]'-CH3 COOH), ions formed by 
the loss of the glucuronide moiety ([M-Na]'-Glu) and [M-Na]*-Glu-H2 0 ), and ions for the 
glucuronide moiety (m/z 175) and ([Glu-H]'-H2 0 ) (m/z 157). The CID spectra were 
present in Appendix 37-38.
3.5.2.2 Androgenic steroid sulfates
The de-sodiated molecular ion [M-Na]* of steroid sulfates is much more stable 
than [M-H]' or [M-Na]' of steroid glucuronides. The more collision energy is used, the 
greater the sensitivity required for determination of CID spectra. A CID spectrum was 
obtained only with testosterone sulfate, spectra of none of the other steroid sulfates could 
be determined due to insufficient sensitivity of the mass spectrometer.
The CID spectrum of testosterone sulfate (Figure 3.10.1) only shows the 
consecutive losses of methyl groups, which are most likely arise from the cleavage of 
C l 8  and C19 bonds.
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Figure 3.10.1 CID of testosterone sulfate from ion of m/z 367; collision energy 48%
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3.6 Conclusions
The steroid conjugates can be ionized with all four ionization techniques: positive 
and negative ESI and APCI. However, there were very different spectra observed when 
using different delivering solvents. It seemed formation of dimers or trimers is favored 
for the investigated steroid glucuronides and sulfates delivered by acetonitrile/water in 
both ESI and APCI source.
Compared with the APCI source, the ESI source has lower chemical noise and 
higher sensitivity, so low flow rate ESI was adopted as the method of choice for 
subsequent on-line analysis for steroid glucuronides and sulfates using micro- or packed 
capillary-LC.
114
Positive ion CID using ESI provides more abundant and diagnostic product ions 
and therefore preferable for the identification of androgenic steroid conjugates, whilst 
negative mode, despite of the lack of specific structure information, provides simpler 
spectra and relative better sensitivities and would be useful for quantification of these 
compounds.
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Chapter 4
HPLC/MS of Free Androgenic Steroids 
and their Conjugates
4.1 Introduction
As a consequence of the significant way of androgenic steroids and their 
conjugates in clinical diagnoses 1’6, determination of these compounds has been an 
important field of analytical chemistry for the biological, clinical and pharmaceutical
7 11sciences ' . In addition to analysis by traditional radioimmunoassay (RIA) and gas 
chromatography (GC), high performance liquid chromatography (HPLC) has become a 
very useful technique for steroid analysis in recent years. Many determination methods 
for androgens using HPLC with ultraviolet (UV) detection have been reported. An 
HPLC optimization method for the separation of a mixture of urinary androgens and 
synthetic anabolic steroids was described by Gonzalo-Lumbreras and Izquierdo-
17 1 ^Homillos ' . The effect of several variables such as mobile phase, column packing 
material and temperature on the separation was studied. The detection limits obtained by 
UV detection were in the range of around 0.01-0.1 pg/ml (S/N = 3) in human 
urinesamples spiked with steroids. Baltes et al. 14 reported the separation of testosterone 
(T) and six of its hydroxylated metabolites in the incubation mixture with cell 
microsomes. Marwah et al. 15 developed a method using HPLC with UV detection at 240 
nm for the determination of 7- oxodehydroepiandrosterone sulfate in human plasma after 
a single dose of 7-oxo-dehydroepiandrosterone 3(3-acetate. Using 1 ml of plasma for 
extraction, the detection limit of the assay was 3 ng/ml (S/N = 3). T and epiT in urine 
were determined using an HPLC method with UV detection (240 nm) after enzymic 
hydrolysis and liquid -liquid extraction by Navajas et al.16.
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However, difficulty in measurement of many androgenic steroids by HPLC-UV 
results essentially from lack of a UV Chromophore in the molecule combined with their 
low concentration in biological fluid, especially in plasma. Mass spectrometry (MS) is a 
powerful and specific technique coupled with HPLC for the determination of androgens. 
Komatsu et al. 17 measured various steroids including A4 -androstenedione and DHEA in 
normal adrenal glands and adrenocortical tumors by HPLC- atmospheric pressure 
chemical ionization (APCI)-MS, whlist the characteristic peaks observed in positive
mode mass spectra. The ratio of glucocorticoid to mineralocorticoid content was
18measured and compared for Cushing’s adenomas and for normal adrenals. Draisci et al. 
reported a method based on tandem MS with on-line micro-HPLC using ion spray (IS) 
interface for the direct detection of natural and synthetic hormone residues in bovine 
serum. Linearity of response to the quantity of each analyte between 10 and 300pg was 
reported in the selected reaction monitoring (SRM) mode, and the limit of detection was 
6-7 pg for the hormones (S/N =3).
Originally, hydrolysis was the first step in their assay l 9 '2 3  of conjugated steroids, 
but hydrolysis invariably results in the loss of valuable information concerning type or 
site of conjugation. Therefore many researchers tried to separate conjugated steroids 
without hydrolysis. Nakajima et al. 2 4  applied HPLC-APCI-MS combined with a column 
switching technique to the determination of serum DHEAS. Human serum samples were 
directly injected into the sample preparation column, DHEAS was separated with an 
analytical column and analyzed by HPLC-APCI-MS in negative mode. The detection 
limit was lOng on-column at a S/N of 3. The same group also showed an application for 
the determination of DHEAS in other tissues including brain, liver, kidney, adrenal and 
testis . Direct determination of glucuronide and sulfate of T and epiT in urine has been 
studied by LC-MS-MS. Bean and Henion2 6  presented a method using micro-bore HPLC
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combined on-line with IS-MS in positive mode with SRM. In contrast, Borts and 
Bowers2 7  used LC-electrospray ionization (ESI)- MS in negative mode. In both methods, 
the detection limits of analytes were in the low nM range in urine. Jia et al. quantified 
urinary 17-ketosteroid sulfates and glucuronides by LC- ion trap MS with sonic spray 
ionization technology. With direct injection of 17-ketosteroid in 100 mM buffer solution, 
sonic spray generated a signal about 20 times stronger than that obtained using ESI, 
thereby enabling use of high buffer concentration without any apparent loss of sensitivity; 
17-ketosteroids could be quantified down to 3 pg/pl using this technique.
In this chapter, two HPLC/MS methods were optimized and established in the aim 
of quantifications of eight androgen steroids and five steroid conjugates respectively. The 
limits of detection, accuracy, precision and linearity of the methods were described.
4.2 Experimental
4.2.1 Materials
Testosterone glucuronide, testosterone sulfate sodium salt and androstanediol 
glucuronide sodium salt were purchased from Steraloids (USA). The other steroid 
conjugates and free steroids were from Sigma-Aldrich Ltd (Poole, Dorset, UK). The 
standards were dissolved in methanol, and further diluted to different concentrations with 
methanol/water ( 1 :1 ) for the experiments.
The HPLC grade methanol, acetonitrile and water were purchased from Fisher 
Scientific (Loughborough, Leicester, UK). Ammonium acetate was purchased from
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Sigma-Aldrich Ltd (Poole, UK). Solvents were filtered using a 0.45jjrn membrane filter 
and constantly degassed during analysis.
Hypersil Cis (150 x 4.6 mm, 5 pm), Cs (150 x 4.6, 5 pm), LUNA Cis (2) (100 x 
2.0 mm, 3 pm), LUNA Phenyl-hexyl (100 x 2.0 mm, 3 pm) columns were purchased 
from Phenomenex (Cheshire, UK).
Human plasma from males and females was obtained from the Welsh Blood 
Service (Ely Valley Road, Talbot Green, Port-y-Clun, CF72 9WB).
4.2.2 UV-visible spectrophotometry and HPLC
UV-visible spectrophotometer (Unicam UV-300, Cambridge, UK) was used to 
determine the UV-visible spectrum of solution of the scan of the steroids of interest in the 
region from 190 nm to 400 nm, using methanol as the reference solution.
Hewlett-Packard 1100 and 1050 models (Waldbom, Germany) were used for 
HPLC experiments, and the temperature was controlled at 40°C. A Hypersil Cis (150x4.6 
mm, 5 pm) column was used for the separation for free androgenic steroids with isocratic 
elution (65% methanol / 35% water) at a flow rate of lml/min after UV detection to the 
APCI interface of mass spectrometer.
A micro-bore column (LUNA Cis (2), 100x2.0 mm, 3 pm) was used for method 
development for free steroids at a flow rate of 300 pl/min to APCI-MS. The gradient 
elution program was shown below:
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Time (min) MeOH (v/v %) H20  ( v / v  % )
0 55 45
5 55 45
25 70 30
27 1 0 0 0
35 1 0 0 0
36 55 45
45 55 45
A LUNA Phenyl-hexyl (100x2.0 mm, 3 pm) column was used for the separation 
of steroid conjugates at a flow rate of 200 pl/min to the ESI interface of mass 
spectrometer. The gradient elution program was below:
Time (min) MeCN (v/v %) lOmM NFLOAc (v/v %)
0 25 75
7 25 75
1 2 50 50
2 0 50 50
2 1 25 75
35 25 75
4.2.3 Mass spectrometry parameters
Mass spectrometric experiments were performed on a Finnigan LCQ ion trap 
mass spectrometer (San Jose, CA) equipped with X-callubar software. The APCI 
interface parameters employed for free steroids in positive mode were as follow:
MS parameter Flow rate of lml/min Flow rate of 0.3ml/min
Vaporizer temperature 550°C 550°C
Sheath gas flow (arbitrary units) 90 arb 40 arb
Auxiliary gas flow (arbitrary 30 arb 10 arb
units)
Discharge current 4.5 \iA 3.5 pA
Capillary temperature 175 °C 150 °C
Capillary voltage 10 V 10 V
Tube lens offset 30 V 30 V
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The ESI interface parameters used for steroid conjugates in negative mode were
as:
MS parameter
Sheath gas flow (arbitrary units) 
Auxiliary gas flow (arbitrary units) 
Spray voltage 
Capillary temperature 
Capillary voltage 
Tube lens offset
Flow rate at 0.2ml/min
100 
20 
4.5 KV 
200°C 
-45 V 
-40 V
4.2.4 Steroid extraction
Plasma samples (2 ml) were diluted with of distilled water (3 ml) in a test tube 
and of diethyl ether (9 ml) added; the contents were vortex mixed thoroughly (30 s). The 
tubes were centrifuged for 5 min at lOOOg, and then the diethyl ether layer was separated 
by freezing the aqueous layer in a carbon dioxide-dry ice bath. The aqueous layer was 
thawed and the above procedure repeated. Finally, the combined diethyl ether extracts 
were evaporated to dryness under a slow stream of oxygen-free nitrogen at room 
temperature. The residue was dissolved in 200 pi of methanol and was injected directly 
into chromatograph.
4.2.5 Assay validation
The repeated measurements were evaluated by an ANOVA method with one­
tailed F-test.
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The intra-day precision of the method was evaluated by injecting four replicates 
of samples at three different concentrations. The inter-day precision was assessed by 
analyzing standard samples at three different concentrations on three days against 
calibration curves. Precision was given by intra-day, inter-day and total coefficient of 
variation.
The linearity was evaluated using results of calibration curves run on three 
different days over the different concentration ranges of standards. Calibration curves 
were constructed by plotting the peak area against the concentration of sample. An 
unweighted least-squares linear regression analysis was used to obtain standard 
calibration curves.
4.3 Free androgenic steroids
4.3.1 UV-visible spectrophotometry
Methanol solutions of some major androgenic steroids were scanned using the 
UV-visible spectrophotomer between the wavelength 190.0 nm to 400.0nm, and their 
wavelength of maximum absorbance are summarized in Table 4.1.
Table 4.1 UV-visible scan of some androgenic steroids
Compound Wavelength of maximum 
absorbance (nm)
Testosterone 238
A4 -Androsten-3 , 17 -dione 238
Dihydrotestosterone 2 0 1
DHEA 2 1 1
5 a-Androstan-3, 17-dione 203
Adrenosterone 238
Androsterone 2 0 1
5a-Androstan-3a, 17(3-diol 199
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4.3.2 HPLC-UV
4.3.2.1. Column
A literature search indicated that reverse-phase separation is the most popular 
method for resolution of many androgenic steroids. Cis and Cs column were chosen to 
test the HPLC separation of a mixture of seven androgens interest. Column efficiency 
was compared between these two columns in Table 4.2.
Table 4.2 Comparison of HPLC parameters between Cl 8  Column and C8  Column
Steroid C l 8  column (150*4.6mm) C8  column (150*4.6mm)
RT Rs N RT Rs N
As-Androstene-3p, 17p-diol 5.45 _ 26886 5.29 — 26051
Testosterone* 6.45 7.00 28462 6.16 6.29 27754
A4 -Androsten-3 , 17 -dione * 8.72 12.72 29261 7.75 9.58 28975
5a-Androstan-3a, 17p-diol 10.32 8.72 64186 8.81 5.90 38346
Dihydrotestosterone 11.19 4.30 34788 9.39 2.78 25969
5a-Androstan-3, 17-dione 15.61 8.24 29651 12.29 8.37 28362
Androsterone 16.43 2.38 37574 13.06 2.76 40352
* detected at 240nm. Acetonitile/water (40:60) was used for both columns.
RT, retention time; Rs, resolution; N, plate number.
4.3.2.2. Elution solvent
Both acetonitrile/water and methanol/water solvent systems were applied to Cis
• 90column for the separation of the seven steroids studied. Lin and Heftmann studied 
retention behavior of 69 androstane derivatives on normal- and reversed-phase HPLC. 
They found that the total number of hydroxyl- and keto groups on the androstane 
molecule was observed to be the most important factor in determining their
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chromatographic behavior. In general, hydroxyl groups contributed more to the polarity 
of the steroid molecules than keto groups, but an a, P-unsaturated keto group makes the 
steroids about as polar as does a hydroxyl group. We observed similar behaviour when 
test steroids were eluted with acetonitrile/water (Figure 4.1). However, when eluted with
Figure 4.1 HPLC separation of seven free steroids with acetonitile/water (40:60)
and detection by UV
mAU ' 
80-
60-
2 0 -
Sample was injected at 20 pi and 1 00pg/ml for each compound.
1. A5-Androstene-3(3, 17|3-diol, 2. Testosterone, 3. A4-Androsten-3, 17 -dione,
4. 5a-Androstan-3a, 17(3-diol, 5. Dihydrotestosterone, 6. 5a-Androstan-3, 17-dione,
7. Androsterone.
methanol/water, a different order of elution was observed. A4 -Androsten-3 , 17 -dione 
was eluted faster than testosterone and 5a-androstan-3, 17-dione was faster than 
dihydrotestosterone and androsterone (Figure 4.2).
Acetonitrile/water was found to be much better than methanol/water for the UV- 
detection at 200 nm, due to the lack of UV absorbance at 200 nm which occurs in 
methanol/water, and the absence of a significant signal attenuation observed at 2 1 0  nm
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i
for steroids without A4 -bond at A ring when eluted with methanol/water (see Figure 4.1 
and 4.2). Moreover, 5a-Androstan-3a, 17(3-diol could not be separated from testosterone 
with methanol/water no matter how the ratio of methanol to water was varied.
Figure 4.2 HPLC separation of seven free steroids with methanol/water (65:35)
and detection by UV
Sig=210,4 Ref=460,80
mAU 2+1
60-
2 0 -
■2 0 -
Sample was injected at 20 pi and lOOpg/ml for each compound.
1. A5-Androstene-3(3, 17(3-diol, 2. Testosterone, 3. A4-Androsten-3, 17-dione, 
5. Dihydrotestosterone, 6. 5a-Androstan-3, 17-dione, 7. Androsterone.
4.3.3 HPLC-MS
4.3.3.1 HPLC-MS for standard androgen mixture
For many of the steroids investigated, the mass spectrometry proved much more 
sensitive and specific than UV spectrophotometry as a detector. As reported in Chapter 2, 
positive APCI/MS was the most sensitive method for the free steroid determinations 
eluted with methanol/water. Figure 4.3 shows a chromatogram of the m/z values which
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relate to the molecular ions or major fragment ions obtained on analysis o f a mixture 
containing eight free androgens. The chrom atogram  shows the presence o f  the molecular 
or m ajor fragment ions at the retention times relating to their elution from the HPLC 
column. The steroids in the mixture are identified by running each individual standard to 
determine its retention time and characteristic peak. The ion distribution o f  the total ion 
current over a protonated m olecule and its fragm ent ion and adduct ion for each free 
androgen is presented in Table 4.3.
Figure 4.3 Reconstructed extracted ion current chromatogram o f  eight steroid mixture by
HPLC-APC1/MS
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A4-Androsten-3, 17 -d ione (lOOpg/pl); 2. Testosterone (lOOpg/pl); 3. DHEA (lng /p l); 4. 5a- 
Androstan-3, 17-dione (lng /p l); 5. Dihydrotestosterone (lng /p l); 6. 5a-A ndrostan-3a, 17(3-diol 
(lng /p l); 7. Androsterone (lng /p l); 8. A5-Androstan-3(3, 17(3-diol (lng/pil).
Mobile phase, methanol/water (65:35 v/v), 20 pi injection.
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Table 4.3 Distribution of the major ions of eight free androgen steroids (%TIC)
Ion I II Ill IV V VI VII VIII
[MH]+ 67 68 _ 4 18 5 _ 7
[M H+lf 13 12 _ 3 _ _ _
[MH-H2]+ 7 5 _ 3 4 6 _ _
[MH-H20 ]+ _ 41 43 27 28 6 49
[MH-H20+1]+ _ _ 7 7 6 5 _ 9
[MH-2H20 ]+ _ _ 30 22 4 14 55 21
[MH-2H2OH]+ _ _ 6 3 _ _ 18 3
[MH+MeOH]+ _ _ _ _ 5 18 _ _
[MH-H2CH-MeOH]+ - - - - 19 - -
I. A4-Androsten-3, 17-dione, II. Testosterone, III. A5-Andtosten-3(3, 17p~diol, IV. Dehydroisoandrosterone 
(DHEA), V. 5a-Androstan-3,17-dione, VI. Dihyrotestosterone (DHT), VII. 5a-Androstan-3a, 17|3-diol, 
VIII. Androsterone.
Table 4.3 shows that, for testosterone and A4 -androsten-3 , 17 -dione, the 
intensities of the protonated molecules far exceed that of any other ions, but that in the 
majority of cases, the ions formed by loss of water ([MH]+-H2 0 ) and ([MH]+-2 H2 0 ), 
contribute more to the %TIC (total ion chromatograph), with the exception of 5a- 
androstan-3, 17-dione and dihydrotestosterone, for which the adduct ions 
([MH]++MeOH) or ([MH]+-H2 0 +Me0 H) make a significant contribution. The carbon 
isotope ions are generally present at no more than 13% for all the test free androgens, and 
fragment ions ([MH]+-H2 ) were present below 7%. In conclusion, the majority of the TIC 
represents protonated molecules or dehydration fragments, so these ions are the most 
convenient and most quantitatively sensitive ions to monitor.
4.3.3.2 Application of serum samples to the HPLC-MS method
After extraction and cleaning up procedure, sample from human plasma were 
analysed by the HPLC-MS method described above. The identifications of the androgens
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of interest were based on their retention time and characteristic m/z values, compared 
with those of standard androgens. Under this conditions, only testosterone could be 
detected as shown in the reconstructed ion chromatogram (RIC) for the testosterone 
protonated molecule (m/z 289) obtained from the extracts of male and female plasmas 
(Figure 4.4), indicating that the present method lacked sufficient sensitivity for routine 
clinical analysis of androgens other than testosterone.
Figure 4.4 Extracted ion current chromatogram for standard testosterone and extract
from male and female plasma sample
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Note, sample was injected at 20 pi, and testosterone standard was at 10 pg/pl.
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4.3.4 Micro-bore LC-MS
As an approach to improve sensitivity sufficiently to determine other androgens 
of interest in bio-samples, the normal LC-MS method was developed to a micro-bore LC- 
MS method with the optimization of the flow rate and MS parameters.
4.3.4.1 Comparison of the flow rates
To compare the sensitivities between the high flow rate and low flow rate for 
APCI source, eight test androgen steroids were injected into the mass spectrometer by 
HPLC pump with methanol/water (50:50). The detection limits were compared at flow 
rate of lml/min and 0.3ml/min (Table 4.4).
Table 4.4 Comparison of the detection limits between high flow rate 
and low flow rate (S/N > 3).
Steroids High flow rate (lml/min) Low flow rate (0.3ml/min)
A4 -Androsten-3 , 17 -dione 25 pg 1 0  pg
Testosterone 2 0  pg 1 0  pg
DHEA 150 pg 25 pg
5a-Androstan-3, 17-dione 150 pg 25 pg
Dihydrotestosterone 1 ng 2 0 0  pg
5a-Androstan-3a, 17p-diol 750 pg 250 pg
Androsterone 2 0 0  pg 50 pg
A5-Androstan-3 p, 17p-diol 500 pg 1 0 0  pg
As shown in Table 4.4, the detection limits are about 2 to 6  times lower at low 
flow rate (0.3 ml/min) than at high flow rate (1 ml/min) for the test androgen steroids,
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therefore, the micro-bore HPLC column was used to develop a more sensitive micro-bore 
LC-MS method at low flow rate (0.3 ml/min).
4.3.4.2 Micro-bore LC separation for ten-androgen mixture
A micro-bore column was used for LC separation to meet the requirement for the 
low flow rate needed to obtain higher sensitivity from the APCI source, for which 
gradient elution was required (described in 4.2.2) to improve the separation. Figure 4.5 
shows the TIC of ten androgens studied in the standard mixture (10 pg/pl for each 
compound) at flow rate at 0.3 ml/min. While the testosterone and As-androstan-3p, 17(3- 
diol were better separated compared with the normal size column, they were still not 
totally resolved. However, these two steroids differ in their characteristic ions in positive 
mode APCI-MS (m/z values of 289 and 273, respectively), thus their separate mass 
spectrometric analysis should not cause problems.
Figure 4.5 Total current chromatogram of ten androgen mixture
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4.3.4.3 Optimization of MS parameters
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In order to get the best sensitivity for the androgenic steroids studied, some 
important mass spectrometric parameters were optimized for an LC flow rate o f 0.3 
ml/min. The sheath gas levels were tested between 20 and 60 arb (arbitrary units), 
keeping all other param eters constant. Figure 4.6 (a and b) shows increases in intensities 
as the sheath gas levels are increased to 30 or 40 arb, and then the intensities drop o ff as
Figure 4.6 The optim ization o f  some important MS parameters 
for eight androgenic steroids
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the sheath gas was increased; the sheath gas level therefore was set to 40 arb, because the 
maximum intensities were observed when the sheath gas was between 30 and 40 arb.
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The effect o f  varying the auxiliary gas levels between 10 and 50 arb as the sheath 
gas levels were constant at 40 arb was investigated. Figure 4.6 (c and d) shows that as the 
auxiliary gas level increased abve 10 arb, the signal intensity decreased for most o f 
steroids except dihydrotestosterone, which showed the maximum value as the auxiliary 
gas increases to 20 arb, and then decreased as the auxiliary gas level increases further. In 
the majority cases o f the investigated steroids, the signals get to the maximum values 
when the auxiliary gas levels were set to 10 arb.
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Varying the discharge current between 3 and 5.5 pA (Figure 4.6, e and f) was 
found, however, to have no significant effects on peak intensity. For most o f  the steroids,
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the signals reached a maximum value when the discharge current was set to 3 pA; 
however, androsterone and dihydrotestosterone show the maximum values as the 
discharge current is at 4.5 pA. So the value o f  3 pA was used for the future experiments.
(e)
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The vaporizer temperature was optimized between 350 °C and 550 °C. 
Testosterone was the only steroid alm ost unaffected by this change in vaporizer 
tem perature. The effects upon the other androgenic steroids are shown in Figure 4.6 (g 
and h). Epitestosterone and androsterone gave the best signals as the tem perature
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increased to 450 °C and then dropped o ff if the tem perature was further increase; whereas 
the other steroids, adrenosterone, DHEA, 5a-androstan-3a, 17(3-diol and androsterone 
showed the sharp increasing signals as the tem perature increased from 350 °C to 450 °C
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and then slowly increased to their maximum values as the tem perature further increased 
to 550 °C. zVi-Androten-3, 17-dione gave the slightly increasing signal over the whole 
range from 350 °C to 550 °C. The vaporizer tem perature was therefore set to 550 °C,
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considering the maximum signal for most steroids and this tem perature, whlist there was 
only a 5% drop o ff for epitestosterone and 15% for androsterone.
Finally the capillary tem perature was optimized between 150 °C and 220 °C. 
Figure 4.6 (i and j)  shows that significant decreases in intensities for A4-androten-3, 17- 
dione, DHEA, 5a-androstan-3a, 17p-diol and androsterone were observed as the
(i)
3 5 0 0 0 0 0
3 0 0 0 0 0 0
e  2 5 0 0 0 0 0  a*
.2 2000000 
2  1500000
-♦—  Adrenosterone 
-■— 4-Androsten-3, 17 -dione 
Testosterone 
-X— DHEA
1000000
5 0 0 0 0 0
1 0 0 150 2 0 0
Capillary temp (C)
25 0
0 )
3 0 0 0 0 0 0  
£>  2 5 0 0 0 0 0  
|  2000000 Epitestosterone
Di'nydrotestosterone
Androsterone
Series4
5 0 0 0 0 0
1 0 0 0 0 0 0
5 0 0 0 0 0
1 0 0 150 200
Capillary temp (C)
2 5 0
tem perature increased from 175 °C and 220 °C, whilst, for adrenosterone, testosterone 
and epitestosterone much sm aller decreases occurred. However, dihydrotestosterone 
exhibited an increase between 150 °C to 190 °C, after which the intensity decreases 
gradually as the tem perature increases further. It was considered that at 150 °C in general
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the steroids gave the best intensities, so this temperature was used for future analysis, 
although there was 30% drop in signal for dihydrotestosterone.
4.3.5 Limits of detection
To screen for the most sensitive scan mode for the mass spectrometer, five 
representative free androgenic steroids were chosen to test the limit of detections in full 
scan, SIM and SRM mode, and the signal to noise ratio was more than three (S/N > 3). 
Known weights of each steroid in the range of 0.5 to 1000 pg were injected in a volumn 
of 10 pi into the HPLC-MS system.
Table 4.5 shows that the sensitivities are about 5 to 25 times greater in SIM mode 
than in full scan mode, and there is similar sensitivity between full scan and SRM mode. 
The SIM mode was therefore chosen for future quantitative LC-MS experiments, 
although this approach was compromised by reduced specificity.
Table 4.5 Limits of detection of five androgenic steroids in different scan mode
Steroid Full scan (pg) SIM (pg) SRM (pg)
Adrenosterone 10 (m/z 301) 0.5 (m/z 301) 1 0 (m/z 301-»265)
Testosterone 25 (m/z 289) 1 . 0 (m/z 289) 50 (m/z 289->271)
DHEA 500 (m/z 271) 50 (m/z 271) 1000 (m/z 271-»253)
Dihydrotestosterone 500 (m/z 291) 1 0 0 (m/z 291) 500 (m/z 291->255)
5a-Androstan-3a, 17p-diol 1000(m/z 257) 1 0 0 (m/z 257) 1000 (m/z 257^161)
4.3.6 Quantitative LC-MS for androgenic steroids
4.3.6.1 Analysis of variance of free androgenic steroids
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In order to evaluate the replicate measurements of the experiment results within 
day and between days, a one-tailed F-test was used to compare the different mean of peak 
area. Analysis of variance (ANOVA) is a powerful statistical technique which can be 
used to separate and estimate the different causes of variation. ANOVA is used to test 
whether the difference between sample means is too great to be explained by the random 
error.
Table 4.6 Daily and overall mean (peak area) of the investigated steroids at three
concentrations by repeated MS-SIM measurements
Steroid Concen­
tration
(pg/jLLl)
Mean
(xE+6 )
Concen­
tration
(pg/pl)
Mean
(xE+6 )
Concen­
tration
(Pg/pl)
Mean
(xE+7)
Adrenosterone 
(m/z 301)
1 0 Dayl 1.44 50 Dayl 4.51 250 Dayl 2 . 1 0
Day2 1.35 Day2 4.84 Day2 1.98
Day3 1.30 Day3 4.41 Day3 2.15
Total 1.36 Total 4.58 Total 2.08
A4-Androsten- 
3 ,17-dione 
(m/z 287)
2 0 Dayl 1.60 1 0 0 Dayl 5.06 500 Dayl 2 . 2 2
Day2 1.27 Day2 5.03 Day2 2.13
Day3 1.54 Day3 5.28 Day3 2.40
Total 1.47 Total 5.12 Total 2.25
Testosterone 
(m/z 289)
2 0 Dayl 1.47 1 0 0 Dayl 4.96 500 Dayl 2.17
Day2 1.32 Day2 5.15 Day2 2.26
Day3 1.40 Day3 4.65 Day3 2.37
Total 1.40 Total 4.92 Total 2.27
Epitestosterone 
(m/z 289)
2 0 Dayl 1.71 1 0 0 Dayl 6.62 500 Dayl 3.02
Day2 1.53 Day2 6.15 Day2 3.07
Day3 1.84 Day3 6.44 Day3 3.29
Total 1.69 Total 6.40 Total 3.13
DHEA 
(m/z 271)
1 0 0 Dayl 1.29 500 Dayl 5.23 2500 Dayl 2 . 2 0
Day2 1.16 Day2 5.59 Day2 2.33
Day3 1.31 Day3 5.54 Day3 2.46
Total 1.25 Total 5.45 Total 2.33
2 0 0 Dayl 1 . 6 6 1 0 0 0 Dayl 8.46 5000 Dayl 3.31
DHT Day2 1.64 Day2 8.85 Day2 3.55
(m/z 291) Day3 1.94 Day3 9.28 Day3 3.73
Total 1.75 Total 8 . 8 6 Total 3.53
1 0 0 Dayl 1.74 500 Dayl 5.63 2500 Dayl 2.82
Androsterone Day2 1.59 Day2 6 . 2 2 Day2 2.82
(m/z 273) Day3 1.57 Day3 6.16 Day3 3.10
Total 1.63 Total 6 . 0 0 Total 2.91
5a-Androstan- 2 0 0 Dayl 1.47 1 0 0 0 Dayl 5.54 5000 Dayl 2.39
3a,17|3-diol Day2 1.65 Day2 5.72 Day2 2.48
(m/z 257) Day3 1.45 Day3 5.97 Day3 2.71
Total 1.52 Total 5.74 Total 2.53
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Table 4.7 Summary of ANOVA results for eight free androgenic steroids by repeated
MS-SIM measurements
Steroid Concentration
(pg/ui)
Source of 
variation
Sum of 
squares
Degree of 
freedom
Mean square F
Adrenosterone 
(m/z 301)
10 Intra-day 1.40 E+ll 9 1.55 E+10 1.30
Inter-day 1.80 E+ll 2 2.01 E+10
50 Intra-day 1.56 E+l 2 9 1.73 E+ll 2.42
Inter-day 8.37 E+ll 2 4.19 E+ll
250 Intra-day 5.87 E+12 9 6.52 E+ll 2.42
Inter-day 3.16 E+12 2 1.58 E+12
A4-Androsten- 
3, 17-dione 
(m/z 287)
20 Intra-day 2.69 E+ll 9 2.99 E+10 4.09
Inter-day 2.44 E+l 1 2 1.22 E+ll
100 Intra-day 3.25 E+ll 9 3.61 E+10 2.03
Inter-day 1.47 E+ll 2 7.33 E+10
500 Intra-day 2.37 E+13 9 2.63 E+12 2.86
Inter-day 1.51 E+13 2 7.53 E+12
Testosterone 
(m/z 289)
20 Intra-day 1.61 E+ll 9 1.79 E+10 1.39
Inter-day 4.97 E+l 0 2 2.48 E+10
100 Intra-day 8.15 E+ll 9 9.05 E+10 1.78
Inter-day 5.24 E+l 1 2 2.62 E+ll
500 Intra-day 1.17 E+13 9 1.30 E+12 2.08
Inter-day 8.03 E+12 2 4.01 E+12
Epitestosterone 
(m/z 289)
20 Intra-day 4.42 E+l 1 9 4.91 E+10 1.97
Inter-day 1.94 E+ll 2 9.69 E+10
100 Intra-day 8.82 E+l 1 9 9.80 E+10 2.25
Inter-day 4.41 E+ll 2 2.20 E+l 1
500 Intra-day 3.57 E+13 9 3.97 E+12 2.04
Inter-day 1.62 E+13 2 8.09 E+12
DHEA 
(m/z 271)
100 Intra-day 1.41 E+ll 9 1.56 E+10 1.88
Inter-day 5.88 E+10 2 2.94 E+10
500 Intra-day 8.85 E+ll 9 9.84 E+10 1.60
Inter-day 3.14 E+ll 2 1.57 E+ll
2500 Intra-day 2.13 E+13 9 2.37 E+12 2.75
Inter-day 1.30 E+13 2 6.50 E+12
DHT 
(m/z 291)
200 Intra-day 4.46 E+l 1 9 4.95 E+10 2.33
Inter-day 2.31 E+ll 2 1.16 E+l 1
1000 Intra-day 1.98 E+12 9 2.20 E+ll 3.12
Inter-day 1.37 E+12 2 6.86 E+l 1
5000 Intra-day 7.4 E+13 9 8.23 E+12 2.19
Inter-day 3.61 E+13 2 1.80 E+13
Androsterone 
(m/z 273)
100 Intra-day 2.41 E+ll 9 2.68 E+10 1.34
Inter-day 7.17 E+10 2 3.58 E+10
500 Intra-day 1.90 E+12 9 2.11 E+ll 2.02
Inter-day 8.55 E+l 1 2 4.28 E+l 1
2500 Intra-day 6.34 E+13 9 7.05 E+12 1.54
Inter-day 2.17 E+13 2 1.08 E+13
5a-Androstan- 
3a, 17(3-diol 
(m/z 257)
200 Intra-day 2.81 E+ll 9 3.12 E+10 1.53
Inter-day 9.56 E+10 2 4.78 E+10
1000 Intra-day 5.97 E+l 1 9 6.64 E+10 2.82
Inter-day 3.74 E+l 1 2 1.87 E+ll
5000 Intra-day 6.43 E+13 9 7.14 E+12 1.58
Inter-day 2.25 E+13 2 1.13 E+13
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To estimate the intra-day and inter-day precision, four repeated injections were 
made on three days at three different concentrations for each of the steroids. An ANOVA 
method was used to test for the difference between these means, and the results are 
summarized in Table 4.6 and 4.7. As shown in Table 4.7, the calculated values of F for 
each steroid at all concentrations are smaller than the critical value (Fcriticai = 4.26, P = 
0.05), so the inter-day variance of the SIM measurements does not significantly differ 
from the intra-day variance.
4.3.6.2 Precision and linearity
The reproducibility of the LC-MS method is described by the coefficient of 
variation (CV), and the corresponding values for each of the selected androgens are 
summarized in Table 4.8 (a to h). The % CV ranges from approximately 4% to 15% for 
total injection precisions, 4% to 13% for intra-day precisions and 5% to 24% for inter­
day precisions. The variations from the inter-day injections are much bigger than from 
the intra-day injections, and adding an internal standard may decrease this variance.
The response of the base peak area in the mass spectra against various 
concentrations were studied for each of the steroids, and found to be linear in the relative 
low range of concentrations for adrenosterone, A4 -androsten-3 , 17-dione, testosterone and 
epitestosterone ( 1 0  to 1 0 0 0  pg/pl); and in the high range concentrations for the other 
steroids (100 pg/pil to 10 ng/pl). Correlation coefficients of the linear regression of these 
steroids are from 0.9991 up to 0.9998. Calibration curves and corresponding equations of 
each steroid are presented in Figure 4.7 (a to h).
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Table 4.8 (a) Precision in the measurem ents o f adrenosterone
Concentration Intra-day Inter-day Total
(pg/pl) (% CV) (% CV) (% CV)
TO 9T 104 04
50 9.0 14.1 10.1
250 4.0 6.3 4.5
Figure 4.7 (a) Calibration curve o f adrenosterone
5.00E+07
y = 78817x + 652751 
R2 = 0.99974.00E+07
3.00E+07
2.00E+07
1.00E+07
0.00E+00
200
Concentration (pg/|il)
400 500 600100 300
Table 4.8 (b) Precision in the m easurem ents o f A4-androsten-3, 17-dione
Concentration
(Pg/pl)
Intra-day
(%CV)
Inter-day
(%CV)
Total
(%CV)
20 11.8 23.8 14.7
100 3.7 5.3 4.0
500 7.2 12.2 8.4
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Figure 4.7 (b) Calibration curve o f A4-androsten-3, 17-dione
5.00E+07
y = 45809x + 519599 
R2 = 0.9992
4.00E+07
3.00E+07
2.00E+07
1.00E+07
0.00E+00
200 400 600
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Table 4.8 (c) Precision in the measurem ents o f testosterone
Concentration
(Pg/pl)
Intra-day
(%CV)
Inter-day
(%CV)
Total
(%CV)
20 9.6 11.3 9.9
100 6.1 10.4 7.1
500 5.0 8.8 5.9
Figure 4.7 (c) Calibration curve o f testosterone
6.00E+07
y = 48311x - 38712 
R2 = 0.9982
5.00E+07
S 4.00E+07
3.00E+07
2.00E+07
1.00E+07
0.00E+00
1000 1200200 400 600 800 
Concentration (pg/pl)
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Table 4.8 (d) Precision in the measurements o f epitestosterone
Concentration Intra-day Inter-day Total
(pg/pl) (%CV) (%CV) (%CV)
~ 2 0  H T  184 14.2
100 4.9 7.3 5.4
500 6.4 9.1 7.0
Figure 4.7 (d) Calibration curve o f epitestosterone
7.50E+07
y = 67279x-246867 
R2 = 0.9982
6.00E+07
J- 4.50E+07
«* 3.00E+07
.50E+07
0.00E+00
200 400 600 800
Concentration (pg/pl)
1000 1200
Table 4.8 (e) Precision in the measurements o f DHEA
Concentration Intra-day Inter-day Total
(pg/pl) (%CV) (%CV) (%CV)
100 TOO 13/7 10.7
500 5.8 7.3 6.1
2500 6.6 11.0 7.6
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Figure 4.7 (e) Calibration curve o f DHEA
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Table 4.8 (f) Precision in the measurements o f dihydrotestosterone
Concentration
(Pg/pl)
Intra-day
(%CV)
Inter-day
(%CV)
Total
(%CV)
200 12.7 19.5 14.2
1000 5.3 9.3 6.2
5000 8.1 12.0 9.0
Figure 4.7 (f) Calibration curve o f  dihydrotestosterone
9.00E+07 
7.50E+07 
S 6.00E+07u
£  4.50E+07 
|  3.00E+07 
1.50E+07 
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0 2000 4000 6000 8000 10000 12000
Concentration (pg/|J.l)
y = 7261.3x + 873845 
R2 = 0.9982
y = 9315.8x + 472905
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Table 4.8 (g) Precision in the measurem ents o f androsterone
Concentration
(Pg/pl)
Intra-day
(%CV)
Inter-day
(%CV)
Total
(%CV)
100 10.0 11.6 10.3
500 7.7 10.9 8.3
2500 9.1 11.3 9.6
Figure 4.7 (g) Calibration curve o f androsterone
6.00E+07 
5.00E+07 
4.00E+07 
3.00E+07 
2.00E+07 
1.00E+07 
0.00E+00
y = 11052x + 1E+06
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Concentration (pg/pl)
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6000
Table 4.8 (h) Precision in the m easurem ents o f androstan-3a, 17(3-diol
Concentration
(Pg/pl)
Intra-day
(%CV)
Inter-day
(%CV)
Total
(%CV)
200 11.6 14.4 12.2
1000 4.5 7.5 5.2
5000 10.6 13.3 11.1
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Figure 4.7 (h) Calibration curve o f androstan-3a, 17p-diol
6.00E+07
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4.3.6.3 Limits o f quantitation
The limit o f quantitation is defined as Yeiank + lOSeiank 3°, and the values o f each 
steroid were calculated using regression lines o f y on x from the appropriate calibration 
curve above. The results were shown in Table 4.9. The steroids with 4-ene-3-one 
structures had relatively low limits o f  quantitation between 2.5 and 4.2 pg, but the 
androgens without this structure had much higher limits o f  quantitation, the values 
ranging from 17.5 to 38.6 pg (Table 4.9).
Table 4.9 Limits o f  quantitation o f the free androgenic steroids
Steroid Limit o f quantitation (pg)
Adrenosterone 2.5
A4-Androsten-3, 17-dione 4.2
Testosterone 4.0
Epitestosterone 2.9
DHEA 20.8
Dihydrotestosterone 26.7
Androsterone 17.5
5a-A ndrostan-3a, 17(3-diol 38.6
147
4.4 Androgenic steroid conjugates
4.4.1 HPLC-UV
Compared to the free steroids, the polarities of steroid conjugates are much 
increased due to introduction of the glucuronide or sulfate group. Therefore, most of the 
steroid conjugates were not retained in the C l 8  or C8  column, so a more polar phenyl- 
hexyl column was chosen for the separation of the steroid conjugates of interest.
The gradient acetonitrile/ ammonium formate system (section 4.2.2) was used for 
the separation of seven selected steroid conjugates. However, there is UV absorbance for 
the buffer system at 2 0 0  nm, which is the maximum absorbance for most of steroid 
conjugates, therefore UV detection is not suitable for quantitative analysis for most of 
steroid conjugates.
Figure 4.8 HPLC separation of seven steroid conjugates and detected by UV at 210 nm
DAD1 D, Sifl=210,4 Ref=3Q0,8D
mAU
20 H
10:
-1 0 :
•2 0 :
-30:
-50 t
mir
Sample was injected at 20 pi and lOOpg/ml for each compound.
* 5a-Androstan-3a, 17(3-diol glucuronide and androsterone sulfate are not detectable by UV. 
1. Testosterone glucuronide, 2. DHEA glucuronide, 3. Androsterone glucuronide,
4 .Testosterone sulfate, 5. DHEA sulfate
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4.4.2 HPLC-MS
4.4.2.1 Separation of seven steroid conjugates by HPLC-MS
The same acetonitrile/ammonium formated gradient system was applied for the 
separation of the steroid conjugates for HPLC-MS, and based on the results described in 
Chapter 3, negative ESI mode was chosen for quantitative analysis of the steroid 
conjugates. For compatibility with ESI/MS, micro-bore a phenyl-hexyl column was used 
with a flow rate of 0.2 ml/min. Figure 4.9 shows the extracted ion chromatograms for the 
separation of seven steroid conjugates.
Figure 4.9 Extracted ion current chromatograms of seven steroid conjugates
by HPLC-MS
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4.4.2.2 Optimization o f buffer concentration for HPLC-M S
To optimize the buffer concentration o f amm onium  formate, the mixture o f seven 
steroid conjugates was injected into the HPLC-ESIM S system with 10, 20, 30, 50 and 
100 mM buffer respectively. With the buffer concentration increasing, the response 
signal decreased avove 20 mM, decreasing sharply after 50 mM, and showing a 65% 
drop at 100 mM (Figure 4.10). Figure 4.11 shows the total ion chromatograph at 10, 30 
and 100 mM buffer concentrations. It was observed that as the buffer concentration 
increased, the retention times became longer and the background noisier. Therefore, the 
buffer concentration o f 10 mM was chosen for steroid conjugate separation, as it offered 
the best detector response, low contamination o f  the mass spectrometer source and lower 
retention times.
Figure 4.10 Optimization of buffer concentration for 
steroid conjugate separation by HPLC-MS
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Figure 4.11 Total ion chromatographs of seven steroid conjugates separated with
different buffer concentrations
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4.4.2.3 Optimization LC-ESI-MS
The mass spectrometer parameters were also optimized for LC-ESI-MS of the 
conjugated androgens at a flow rate of 0.2 ml/min. First, the sheath gas levels were tested 
between 60 and 100 arb. As figure 4.12 (a and b) shows intensities increased as the 
sheath gas levels were increased to 100 arb for testosterone glucuronide (T G), 5 a- 
androstan-3a, 17p-diol (Diol G), androsterone glucuronide (A G) and androsterone 
sulfate (A S), with dehydroisoandrosterone sulfate (DHEA S) showing an increase to
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optimum intensity at between 70 and 100 arb, whereas, dehydroisoandrosterone 
glucuronide (DHEA G) and testosterone sulfate (T S) exhibit maximum intensities at 90 
arb and then show a small decline as the sheath gas levels are further increased to 100 
arb. The sheath gas level was therefore set to 100 arb, as this provided the best overall 
ionization for the majority o f  the steroid conjugates.
Figure 4.12 Optimization o f  some important MS parameters for eight androgenic steroids 
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The auxiliary gas levels were altered between 10 and 60 arb, and the resulting 
intensities o f  the steroid conjugates against this variation are presented in Figure 4.12 (c
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and d). Except for A G, which showed no significant change in signal as the sheath gas 
level was varied in this range, most o f  the investigated steroid conjugates showed 
increases to optimum ionization as the auxiliary gas levels were increased to 20 arb, 
which then decreased to minimum values as the gas levels were increased to 30 to 60 arb. 
Sheath gas level were therefore set to 20 arb for further experiments.
(c)
3500 0 0 0
3 000 0 0 0
2 500 0 0 0
c  2000000 
1500000
4)
^  1000000
5 000 0 0
20 400 60
Auxiliary gas (arb)
T G 
- * -D io l  G 
A G
(d)
6000 0 0 0
5000000
DHEA G
4 0 0 0 0 0 0
3000 0 0 0 DHEA S
2000000
1000000
Auxiliary gas (arb)
The spray voltage was optimized between 2.5 and 4.5 kV. Figure 4.12 (e and f) 
show that base peak intensities were significantly affected by spray voltage variation. O f
the steroid conjugates, DHEA G and T G exhibit increases in signals from 2.5 to 3 kV,
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little further change between 3 and 4 kV, and then a sharp decrease from 4 to 4.5 kV. The 
other steroid conjugates showed parabolic curves between 2.5 and 4.5 kV (Figure 4.12 e 
and 0  with maximum intensities at 3.5 kV. There was only an approximate 5% drop in 
signal for T G if the spray voltage was set to 3.5 kV, thus this value was selected for later 
experim ents because it was the best value for the m ajority o f  the steroid conjugates.
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Finally the capillary tem perature was varied between 170 and 250 °C. As shown in 
Figure 4.12 (g and h), each conjugate showed a characteristic response to increased 
capillary temperature. Diol G, DHEA G and A S exhibited a sim ilar response when the
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capillary tem perature was changed, and gave an optimum signal with a capillary 
tem perature o f  200 °C. A G and T S gave an optimum signal at between 200 and 220°C, 
and this intensity tended to decrease sharply as the capillary tem perature was increased.
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DHEA S on the other hand showed the best intensity at 190 °C, whereas T G exhibits a 
stable intensity between 170 and 210 °C, and a maximum intensity as the tem perature 
increased to 220 °C, the signal decreasing as the tem perature was increased further. 
Overall a capillary tem perature o f  200 °C gives an optimum intensity for four o f  the
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seven steroid conjugates whilst having the least effect on the optimum signal of the other 
steroid conjugates, so this temperature was used for the further analysis.
4.4.2.4 Mass spectra of seven steroid conjugates by HPLC-MS
The ion distribution to TIC for each of steroid conjugates was summarized in 
Table 4.10. The major ions observed using the optimized conditions of HPLC-MS were 
the deprotonated molecule [M-H]', sodium formate adduct [M-H+HCOONa]', 
deprotonated dimer [2M-H]' and, for testosterone glucuronide, DHEA glucuronide and 
androsterone glucuronide, sodium adduct dimer [2M-2H+Na]\ For steroid sulfates and 
5a-androstan-3a, 17P-diol glucuronide, the desodium ion [M-Na]' was intense and 
accompanied by a formid adduct [M+HCOO]’, the desodium dimer [2M+H-2Na]' and 
[2M-Na]\ The intensity of the deprotonated molecule or desodiated ion far exceeds that 
of any of the other ions, and so the deprotonted or desodiated ions were selected as the 
most useful ions for quantitative analysis.
Table 4.10 Distributions of the major ions of the eight conjugated androgens (%TIC)
Ion TG DHEA G DiolG AG TS DHEA S A S
[M-H]’ 67 67 _ 71 _ _
[M-H+HCOONa]' 8 9 _ 8 _ _ _
[2M-H]* 6 9 _ 8 _ _ _
[2M-2H+Na]- 2 2 2 _
[M-Naf _ 65 _ 86 73 73
[M+HCOOf _ _ 7 _ 2 7 5
[2M+H-2Na]’ _ _ 14 _ 2 1 3
[2M-Na]" - - 3 - 4 3 8
4.4.3 Limits of detection
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Five steroid conjugates were tested for the different scan modes (Full scan, SIM 
and SRM) to screen for the most sensitive detection method. Table 4.11 shows the limits 
of detection of these steroid conjugates by different scan mode, and, in the majority of 
cases, the sensitivity of detection in SIM mode is about ten times greater than that in full 
scan mode, and two times higher than in SRM mode. Therefore, the SIM mode was used 
for further quantitative analyses.
Table 4.11 Limits of detection of five steroid conjugates in different scan modes
Steroid conjugate Full scan (pg) SIM (pg) SRM (pg)
Testosterone glucuronide 500 (m/z 463) 50 (m/z 463) 1 0 0 (m/z 463-»445)
5a-Androstan-3a, 17p-diol 500 (m/z 467) 50 (m/z 467) 1 0 0 (m/z 467-»449)
glucuronide
Androsterone glucuronide 500 (m/z 465) 50 (m/z 465) 1 0 0 (m/z 465->447)
Testosterone sulfate 250 (m/z 367) 25 (m/z 367) 50 (m/z 367-»352)
Androsterone sulfate 250 (m/z 369) 25 (m/z 369)
-
4.4.4 Quantitative LC-MS for androgenic steroid conjugates
4.4.4.1 Analysis of variance of androgenic steroid conjugates
An ANOVA method was also used to analysis the variances for the five 
androgenic steroid conjugates, and results were summarized in Tables 4.12 and 4.13.
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Table 4.12 Daily and overall mean (peak area) of the investigated steroid conjugates
at three concentrations by repeated MS-SIM measurements
Steroid Concentra­ Mean Concentrtra- Mean Concentra­ Mean
conjugate tion (pg/nl) (xE+5) tion (pg/ptl) (x E+6 ) tion (pg/pil) (x E+7)
Dayl 3.21 Dayl 2.97 Dayl 1.38
TG 1 0 0 Day2 3.58 1 0 0 0 Day2 3.03 5000 Day2 1.53
(m/z 463) Day3 3.27 Day3 3.42 Day3 1.61
Total 3.35 Total 3.14 Total 1.51
Dayl 3.20 Dayl 2.85 Dayl 1.35
DiolG 1 0 0 Day2 3.70 1 0 0 0 Day2 3.13 5000 Day2 1.53
(m/z 467) Day3 3.53 Day3 3.36 Day3 1.48
Total 3.48 Total 3.11 Total 1.45
Dayl 4.89 Dayl 4.26 Dayl 2.09
AG 1 0 0 Day2 5.60 1 0 0 0 Day2 4.55 5000 Day2 2.34
(m/z 465) Day3 5.35 Day3 5.04 Day3 2 . 2 1
Total 5.28 Total 4.62 Total 2 . 2 2
Dayl 3.83 Dayl 3.34 Dayl 1.67
TG 50 Day2 4.22 500 Day2 3.83 1 0 0 0 Day2 1.82
(m/z 367) Day3 3.62 Day3 3.95 Day3 1.87
Total 3.89 Total 3.70 Total 1.79
Dayl 3.52 Dayl 3.18 Dayl 1.50
AS 50 Day2 3.52 500 Day2 3.54 1 0 0 0 Day2 1 . 6 6
(m/z 369) Day3 4.07 Day3 3.55 Day3 1.72
Total 3.70 Total 3.42 Total 1.63
A one-tailed F-test was used to test the significant difference between intra-day 
and inter-day variance. All the calculated F values shown in Table 4.13 are smaller than 
the critical F value (Fcriticai = 4.26, P = 0.05), therefore, we can conclude that there is no 
significant difference between intra-day and inter-day variance.
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Table 4.13 Summary of ANOVA results for five androgenic steroid conjugates by
repeated MS-SIM measurements
Steroid
conjugate
Concentra­
tion (pg/|il)
Source of 
variation
Sum of 
squares
Degree of 
freedom
Mean
square
F
TG 
(m/z 463)
1 0 0 Intra-day 5.74 E+9 9 6.38 E+ 8 2.51
Inter-day 3.20 E+9 2 1.60 E+9
1 0 0 0 Intra-day 1.58 E+12 9 1.75 E+ll 1.35
Inter-day 4.74 E+ll 2 2.37 E+ll
5000 Intra-day 1.25 E+13 9 1.39 E+12 3.95
Inter-day 1.10 E+13 2 5.50 E+12
DiolG 
(m/z 467)
1 0 0 Intra-day 1.53 E+10 9 1.70 E+9 1.53
Inter-day 5.23 E+9 2 2.61 E+9
1 0 0 0 Intra-day 9.40 E+ll 9 1.04 E+ll 2.47
Inter-day 5.17 E+ll 2 2.58 E+ll
5000 Intra-day 1.98 E+13 9 2.20 E+12 1.64
Inter-day 7.22 E+12 2 3.61 E+12
AG 
(m/z 465)
1 0 0 Intra-day 1.56 E+10 9 1.74 E+9 2.99
Inter-day 1.04 E+10 2 5.19 E+9
1 0 0 0 Intra-day 2.49 E+12 9 2.77 E+ll 2.27
Inter-day 1.26 E+12 2 6.29 E+ll
5000 Intra-day 1.57 E+13 9 1.75 E+12 3.58
Inter-day 1.25 E+13 2 6.26 E+12
TS 
(m/z 367)
50 Intra-day 9.81 E+9 9 1.09 E+9 3.39
Inter-day 7.39 E+9 2 3.70 E+9
500 Intra-day 1.27E+12 9 1.41 E+ll 2.96
Inter-day 8.35 E+ll 2 4.18 E+ll
2500 Intra-day 2.07 E+13 9 2.30 E+12 1.87
Inter-day 8.60 E+12 2 4.30 E+12
AS 
(m/z 369)
50 Intra-day 2.28 E+10 9 2.53 E+9 1.56
Inter-day 7.92 E+9 2 3.96 E+9
500 Intra-day 9.62 E+ll 9 1.07 E+ll 1.64
Inter-day 3.50 E+ll 2 1.75 E+ll
2500 Intra-day 1.68 E+13 9 1.86 E+12 2.95
Inter-day 1.10 E+13 2 5.49 E+12
4.4.4.2 Precision and linearity
Precision in the measurements of the steroid conjugates was also studied by 
repeatedly injecting samples at three different concentrations (100 pg/pl, 1 ng/pl and 5 
ng/pl for steroid glucuronides; 50, 500 pg/pl and 2.5 ng/pl for steroid sulfates) over three
days. The intra-day coefficient variances are between 6.0% and 13.6%, and the inter-day 
values range from 11.3% to 17.5%, whereas the total coefficient variances are from 7.2% 
to 14.3% (Table 4.14 a to e). It seemed that the precisions for steroid conjugates using the 
ESI source are not as good as those o f  free steroids with APCI source, this may be 
because the ESI source is more sensitive to interferences.
Responses to all the five steroid conjugates were found linear in the investigated 
range o f  concentrations (100 pg/pl to 10 ng/pl for steroid glucuronides and 50 pg/pl to 
2.5 ng/pl for steroid sulfates). Correlation coefficients o f linear regression are from 
0,9997 up to 0.9999. Calibration curves and regression equation are presented in Figure 
4.13 (a to e).
Table 4.14 (a) Precision in the measurements o f 
testosterone glucuronide
Concentration
(Pg/pl)
Intra-day
(%CV)
Inter-day
(%CV)
Total
(%CV)
100 7.5 11.9 8.5
1000 13.3 15.5 13.8
5000 7.8 15.6 13.8
Figure 4.13 (a) Calibration curve o f  testosterone glucuronide
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Table 4.14 (b) Precision in the measurements o f
5a-androstan-3a, 17p-diol glucuronide
Concentration Intra-day Inter-day Total
(pg/pl) (%CV) (%CV) (%CV)
100 11.9 14/7 12.4
1000 10.4 16.3 11.7
5000 10.2 13.1 10.8
Figure 4.13 (b) Calibration curve o f 5a-A ndrostan-3a, 17p-diol glucuronide
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Table 4.14 (c) Precision in the measurem ents o f 
androsterone glucuronide
Concentration
(Pg/pl)
Intra-day
(%CV)
Inter-day
(%CV)
Total
(%CV)
100 7.9 13.6 9.2
1000 11.4 17.2 12.7
5000 6.0 11.3 7.2
Figure 4.13 (c) Calibration curve o f androsterone glucuronide
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Table 4.14 (d) Precision in the measurements o f
testosterone sulfate
Concentration
(Pg/pl)
Intra-day
(%CV)
Inter-day
(%CV)
Total
(%CV)
50 8.5 15.6 10.1
500 10.2 17.5 11.8
2500 8.5 11.6 9.1
Figure 4.13 (d) Calibration curve o f testosterone sulfate
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Table 4.14 (e) Precision in the m easurements o f
androsterone sulfate
Concentration
(Pg/pl)
Intra-day
(%CV)
Inter-day
(%CV)
Total
(%CV)
50 13.6 17.0 14.3
500 9.6 12.2 10.1
2500 8.4 14.4 9.8
Figure 4.13 (e) Calibration curve o f androsterone sulfate
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4.4.4.3 Limits o f quantitation
Limits o f quantitation o f each steroid conjugate were also studied based on the 
regression lines o f  y on x from the calibration curves above, and the results were present 
in Table 4.15. The limits o f quantitation o f steroid glucuronides ranged from 89.4 to 
139.6 pg, whilst lower values, from 60.2 to 55.6 pg, were obtained for steroid sulfates.
y = 6432.2x+ 101859 
R2 = 0.9999
0 1000 2000 3000 4000 5000 6000
Concentration (pg/pl)
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Table 4.15 Limits of quantitation of the steroid conjugates
Steroid conjugate Limit of quantitation (pg)
Testosterone glucuronide 132.8
5a-Androstan-3a, 17p-diol glucuronide 139.6
Androsterone glucuronide 89.4
Testosterone sulfate 55.6
Androsterone sulfate 60.2
4.5 Conclusions
LC-MS methods were developed in the aim of quantitative analysis of some 
androgenic steroids and their glucuronide or sulfate conjugates in this chapter. C l 8  and 
C8  columns were compared to get the better separation for the androgenic steroids, and 
then a LC-APCI/MS method was used to successfully detect and identify testosterone 
from male and female plasma samples. In order to increase the sensitivity, APCI/MS 
parameters were optimized for a micro-bore column employing a lower flow rate to give 
the best intensities of their characterized peaks of these steroids. Limits of detection for 
different scan modes were determined and compared, and the more sensitive SIM mode 
was chosen for the simultaneous quantitative analysis of eight free steroids. An ANVOA 
method was used to estimate the variance. The precision and the linearity of quantitation 
for each compound were determined.
In the second part of this chapter, a LC-ESI/MS method was developed and the 
parameters of ESI/MS were optimized for the analysis the steroid conjugates. Following 
a similar procedure to the free steroids, the SIM scan mode was determined as the most 
appropriate mode for quantitative analysis of five steroid conjugates, and the precision,
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linearity and the limit of quantitation were similarly evaluated for each of these 
conjugates.
The LC-MS technique discussed in this chapter has provided a reliable for the 
determination of steroids and their conjugates in the biological fluids. Moreover, it 
generates structural information at the same time of analysis, and it only detects ionizable 
components in the specified mass range, thus avoiding many interferences by choice of a 
mass range or “window” applicable to the compounds of interest, therefore, this 
technique is more specific compared to the other techniques such as RIA and HPLC 
itself. However, concentration steps may be need in the application of the clinical or 
biological analysis due to the extremely low concentration of many steroids of interest in 
biological fluids.
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Chapter 5
Studies o f Derivatization of Androgenic Steroids and 
their Conjugates by HPLC-MS
5.1 Introduction
As discussed in Chapter 4, LC-MS has become an important technique and been 
extensively studied by many researchers for androgenic steroid analysis. However, 
sensitivity is still a challenge for direct determination of most androgenic steroids in 
biological systems due to very low concentration of these compounds. Derivatization is a 
useful technique that can enhance the performance of analytes commonly used in GC or 
GC-MS, but still not widely applied in LC-MS.
In GC or GC-MS analysis, trimethylsiyl (TMS) and other alkysilyl ethers for 
hydroxy functions and the O-methyloxime (MO) for ketonic functions have been 
commonly used for derivatization agents. Kintz et al. determined DHEA 1 and 
testosterone (T) 2 in hair derivatized with silyl ether by GC-MS to confirm the 
physiological concentration range of these compounds. Using TMS ether derivatization 
and GC-MS, the concentrations of T, its glucuronide, androsterone and epitestosterone 
(ET) in blood spots were investigated by Peng et al. 3. A method for determination of 
urinary DHEA and DHEAS using GC-MS was reported by Dehennin et al. 4  The DHEAS 
was extracted, hydrolyzed, and the liberated DHEA was derivatized to tert- 
butyldimethylsilyl ether and then analyzed by GC-MS with selected ion monitoring 
(SIM) to investigate the effect of a single dose of DHEA on the urinary androgen profile. 
Choi et al. 5 introduced pentafluorophenyldimethylsilyl (flophemesy)-TMS derivatives for 
simultaneous determination of eight steroids (AD, DHT, DHEA, T, A, ET, progesterone 
and pregneolone) in human hair, which was done with GC-MS using [ H3 ]T as internal 
standard (I.S.). The method involved alkaline digestion, liquid-liquid extraction and 
subsequent conversion to the flophemesyl-TMS ethers, which formed an intense 
molecular ion and minimized background noise so that a sensitive analysis was achieved
with SIM. The detection limits of the steroids varied in the range of 0.02 to 0.5 ng/g 
(S/N=3). Scherer et al. 6 reported a method for the determination of T in human hair by 
GC-MS using [ H3]T as I.S. They showed that the derivatization with heptafluorobutyric 
anhydride gave rise to high mass ions thus diminishing background noise, and that these 
derivatives had shorter retention times than those of MO-TMS ethers. The detection limit 
was 20 pg (S/N=3.4). Tagava et al. presented a determination method for DHEAS and 
pregnenolone sulfate (PREGS) in serum of patients with hyperthyroidism and 
hypothyroidism using GC-SIM-MS after hydrolysis and derivatization with 
heptafluorobutyric anhydride.
Although conjugated metabolites have usually been analyzed by GC or GC-MS 
after enzymic or alkaline hydrolysis and derivatization, some methods not requiring 
deconjugation have been described. A simplified method for measurement of serum 
DHEA and DHEAS using GC-MS-MS in a single injection with selected reaction 
monitoring (SRM) was reported by Zemaitis and Kroboth 8 It appeared that at the 
elevated temperature of the GC injector port, a reproducible decomposition occurred in 
which the elements of sulfuric acid were removed and one of three isomers is formed 
with different location of double bonds in the steroid A- or B-ring. A method for 
simultaneous determination of nine urinary androgen glucuronides by high temperature 
GC-MS after derivatization to methyl ester-TMS ethers was reported by Choi et al. 9.
In recent years, derivatization technique has been applied to LC-MS, although it is 
still not widely used. Shackleton et al. 10 developed a method to derivatize nine 
testosterone fatty acid esters to Girard hydrozones, and the method was also applied to 
the measurement of testosterone fatty acid esters in the plasma of healthy volunteers after 
intramuscular adminstration of testosterone fatty acid esters using LC-ESI/MS/MS. Liu 
and co-workers11 described a method to convert neutral oxosteroids into their oximes by
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treatment with hydroxyl ammonium chloride in aqueous methanol. The fragmention 
pathways of these steroid oximes were studied by ESI/MS/MS, and the detection limits 
were found to be improved about 2 0  times relative to free steroids.
In this chapter, we have developed a derivatization method to improve the 
sensitivities of detection for the analysis of androgenic steroids and their conjugates by 
LC-ESI/MS/MS.
5.2 Experimental
5.2.1 Materials
HPLC grade methanol, acetonitrile, water and analytical grade ethanol were 
purchased from Fisher Scientific (Loughborough, Leicester, UK). Formic acid, acetic 
acid and most of the steroids were purchased from the Sigma-Aldrich Co. Ltd. (Poole, 
Dorset, UK), except 5P-androstan-17P-ol-3-one, A4-androsten-17a-ol-3-one, A4 - 
androsten-17p-ol-3-one sulfate sodium salt and A4-androsten-17a-ol-3-one glucuronide 
which were purchased from Steraloids INC (Newport RI, USA).
Hydrazide-TMPP reagent, (4-hydrazion-4-oxobutyl) [tris (2,4,6-
trimethoxyphenyl)] phosphonium bromide was a kind gift from Glaxo Reseach and 
Development Ltd.
A LUNA Ci8 (2) (100 x 2.0 mm, 3 pm) column and guard cartridge were 
purchased from Phenomenex (Cheshire, UK).
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5.2.2 Derivatization
A hydrazide-TMPP reagent stock solution (1 mg/ml) was prepared by dissolving 
the solid reagent in ethanol-glacial acetic acid (9:1, v/v) using an ultrasonic bath. This 
solution is stable without significant decomposition at 20°C for at least one day. The 
steroid was dissolved in methanol as a stock solution ( 1 0 0  pg/ml), and 1 0  pi was added 
into 100 pi freshly prepared TMPP reagent solution; after briefly mixing in ultrasonic 
bath, the solution was allowed to react in a 60°C water bath for two hours.
5.2.3 HPLC parameters
The derivatized steroids were injected by an auto-sampler through the column into 
the mass spectrometer. The column temperature was maintained at 40°C, and the flow 
rate was 0.4ml/min with 5 pi volume injection. Gradient system (a) was used to study an 
individual derivatized steroid and (b) was used for the separation of derivatized steroid 
mixtures.
(a)
Time (min) MeCN containing 0.1% Water containing 0.1%
formic acid (v/v %) formic acid (v/v %)
0 35 65
1 0 60 40
1 2 60 40
(b)
Time (min) MeCN containing 0.1% Water containing 0.1%
formic acid (v/v %) formic acid (v/v %)
0 35 65
6 35 65
7 40 60
15 45 55
25 45 55
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5.2.4 MS parameters
Mass spectrometric experiments were performed on a Finnigan LCQ ion trap mass 
spectrometer (San Jose, CA) equipped with X-callubar software. The ESI interface in 
positive mode was used for the analysis and the major parameters are listed as below:
MS parameter HPLC Flow rate of 0.4ml/min
Sheath gas flow (arbitrary units) 80
Auxiliary gas flow (arbitrary units) 20
Spray voltage 4.5 kV
Capillary temperature 250°C
Capillary voltage 40 V
Tube lens offset 50 V
5.3 Derivatization o f  androgenic steroids
5.3.1 Structure of the derivatizing reagent
The structure of the derivatizing reagent, (4-hydrazion-4-oxobutyl)
[tris (2,4,6-trimethoxyphenyl)] phosphonium bromide was shown in Figure 5.1.
Figure 5.1 Structure of hydrazide-TMPP reagent12
OMe
MeO
.OMe
OMe
MeO
NH
OMe
OMe
MeO
OMe
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5.3.2 Reaction of hydrazide-TMPP reagent with androgenic steroids
As shown in Figure 5.2, steroid derivatives were formed by the reaction of the
1 ?hydrazine group in the hydrazide-TMPP reagent with the keto group in the steroids . 
The resulting positive charge introduced into the structures of the steroid derivative 
enhances their ionization efficiencies by ESI-MS.
Figure 5.2 Reaction of hydrazide-TMPP reagent with androgenic steroids
,NH2  0
r 2
A cetic  ac id N  -
NHAr
\
HoO
Ar = 2 ,4 ,  6 - trimethoxyphenyl
5.3.3 Optimization of steroid derivatization reaction
5.3.3.1 Stability of hydrazide-TMPP reagent
The solid hydrazide-TMPP reagent was stored in a fridge and found to be stable 
for at least three months. However, when dissolved in ethanol-glacial acetic acid (9:1, 
v/v), the solution was found to have undergone about 50% degradation by the second 
day, a little further degradation by the third day, and no further degradation by the fourth
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day. The reagent solution was therefore prepared fresh everyday for the derivatization 
experiments. Figure 5.3 shows the stability o f  the reagent solution detected by LC-MS for 
four days.
Figure 5.3 Stability of hydrazide-TMPP reagent 
solution (m/z 633)
1.20E+08
1.00E+08
.00E+07C/5fi
§  6.00E+07 
|  4.00E+07 
2.00E+07
0.00E+00
0 1 54
5.3.3.2 Optimization o f the react conditions
To gain the maximum reaction o f  Hydrazide-TM PP reagent with the investigated 
steroids, at least 30-fold excess o f  the reagent was used for the reaction. The reaction 
conditions were optimized by a study o f  the effect o f incubation tem perature on yield. 
Samples were incubated at room tem perature in sonic bath for 30 minutes, a water bath 
heated to 60 °C for 1 hour, 2 hours and 3 hours, and then further heated to 80 °C for 1 
hour.
Figure 5.4 shows that the intensities o f derivatization products are increased as 
the tem perature increases, reaching m aximum  values after heating at 60 °C for 2 hours. In 
the case o f  testosterone, 5a-androstan-3, 17-dione, and dihydrotestosterone derivatives, 
heating for 3 hours at 60 °C caused the intensities to drop slowly, and to fall sharply for
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DHEA and epitestosterone derivatives. When the tem perature was increased to 80 °C, the 
intensities for all the test steroid derivatives decrease to the level observed at o f room 
temperature.
Figure 5.4 Optimization of derivatization conditions
2.50E+07
2.00E+07
s  1.50E+07
— 1.00E+07
6 0 (1  hour) 60 (2 hours) 60 (3hours) 80 ( 1  hour) 
Temperature
1. Testosterone; 2. Epitestosterone; 3. Dehydroisoandrosterone; 4. Dihydrotestoserone; 
5. 5a-androstan-3, 17-dione
5.4 HPLC-MS of steroid derivatives
5.4.1 HPLC-MS o f hydrazide-TMPP reagent
The hydrazide-TM PP reagent was eluted within two minutes. Figure 5.5 shows 
total ion chromatograph o f  the reagent and the corresponding mass spectrum. A very 
strong peak o f [M]+ (m/z 633) was observed, as well as the peak o f [M-NHs]+ in a 
relative low abundance.
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Figure 5.5 (a) Total ion chromatography of hydrazide-TMPP reagent (b) mass spectrum
of hydrazide-TMPP reagent
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5.4.2 HPLC-MS of derivatized steroids
5.4.2.1 Chromatography of steroid derivatives
Derivatization changed the chromatographic character of the investigated steroids, 
and the retention time of the derivatives was longer compared to the corresponding non- 
derivatized steroids. TMPP-derivatives of conjugated steroids were retained on the C l 8  
column, which did not retain the non-derivatized conjugates. Retention times of the non­
conjugated steroid derivatives fall between the steroid glucuronide derivatives which 
elute early and steroid sulfate derivatives that are considerably retained for all the 
investigated compounds. Table 5.1 presented the retention times of the TMPP-derivatives 
of some steroids and their conjugates.
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Table 5.1 Retention times of TMPP derivatives of some steroids 
and their conjugates
Steroid derivatives Retention 
time (min)
Steroid derivatives Retention 
time (min)
Testosterone 11.63, 13.48 Dehydroisoandrosterone 12.44
Testosterone G* 5.24, 8.16 Dehydroisoandrosterone G 4.64
Testosterone S* 14.86, 16.60 Dehydroisoandrosterone S 16.06
Androsterone 16.41 Etiocholan-3a-ol-17-one 16.19
Androsterone G 11.07 Etiocholan-3a-ol-17-one G 10.98
Androsterone S 19.15 Etiocholan-3a-ol-l 7-one S 19.55
*G, glucuronide; S, sulfate. Experimental conditions are refer to 5.2.3 (a).
Only one peak was observed in the extracted ion current chromatogram for those 
of steroids without a A4  bond after reaction of the keto-group with the TMPP reagent, but 
for those steroids of with a A4  bond system e.g. testosterone, its conjugated derivatives 
and epitestosterone derivative (Table 5.1), there were two peaks observed, whilst three 
peaks were obtained for A4 -androsten-3 , 17-dione and A4 -androstene-3 , 11, 17-trione 
derivatives (Figure 5.7).
As the result of derivatization, two types of products could be formed: the keto- 
type hydrazone and the enol-type hydrazone. The keto-type may be dominant because it 
is much more stable than the enol-type, however, the A4 -double bond in the A-ring of 
testosterone and epitestosterone helps to stabilize the other two double bonds in the enol 
type hydrazone, and make it more competitive in the derivatized reaction. This also might 
explain two of the three peaks observed in the spectra of A4-androsten-3,17 dione and A4 - 
androstene-3, 11, 17-trione, whilst the third peak may be the ‘ketone-tautomer’ of the 17- 
one derivative. The conversion from ketone-type testosterone derivative to enol-type is 
presented in Figure 5.6. Another possibility is that there were two stereo-isomers (cis- or
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trans-, Figure 5.2) formed after derivatization, and they were simply not separated for the 
steroid derivatives without A4 bond.
Figure 5.6 Tautomerization of testosterone derivative
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(OMe)3Ph 
(OMe) 3 Ph— P— Ph(MeO) 3 / - \ / c7 ' - \ / c>
N_N=\  /" \  A r
V J
Ketone-type testosterone hydrazone Enol-type testosterone hydrazone
However, there is only one peak observed in the extracted ion current 
chromatograph of 5a-androstan-3, 17-dione derivative and 5a-androstan-3a-ol-ll, 17- 
dione derivative, under various conditions of the HPLC solvent gradient. There are either 
two different compounds not to separated or only one compound resulted from the 
competition between 17-one and 3-one or 11-one. The latter is probably the case for 5a- 
androstan-3a-ol-ll, 17-dione derivative, since there is much bigger steric hindrance at 
C ll than that at C l7. The extracted ion current chromatogram of the TMPP-derivatives 
of selected steroids and steroid conjugates is present in Figure 5.7.
Figure 5.7 Extracted ion chromatogram of eight steroid TMPP-derivatives
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5.4.2.2 Mass spectra of steroid TMPP-derivatives
The steroid TMPP-derivatizes, in which the molecular ion of the parent steroid 
was increased by 615 mass units by the TMPP moiety, were investigated under ESI-MS 
condition due to the introduction of the positive charge in the derivatization reaction. For 
the TMPP-derivatives of non-conjugated steroids, M+ was generally dominant in the 
spectrum of each of these compounds, with the exception of DHT and 5P-androstan-17p- 
ol-3-one, in the spectra of which the fragment ion at m/z 633 was the most intensive 
peak. There were also isotope peaks of [M+l] +, [M+2] + and [M+3] + observed in each 
of these spectra. Significant peaks assigned to dehydration of the molecular ion were 
observed in the spectra of non-derivatized steroids without a 4-ene-3-one group (Chapter 
3), but peaks due to loss of water were not observed the spectra of their TMPP- 
derivatives. It seemed that the spectra of DHT and 5p-androstan-17p-ol-3-one contained
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more fragments than their 17-one isomers. The major ions of the derivative of each non-
conjuated steroid are presented in Table 5.2.
Table 5.2 Major ions of TMPP-derivatives of non-conjugated steroids by ESI-MS
Steroid M+ [M+l]+ [M+2]+ [M-176]+ m/z
633
m/z
616
m/z
587
m/z
570
Dehydroisoandroste­ 903.6 904.6 905.6 _ _ _ _
rone (DHEA) (100) (47) (13)
5a-Androstan-3, 17- 903.6 904.6 905.6 _ _ _
dione (100) (44) (14)
Etiocholan-3|3-ol-l 7- 905.6 906.6 907.6 _ _ _ _ _
one (100) (49) (15)
5a-Androstan-3|3-ol- 905.6 906.6 907.6 _ _ _ _ _
17-one (100) (46) (15)
Androsterone 905.6 906.6 907.6
(100) (43) (14)
Etiocholan-3a-ol-17- 905.6 906.6 907.6 _ _ _ _ _
one (100) (44) (15)
5a-Androstan-17|3- 905.6 906.6 907.6 633.4 616.4 587.4 570.3
ol-3-one (DHT) (65) (31) (8) (100) (33) (9) (11)
5(3-Androstan-l 70- 905.6 906.6 729.4 633.4 616.4 587.4 570.3
ol-3-one (30) (14) (60) (100) (33) (13) (6)
5a-Androstan-3 (5-ol- 905.6 906.6 907.6 _ — _ _ _
16-one (100) (47) (15)
5a-Androstan-3a-ol- 919.6 920.6 921.6 _ _
11, 17-dione (100) (44) (14)
5a-Androstan-3a, 921.6 922.6 923.6 _
11 (3-diol-l 7-one (100) (48) (14)
For the derivatives of steroid glucuronides, M+ was the most intense peak in the 
spectrum of each compound which was also increased by 615 mass units relative to the 
original steroid, whereas, for the derivatives of steroid sulfates, [M+H-Na]+ was the 
dominant peak in each case, although a molecular ion (M+) was also observed in low
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relative abundance. The major ions of the TMPP-derivatives of each conjugated steroid
are presented in Table 5.3.
Table 5.3 Major ions of TMPP-derivatives of conjugated steroids by ESI-MS
Steroid
Derivative
M+ [M+l]+ [M+2]+ [M+H-Na]+ [M+H-Na+1]+ [M+H-Na+2]+ m/z
887
DHEA G 1079.3 1080.3 1081.3 _ — _ _
(100) (45) (16)
DHEA S 1005.3 983.3 984.3 985.3
(7) (100) (40) (16)
Androsterone G 1081.4 1082.4 1083.4
(100) (51) (17)
Androsterone S 1007.3 985.3 986.3 987.3 887.5
(9) (100) (40) (15) (17)
Etiocholan-3oc- 1081.4 1082.4 1083.4 _ _ _
ol-l 7-one G (100) (51) (15)
Etiocholan-3a- 1007.3 985.3 986.3 987.3 887.5
ol-l 7-one S (20) (100) (46) (15) (87)
DHEA, dehydroisoandrosterone; G, glucuronide; S, sulfate
TMPP-derivatives of steroids without a A4-bond
The peak intensities in the extracted current chromatograms observed with 17-one 
derivatives were much higher than those from 3-oxo derivatives for keto-steroids. For 
example, the peak intensities of DHT and 5(3-Androstan-17(3-ol-3-one derivatives are 
more than 50 times lower that those of their 17- or 16-one isomers. Therefore, the keto- 
group at D ring may be more reactive than the keto-group at the A ring for the 
derivatization reaction. However, there seems an exception when Aj-double bond is 
present at A ring, because very intense peaks were observed for testosterone and 
epitestosterone derivatives (Table 5.6). For the 17-one steroids, there was little difference
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in signal strengths between either the 5a- and 5p- isomer, or the 3a-ol and 3 P-ol isomers 
(Table 5.4). As to the two dione-steroids, only one peak observed in their spectra, but the 
peak intensities are higher than those steroid derivatives containing only one oxo group. 
The peak intensities in the extracted current chromatogram for DHT and its isomers at 
m/z of 905 are listed in table 5.4.
Table 5.4 Peak intensities of TMPP-derivatives of eleven oxo-steroids
Steroid
Concentration of 
react steroid 
( p g / m l )
m/z Peak
intensity
*5a-Androstan-17p-ol-3-one (DHT) 1 0 . 0 905.6 1.01 X  106
* 5 p-Androstan-17 p-ol-3 -one 1 0 . 0 905.6 5.19 x 10s
5a-Androstan-3P-ol-17-one 1 . 0 905.6 4.80 x 106
5a-Androstan-3a-ol- 17-one 1 . 0 905.6 7.95 x 106
5p-Androstan-3a-ol-l 7-one 1 . 0 905.6 7.95 x 106
5 P- Androstan-3 P-ol-17-one 1 . 0 905.6 5.31 x 106
5a-Androstan-3 p-ol-16-one 1 . 0 905.6 6.28 x 1 0 6
A5-Androstan-3P-ol-17-one 1 . 0 903.6 5.25 x 106
5a-Androstan-3 a, lip-diol-17-one 1 . 0 921.6 3.95 x 106
5 a-Androstan-3, 17-dione 1 . 0 903.6 1 . 1 2  x 1 0 7
5a-Androstan-3a-ol-ll, 17-dione 1 . 0 919.6 2 . 2 2  x 1 0 7
Note: sample was injected at 5 pi.
TMPP-derivatives of 4-ene-3-oxo steroids
There were two peaks observed in the total ion chromatogram for testosterone, its 
conjugated derivatives and epitestosterone derivative, three peaks observed for A4 - 
androsten-3, 17-dione derivative and four for the derivative of A4 -androstene-3 , 11, 17- 
trione. The ions showed in the mass spectrum of each are presented in Table 5.5.
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The spectra of the two peaks were in each case extremely similar for the 
derivatives of testosterone, its conjugates and epitestosterone. There was only slight 
difference in abundance of their isotope peaks. However, absolute peak intensities of the 
peaks are quite different for each of these derivatives as in Table 5.6. For the derivatives 
of testosterone, its conjugates and epitestosterone, the intensities of later eluting peak are 
about x2 - x4 higher than those of the first. The later eluting peak may therefore be the 
enol-type product of the derivatization reaction, because the three conjugated double 
bonds make it more stable than the keto-type product, therefore favouring its formation in 
the reaction.
There were three peaks observed for A4 -androsten-3 , 17-dione derivative in its
total ion chromatogram. The spectra of peak one and peak three are very similar, only
slight differences in the isotope peaks of m/z 901.6, but peak two showed a very different
spectrum that contained a very intense peak at m/z 758.9, corresponding to a doubly
charged ion derived from the bi-TMPP derivative. It therefore appear that when the A4 -
double bond is present, both the 3- and 17-oxo group can be derivatized, whereas, there
was no corresponding ion was observed in the spectra of 5a-androstan-3, 17-dione and
11-ketoandrosterone derivatives, which lack the A4 -double bond. Thus there were only
mono-TMPP derivatives produced in the di-oxo steroids without A4 -double bond in ring
A. In a similar pattern, four peaks were obtained in the total ion chromatogram of the A4 -
androstene-3, 11, 17-trione derivative. The first two peaks showed very similar spectra,
with a molecular ion of m/z 915.5 dominant. In peak three, however, the most intense ion
in the spectrum was observed at m/z 715.4, corresponding to a triply-charged ion derived
from the tri-TMPP derivative, and this peak was accompanied by a much weaker but
significant ion of m/z 765.8, corresponding to a doubly-charged ion derived for a di-
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substituted TMPP-derivative. The m/z 765.8 ion was also present and dominant in the 
spectrum of peak four, probably due to the incomplete HPLC separation of di- and tri­
substituted TMPP-derivatives. The peak intensities of these observed ions were presented 
in Table 5.6.
Table 5.6 Comparison of the peak intensities of the TMPP-derivatives of 4-ene-3-oxo steroids
Steroid m/z Peak 1 m/z Peak 2 m/z Peak 3 m/z Peak 4
Testosterone 903.6 2.22 x 106 903.6 9.14 x 106 _ _ _
Epitestosterone 903.6 2.01 x 106 903.6 7.85 x 106 _ _ _
Testosterone G 1079.5 6.53 x 106 1079.5 1.64 x 107 _ _ _
Testosterone S 983.3 8.23 x 106 983.3 3.15 x 107 _ _ _
A4-Androsten-3, 901.6 8.81 x 106 758.9 1.24 x 106 901.6 1.10 x 107 _
17-dione 901.6 2.46 x 106
A4-androstene-3, 915.5 6.91 x 106 915.5 6.89 x 105 715.4 9.01 x 105 765.8 1.36 x 106
11, 17-trione 915.5 3.87 x 106
For A4 -androsten-3 , 17-dione, the intensity of m/z 901.6 in peak three is a little 
stronger than that in peak one, and more than four times that in peak two. Both the ion of 
m/z 901.6 and 758.9 are present in the spectra of peak two, but the intensity of m/z 758.9 
is about as half as that of m/z 901.6, therefore, the mono-TMPP derivative is the major 
product in the derivatization reaction. As to A4 -androstene-3 , 11, 17-trione, the 
derivatization yields a more complicated mixture of product, with both the bi-TMPP (m/z
715.4) and tri-TMPP (m/z 765.8) derivatives, as well as the mono-TMPP product (m/z
915.5) observed. The intensity of m/z 915.5 in peak one is the strongest one in all four 
peaks, and it is almost ten times to the one in peak two. Although ion at m/z 715.4 was 
observed in peak three, it is very weak, about ten times lower in abundance than those of 
m/z 915.5 and m/z 765.8 in peak four. Therefore, the mono-TMPP and tri-TMPP 
derivatives are major products in the reaction.
5.4.3 HPLC-MS/MS o f steroid derivatives
5.4.3.1 CID spectra of TMP- derivatives of steroids without a A4 -bond 
Non-conjugated steroids
A fragment ion of m/z 859 was observed in the CID spectra derived from the 
molecular ion of DHT and all of its isomers, which corresponded to loss of nitrogen and 
water ([M-N2 -H2 0 ]*). The fragment ions from the fission of the TMPP group were 
observed in quite high abundances at m/z 616, 600, 570 and 533 (Figure 5.5 b). These 
fragments were very similar for all the 17-one and 16-one isomers, with the fragment ion 
at m/z 533 dominant in the spectra of these compounds, whereas the spectra of the 3-one 
isomers were dominated by the peak at m/z of 600. A further difference was apparent 
between 17-one and 3-one isomers: whilst in the spectra of 3-one isomers, m/z 889, 
corresponding to loss of oxygen, was present relatively low abundances, no such an ion 
was detected in the spectra of the 17-one isomers. Some typical spectra of these steroids 
are present in Figure 5.8.1-2, and the proposed of the identity fragment ions and their 
abundances are listed in the Table 5.7.
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Figure 5.8.1 CID of DHT derivative
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Figure 5.8.2 CID of androsterone derivative
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The CID spectra of the TMPP-derivatives of 5a-Androstan-3, 17-dione (Figure 
5.9.1) and of DHEA (Figure 5.9.2) contained a similar set of fragments characteristic of 
the TMPP group; m/z 533 was dominant in both spectra. Fragment ions assigning from 
Wolff-Kishner reaction (m/z 857) were also present, and the spectrum of DHEA, 
contained a fragment ion at m/z 873, representing loss of 30 mass units from the parent 
ion.
Figure 5.9.1 CID of 5a-androstan-3, 17-dione derivative
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Figure 5.9.2 CID of DHEA derivative
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It seems that the mechanism of the fragmentation of the 11 p-hydroxyandrosterone 
derivative (Figure 5.10.1) is as the same as the 17-one isomers of DHT (Figure 5.8.1), 
because the CID spectrum of the former was very similar to the latter, indicating that the 
second hydroxy group does not cause any difference in the fragmentation pathway. 
However, in the case of 11-ketoandrosterone (Figure 5.10.2) the spectrum is different, the 
abundance of m/z 616 being enhanced relative to 5a-Androstan-3, 17-dione and DHEA 
in its CID spectrum, probably suggesting that the additional keto-group at the Cl 1 of the 
structure modifies the fragmentation process of the 1 1 -ketoandrosterone derivative.
191
Figure 5.10.1 CID of 11 p-hydroxyandrosterone derivative
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Figure 5.10.2 11-Ketoandrosterone derivative
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Table 5.7 CID of the TMPP-derivatives of eleven non-conjugated steroids
without a A4 -bond system
Steroid Parent Collision Product ions
ion energy
(%)
m/z (relative abundance %)
1 905 40 859 (11), 616 (78), 600 (21), 586(7), 570 (7), 559 (11), 543 (28), 533 (100)
2 905 42 859 (12), 616 (83), 600 (26), 586(5), 570 (13), 559 (8), 543 (30), 533 (100)
3 905 42 859 (14), 616 (94), 600 (24), 586(5), 570 (14), 559 (7), 543 (36), 533 (100)
4 905 40 859 (11), 616 (79), 600 (22), 586(6), 570 (7), 559 (8), 543 (32), 533 (100)
5 905 42 889 (2), 859 (6), 616 (95), 600 (100), 586(7), 570 (10), 559 (11), 543 (37), 533 (87)
6 905 42 889 (5), 859 (5), 616 (95), 600 (100), 586(7), 570 (9), 559 (13), 543 (44), 533 (80)
7 905 42 859 (12), 616 (62), 600 (21), 586(3), 570 (9), 559 (16), 543 (24), 533 (100)
8 903 42 857 (11), 616 (93), 600 (27), 586(6), 570 (12), 559 (9), 543 (36), 533 (100)
9 919 40 873 (15), 616 (100), 600 (23), 570 (18), 559 (11), 543 (35), 533 (69)
10 921 42 875 (11), 616 (86), 600 (21), 586(6), 570 (15), 559 (8), 543 (34), 533 (100)
11 903 40 873 (4), 857 (15), 616 (87), 600 (24), 586 (5), 570 (8), 559 (10), 543 (32), 533 (100)
1. Etiocholan-3P-ol-l7-one, 2. Etiocholan-3a-ol-17-one, 3. 5a-Androstan-3P*ol-17-one, 4. Androsterone, 5. DHT, 6. 
5P-Androstan-17p-ol-3-one, 7. 5a-Androstan-3 P-ol-16-one, 8. a-Androstan-3, 17-dione, 9. 11-ketoandrosterone, 10. 
11 P-hydroxyandrosterone, 11. DHEA
Conjugated derivatives
The CID spectra of the TMPP-derivatives of the conjugated steroids were quite 
simple compared to those of the free steroids. It seemed that the steroid glucuronide 
derivatives were more likely to lose the glucuronide moiety rather than TMPP moiety, 
because [M-Glu]+ was dominant in the CID spectra of all the conjugated steroid 
derivatives investigated. For the androsterone glucuronide derivative (Figure 5.11.1), the 
most intense ion was at m/z 905, and there were further fragment peaks at m/z 533, 543, 
and 616 observed in the CID spectrum at relatively strong abundance, originating from 
the TMPP moiety. The [M-H2 0 ]+ (m/z 1063) and [M-H2 0 -N2 ]+ (m/z 1035) ions were 
also observed in this spectrum, as well as peaks at m/z 975 and 947 in relatively low 
abundances. The CID spectrum of its 5p-H isomer (Figure 5.11.2) was much simpler, the 
spectrum containing no fragment ions other than that at m/z 905, as was also the case for
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the DHEA glucuronide derivative (Figure 5.11.3). The proposed identity of fragment ions 
of these compounds and their abundances are listed in the Table 5.8.
Figure 5.11.1 CID of androsterone glucuronide derivative
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Figure 5.11.2 CID of etiocholan-3a-ol-17-one glucuronide derivative
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Figure 5.11.3 CID of DHEA glucuronide derivative
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The CID spectra for the steroid sulfate derivatives (except testosterone sulfate 
derivative) could not be determined by collision cell fragments due to their low efficiency 
of fragmentation, and therefore, the source skimmer was used to obtain their CID spectra. 
Fragment ion at m/z 903 was observed in a low intensity, corresponding to loss of sulfate 
sodium moiety (-SC^Na) and fragment ion at m/z 885, corresponding to further loss of 
water, was the most intense peak in the source CID spectrum of DHEA sulfate derivative 
(Figure 5.12.1). No fragment ions assigning from cleavage of the TMPP structure was 
observed, in contrast to the spectra of free steroid TMPP-derivatives, and this might be 
explained by the strong negative charge in the sulfate group, which make the whole 
structure more stable. A significant fragment at m/z 181 was also observed in the spectra, 
but its origin is not clear. Very similar spectra were observed for the TMPP-derivatives of 
androsterone sulfate (Figure 5.12.2) and eticholan-3a-ol-17-one sulfate (Figure 5.12.3), 
but the relative intensities of the peaks at m/z 905 and 181 were much lower for the latter.
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Figure 5.12.1 CID of DHEA sulfate derivative
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Figure 5.12.2 CID of androsterone sulfate derivative
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Figure 5.12.3 CID of etiocholan-3a-ol-17-one sulfate derivative
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Table 5.8 CID spectra of TMPP-derivatives of conjugated steroids lacking a A4 -bond system
steroid Parent Collision Product ions
ion energy
(%)
m/z (relative abundance%)
AG 1081 40 1063 (10), 1035 (24), 975 (7), 947 (16), 905 (100), 616 (40), 533 (9)
DHEA G 1079 35 1033(3), 903 (100)
DHEA S* 983 40 903 (23), 885 (100), 181 (18)
AS* 985 40 905 (8), 887 (100), 181 (15)
EG 1081 35 905(100)
ES* 985 20 905 (2), 887(100), 181 (6)
♦Spectrum was obtained by source CID.
A G, androsterone glucuronide; DHEA G, dehydroisoandrosterone glucuronide;
DHEA S, dehydroisoandrosterone androsterone A S; androsterone sulfate;
E G, Etiocholan-3a-ol-17-one glucuronide; E S, Etiocholan-3a-ol-17-one sulfate
5.4.3.2 CID spectra of TMPP-derivatives of the steroids with a A4 -bond system
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Non-conjugated steroids
Differentiation of testosterone from its 17a-OH isomer epitestosteone could not 
be achieved from the CID spectra of their TMPP-derivatives, because they gave not only 
the same fragments but also similar abundances of those fragments. Their spectra 
essentially contained a fragment ion at m/z 857, the product from Wolff-Kishner 
reduction, and also a series of fragment ion peaks from the TMPP group (m/z 616, 601, 
600, 570, 543, 533, 371). As reported above, there were two peaks observed in the total 
ion chromatographs for testosterone and epitestosterone derivatives. The CID spectra of 
these two peaks were also very similar, however, the slight differences of the ratio of 
relative abundance of m/z 600 and its isotope peak m/z 601 between these two peaks 
(Table 5.9) may indicate some differences of their steric structures. Typical CID spectra 
of TMPP-derivatives of steroids with a A4 -bond are show in Figure 5.13, 5.14.1-2, 5.15.1- 
2 and 5.16.1-2, and details of these spectra are summarized in Table 5.9.
Figure 5.13 CID of testosterone derivative
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The CID spectra of A4 -androsten-3 , 17-dione derivative generated from a parent 
ion of m/z 901 were also investigated (Figure 5.14.1-2). Of the three peaks previously 
observed in total ion chromatograph, the CID spectrum of peak one was quite different 
from those of peaks two and three. A fragment ion at m/z 616 was dominant in the 
spectrum of peak one, whilst m/z 533 was dominated in the spectra of peaks two and 
three. Moreover, fragments of m/z 369 was observed in the spectra of peak two and three, 
but no such an ion found in the spectrum of peak one. Comparing the CID spectra of 
peaks two and three of the A4 -androsten-3 , 17-dione derivative with that of the 
testosterone derivative, it seems the pattern of their dissociation is similar, so peaks two 
and three may be correspond to the 3-oxo product formed during the derivatization of A4- 
androsten-3, 17-dione, that may also undergo structure tautomerization in a similar 
manner to testosterone. A CID spectrum of the bi-derivative product (m/z 759) was not 
available due to insufficient abundance.
Figure 5.14.1 CID of A4 -androsten-3 , 17-dione derivative (peakl)
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Figure 5.14.2 CID of A4-androsten-3, 17-dione derivative (peak2)
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The pattern of dissociation observed for A4 -androstene-3 , 11, 17-trione from patent 
ion at m/z 915 was very similar to A4 -androsten-3 , 17-dione. The CID spectrum of peak 
one was also different from those of peaks two and four. In the former m/z 616 was 
dominant, but m/z 533 was most intense in the latter. In addition, there was a peak at m/z 
383 observed in the latter CID spectra but not observed in the former. The CID spectra of 
bi- and tri-derivatives were also not achieved as the result of their sensitivities. The CID 
spectra of A4 -androstene-3 , 11, 17-trione TMPP derivative from peak 2 and peak 4 are 
shown in Figure 5.15.1-2.
200
Figure 5.15.1 CID of A4-androstene-3, 11, 17-trione derivative (peakl)
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Figure 5.15.2 CID of A4 -androstene-3 , 11, 17-trione derivative (peak2)
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Conjugated steroids
CID spectra of conjugated testosterone derivatives were quite simple, only m/z of 
903 was observed in the spectrum of testosterone glucuronide (Figure 5.16.1), 
corresponding to the loss of glucuronide moiety. Whilst besides m/z 903, there was only 
a peak of low abundance at m/z 885 in the spectrum of testosterone sulfate (Figure 
5.16.2), corresponding to the further loss of water. There was no difference observed 
between peaks one and two for either of these two conjugated derivatives.
Figure 5.16.1 CID of testosterone glucuronide derivatve
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Figure 5.16.1 CID of testosterone sulfate derivative
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Table 5.9 ESI-MS/MS of derivatized androgenic steroids
Steroid Parent
ion
Collision
energy
(%)
Product ions 
m/z (relative abundance)
T 903 (peak 1) 40 857 (5), 616 (54), 601 (15), 600 (18), 570 (6), 543 (8), 533 (100), 371 (7)
903 (peak2) 40 857 (6), 616 (54), 601 (15), 600 (19), 570 (5), 543 (9), 533 (100), 371 (7)
ET 903 (peakl) 40 857 (6), 616 (54), 601 (14), 600 (19), 570 (6), 543 (7), 533 (100), 371 (7)
903 (peak2) 40 857 (6), 616 (51), 601 (15), 600 (16), 570 (6), 543 (7), 533 (100), 371 (7)
A^Dione 901 (peak I) 42 855 (15), 616 (100), 601 (5), 600 (29), 570 (14), 559 (12), 543 (41), 533 (92)
901 (peak 2) 42 855 (8), 616 (68), 601 (17), 600 (24), 570 (9), 559 (4), 543 (12), 533 (100), 369 (6)
901 (peak 3) 42 855 (8), 616 (66), 601 (15), 600 (24), 570 (9), 559 (3), 543 (10), 533 (100), 369 (6)
A^Trione 915 (peak 1) 42 869 (20), 616 (100), 601 (2), 600 (27), 586 (7), 570 (18), 559 (13), 543 (42), 533 (50)
915 (peak 2) 42 869 (8), 616 (74), 601 (16), 600 (40), 586 (3), 570 (11), 559 (5), 543 (15), 533 (100), 383 (5)
915 (peak 4) 42 869 (8), 616 (69), 601 (18), 600 (42), 586 (3), 570 (10), 559 (4), 543 (11), 533 (100), 383 (6)
T G 1079 (peakl) 37 903 (100)
1079 (peak2) 37 903 (100)
T S 983 (peak 1) 37 903 (100), 885 (4)
983 (peak 2) 37 903 (100), 885 (5)
■"Spectrum was achieved by source CID.
T, testosterone; ET, epitestosterone; A4 - Dione, A4-androstene-3, 17-dione;
A4- Trione, A4-androstene-3,11 ,17-trione; T G, testosterone glucuronide; T S, testosterone sulfalte.
5.4.4 Limits of detection
Limits of detection for steroids with the ESI source were significantly improved 
by derivatization (Figure 5.17). Although structural information could be obtained by 
ESI-MS for the steroids investigated, the sensitivities obtained were disappointing. 
Comparing steroids with their TMPP-derivatives in full scan mode, the minimum level at 
which most of free non-conjugated steroids were detectable was 10 ng, and only the 4- 
ene-3-one steroids could be detected at lng. However, the sensitivities for steroid 
conjugates were much better than the non-conjugated steroids by negative ESI-MS. The 
detection limits were 500 pg for the steroid glucuronides and 250 pg for the sulfates 
(Refer to chapter 4, table 4.11). In contrast, the detection limits for most of the TMPP- 
derivatives of conjugated and non-conjugated steroids were no more than 2 0  pg,
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significant exception however included dihydrotestosterone and 5(3-androstan-17p-ol-3- 
one derivatives for which the detection limit was 1 ng. Formation o f the TM PP- 
derivatives generally increased sensitivities 50 to 100 times for non-conjugated steroids 
and more than 20 times for conjugated steroids. Even compared to the APCI source, 
which is more sensitive for most o f non-conjugated steroids, derivatization also provides 
a substantial improvement (Refer to chapter 4, table 4.5). Therefore, derivatization 
method should benefit the analysis o f some o f these compounds in biological fluids, in 
which the concentrations are very low.
600
Figure 5.17 Comparison of limits detection between non- 
derivatized and derivatized steroids in full scan mode
500500
6JD 500
g 400 o
5  300
4-  200
J  100
H Non-derivatized steroid 
□  Derivatized steroid
250 250
Steroid
1 .Testosterone (m/z 289/903); 2. Dihydrotestosterone m/z 291/905); 3. Dehydroisoandrosterone 
(m/z 271/903); 4. Androsterone (m/z 273/905); 5. Dehydroisoandrosterone glucuronide 
(m/z 463/1079); 6. Androsterone glucuronide (m/z 465/1081); 7. Dehydroisoandrosterone sulfate 
(m/z 367/983); 8. Androsterone sulfate (m/z 369/985).
The limits o f detection were also studied by the different scan modes for the 
steroid derivatives. Androsterone, etiocholan-3p-ol-17one, dehydroepiandrosterone, 
dehydroepiandrosterone glucuronide and androsterone glucuronide were used for 
comparisons, and the results are summarized in Table 5.10.
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Table 5.10 Limits of detection of TMPP-derivatives of some steroids
by full scan, SIM and SRM mode of MS (S/N> 3)
Steroid derivative Full scan (pg) SIM (pg) SRM (pg)
Androsterone 10 (m/z 903) 10 (m/z 905) 2 (m/z 905 533)
Etiocholan-3 p-ol-17one 10 (m/z 905) 10 (m/z 905) 2 (m/z 905 533)
DHEA 10 (m/z 903) 10 (m/z 903) 2 (m/z 903 -> 533)
DHEA glucuronide 20 (m/z 1079) 20 (m/z 1079) 5 (m/z 1079-> 903)
Androsterone glucuronide 2 0  (m/z 1081) 2 0  (m/z 1081) 5 (m/z 1081—> 905)
The comparisons in Table 5.10 show that SRM is about four to five times more 
sensitive than full scan and SIM mode. Moreover, SRM is less prone to chemical noise 
than full scan and more specific than SIM mode, as it monitors only selected transitions 
from parent ions to daughter ions. As the objective of this work is to detect a very low 
concentration of androgenic steroids in biological fluids, the SRM mode would benefit 
this purpose.
5.5 Quantitative LC-MS for androgenic steroid derivatives
5.5.1 Separation of 5 steroid derivatives by HPLC-MS
A gradient system (Section 5.2.3) was applied for the separation of the TMPP- 
derivatives of five androgenic steroids at a flow rate of 0.4 ml/min. The five compounds 
were totally separated by micro-bore Ci8 column, and the conjugated derivatives were 
eluted faster than the unconjugated derivatives. The total ion chromatograph and the 
extracted ion chromatograph of each compound by SRM mode of MS were showed in 
Figure 5.18.
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Figure 5.18 Total ion chromatograph and extracted ion chromatograph of five steroid
derivatives
11.69
1 0 0 -. 12.77 14.36
TIC
17.44
5.62
EtiochaJan-3oi *oM7 one
< 50- DHEA
100-,
DHEA
glucuronide
0 2 4 6 8 10 12 14 16 18 20
T i m e  ( m i n )
Note: sample was injected at 5 pi and at 1 ng/pl o f  each compound.
5.5.2 Analysis of variance of androgenic steroid derivatives
An ANOVA method was used to analyses the variances for the androgenic steroid 
derivatives, and the results were summarized in table 5.11 and 5.12.
A one-tailed F-test was used to test the significant difference between intra-day 
and inter-day variance. All the calculated F values shown in Table 5.12 are smaller than 
the critical F value (Fcriticai = 5.14, P = 0.05), therefore, we can conclude that there is no 
significant difference between intra-day and inter-day variance.
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Table 5.12 Summary of ANOVA results for steroid TMPP-derivatives by repeated
MS-SRM measurements
Steroid Concentra­
tion
(pg/jLll)
Source of 
variation
Sum of 
squares
Degree of 
freedom
Mean
square
F
Etiocholan-3(3-ol- 
17 one 
(m/z 905)
5 Intra-day 2.08 E+9 6 3.47 E+ 8 1.36
Inter-day 9.48 E+ 8 2 4.74 E+ 8
50 Intra-day 4.66 E+ll 6 7.76 E+10 0.95
Inter-day 1.48 E+ll 2 7.40 E+10
2 0 0 Intra-day 8.09 E+ll 6 1.35 E+ll 1.40
Inter-day 3.78 E+ll 2 1.89 E+ll
Androsterone 
(m/z 905)
5 Intra-day 9.18 E+ 8 6 1.52 E+ 8 0.63
Inter-day 1.92 E+ 8 2 9.60 E+7
50 Intra-day 6.17 E+10 6 1.03 E+10 0.70
Inter-day 1.44 E+10 2 7.21 E+9
2 0 0 Intra-day 5.59 E+ll 6 9.32 E+ll 1.64
Inter-day 4.79 E+ll 2 2.40 E+l 1
DHEA 
(m/z 903)
5 Intra-day 2.46 E+9 6 4.10 E+ 8 2.25
Inter-day 1.84 E+9 2 9.22 E+ 8
50 Intra-day 1.25 E+ll 6 2.08 E+10 3.27
Inter-day 1.36 E+ll 2 6.80 E+10
2 0 0 Intra-day 8.91 E+ll 6 1.48 E+ll 0.94
Inter-day 2.80 E+ll 2 1.40 E+ll
DHEA 
glucuronide 
(m/z 1079)
5 Intra-day 2.05 E+ 8 6 3.42 E+7 2.83
Inter-day 1.93 E+ 8 2 9.67 E+7
50 Intra-day 5.95 E+10 6 9.92 E+9 1.58
Inter-day 3.14 E+10 2 1.57 E+10
2 0 0 Intra-day 1.58 E+12 6 2.63 E+ll 1.70
Inter-day 8.97 E+ll 2 4.49 E+ll
Androsterone 
glucuronide 
(m/z 1081)
5 Intra-day 4.98 E+9 6 8.30 E+ 8 2.25
Inter-day 3.74 E+9 2 1.87 E+9
50 Intra-day 2.92 E+ll 6 4.87 E+10 0.79
Inter-day 7.73 E+10 2 3.86 E+10
2 0 0 Intra-day 1.99 E+12 6 3.31 E+ll 1.99
Inter-day 1.32 E+12 2 6.60 E+ll
5.5.3. Precision and linearity
Precision in the measurements of the steroid derivatives was also studied by 
repeatedly injecting samples at three different concentrations (5 pg/pi, 50 pg/pl and 200
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pg/fal for steroid derivatives) over three days. The intra-day coefficient variances are 
between 7.8% and 21.9%, and the inter-day values range from 9.2% to 25.4% , whereas 
the total coefficient o f variances are from 8.1% to 21.8% (Table 5.13 a to e).
All the five steroid derivatives were found to give a linear response in the 
investigated range o f  concentrations (5 to 200 pg/pl). Correlation coefficients o f linear 
regression are from 0.9997 up to 0.9999. Calibration curves and regression equation are 
presented in Figure 5.19 (a to e).
Table 5.13 (a) Precision o f Etiocholan-3(3-ol-17 one TM PP-derivative
Concentration
(Pg/pl)
Intra-day
(%CV)
Inter-day
(%CV)
Total
(%CV)
5 18.3 21.3 19.1
50 21.9 21.4 21.8
200 7.8 9.2 8.1
Figure 5.19 (a) Linearity o f etiocholan-3(3-ol-17 one TM PP-derivative
<us-es
-a
a>a.
5.25E+06
4.50E+06
3.75E+06
3.00E+06
2.25E+06
1.50E+06
7.50E+05
0.00E+00
y = 23892x - 18385
R = 0.999
50 100 150
C oncentration  (pg/pl)
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Table 5.13 (b) Precision o f androsterone TM PP-derivative
Concentration Intra-day Inter-day Total
(pg/|il) (%CV) (%CV) (%CV)
5 14^9 1L8 14.2
50 13.7 11.5 13.2
200 9.9 15.8 11.7
Figure 5.19 (b) Linearity o f androsterone TM PP-derivative
3.50E+06
3.00E+06 -
y =  15227x+ 1723.6 
R2 = 0.9982
2.50E+06
2.00E+06
1.00E+06
5.00E+05 -
0.00E+00
100 150
C oncentration (pg/pl)
200 250
Table 5.13 (c) Precision o f DHEA TM PP-derivative
Concentration
(Pg/pl)
Intra-day
(%CV)
Inter-day
(%CV)
Total
(%CV)
5 17.0 25.5 19.5
50 13.6 24.6 17.0
200 10.4 10.1 10.3
2 1 0
Figure 5.19 (c) Linearity o f DHEA TM PP-derivative
100 150
C oncentration (pg/|il)
y =  18165x + 84419 
R2 = 0.999
05
4.00E+06 - 
3.50E+06 - 
3.00E+06 - 
2.50E+06 - 
2.00E+06 - 
1.50E+06 - 
1.00E+06 - 
5.00E+05 - 
0.00E+00 - 
0
Table 5.13 (d) Precision o f DHEA glucuronide TM PP-derivative
Concentration
(Pg/pl)
Intra-day
(%CV)
Inter-day
(%CV)
Total
(%CV)
5 8.1 13.7 9.8
50 9.1 11.4 9.7
200 9.6 12.5 10.4
Figure 5.19 (d) Linearity o f DHEA glucuronide TM PP-derivative
6.00E+06
5.00E+06 -
£  4.00E+06
J  3.00E+06os
£  2.00E+06 
1.00E+06 
0 .0 0 E+ 0 0
y = 27014x- 148734
50 100 150
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2 1 1
Table 5.13 (e) Precision o f androsterone glucuronide TM PP-derivative
Concentration
(Pg/pl)
Intra-day
(%CV)
Inter-day
(%CV)
Total
(%CV)
5 14.9 22.4 17.9
50 16.3 14.6 15.9
200 10.5 14.9 11.8
Figure 5.19 (e) Linearity o f androsterone glucuronide TM PP-derivative
6.00E+06
5.00E+06 - y = 2 6 7 4 0 x + 84499 
R2 = 0.9994.00E+06 -
3.00E+06 -
2.00E+06 -
1.00E+06 -
O.OOE+OO
100 150
Concentration (pg/jj.1)
200 250
5.5.4 Limits o f quantitation
Limits o f quantitation o f each steroid derivative were also studied based on the 
regression lines o f y on x from the previously calibration curves, and the results were 
present in Table 5.14.
Table 5.14 Limits o f quantitation o f  five steroid derivative
Steroid derivative Limit o f quantitation (pg)
Etiocholan-3p-ol-17 one 16.2
Androsterone 25.4
DHEA 21.3
DHEA glucuronide 14.3
Androsterone glucuronide 14.5
2 1 2
5.6 Conclusions
In this chapter, a derivatization method was developed in the aim of increasing the 
sensitivities and quantitation for detection of the investigated androgenic steroids and 
their conjugates. The derivatization of steroids interest was carefully studied and 
optimized by different conditions to get maximum reaction yields, and then a LC-ESI/MS 
method was used to detect these product derivatives on line, with no need of sample 
pretreatment. The chromatographic characteristics of these derivatives were studied, and 
they were found to have longer retention time compared to the non-derivatized steroids. 
There was more than one peak observed in the total ion chromatographs of 4-ene-3-oxo 
steroid derivatives, and the possible reasons were considered. The full scan and CID mass 
spectra were also studied for each individual steroid derivative and different scan modes 
were compared to choose the most sensitive mode for quantitative analysis.
A second gradient system was set up to get baseline separation of the TMPP- 
derivatives of five steroids interest, and an ANVOA method was used to estimate the 
intra-day and inter-day variance for simultaneous quantitation of these five compounds. 
The precision, linearity and limit of quantitation were also measured for each of these 
compounds. Results showed that the derivatization method significantly improved the 
sensitivity of most investigated steroids and the method could possibly be applied for 
steroid residue analysis in biological fluids. However, internal standard may need to 
decrease variability during the experiments. Further work is required including 
optimization of the derivatized reaction to improve the activity of 3-oxo cholestane- 
steroids, and separation of other steroid derivatives due to the similarities of their mass
213
spectra after derivatization. Because of time limitation this direction could not be further 
pursued, but it is clearly a promising direction for future studies.
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Appendix 1. 5p-Dihydrotestosterone: MS of ion m/z 273; collision energy 28%
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Appendix 2. Etiocholan-3p-ol-17-one: MS2  of ion m/z 273; collision energy 28%
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Appendix 3. Etiocholan-3a-ol-17-one: MS of ion m/z 273; collision energy 28%
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Appendix 4. Epiandrosterone: MS of ion m/z 273; collision energy 28%
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Appendix 5. Androsterone: MS2 of ion m/z 273; collision energy 28%
28% s t e ro i d 7  1 0 u g # 1 4 - 1 8  RT: 0 . 5 6 - 0 . 7 2  AV: 5 SB:  3 7  0 . 0 3 - 0 . 4 3 ,  0 . 9 3 - 1 . 9 5  N L : 1 . 5 4 E 4  
T: + c Full m s 2  2 7 3 . 0 0 @ 2 8 . 0 0  [ 7 5 . 0 0 - 2 7 4 . 0 0 ]
1 0 0 —]
9 0 -
8 0 -
7 0 -
8  = 
g 60-*oc
I  50-^  
0)
3 0 -
2 0 -
1 0 1 6 3 . 0
91. 1 1 1 1 . 1
1 2 3 . 5 1 4 7 , 2  161 . 1
' I I ' I | 
8 0  1 0 0
-t—r^T" 
1 2 0
' ’ I 
1 6 0
Y-t
1 7 3 . 2
i I I i i
1 9 9 . 3 213^X17.1 2411
1 4 0
i ' ' ' r 
1 8 0  2 0 0
1 ' ' ' I
2 2 0  2 4 0
m / z
Appendix 6 . 5P-Dihydrotestosterone: MS of ion m/z 255; collision energy 30%
30% s t e ro i d 1 1  1 0 u g _ 0 1 1 1 0 8 1 1 3 7 3 4 # 1 9 - 2 5  RT: 0 . 7 5 - 0 . 8 9  AV: 7 SB:  13  0 . 1 0 - 0 . 5 9  NL: 9 . 9 9 E 4  
T: + c Full m s 2  2 5 5 . 0 0 @ 3 0 . 0 0  [ 7 0 . 0 0 - 2 5 6 . 0 0 ]
1 9 9 . 2
1 0 0 - 1
9 0 -
8 0 -
7 0 -
6 0 -
<  5 0 -
1  4 0 -  en
3 0 -
2 0 -
1 0 -
1 5 9 . 2
1 4 5 . 2
121.1
133 . 1
107 . 1
7 9 , 2
9 3 , 2  9 5 . 2
I T 1 
1 0 0
l~L -1—1
14 7 . 1
1 7 3 . 2
161 . 1
"I I | I T 
1 6 0  
m/ z
1 8 5 . 2
1 8 7 . 2
[ i i "
1 8 0
2 1 3 . 2
227."
212^3 2 2 6 , 2
1—r “T 
200  22080 120
^  r 
1 4 0
255.2
2 7 3 . 3
— I— 1— ^  
2 6 0
2 5 5 . 3  
2 3 9 . 9  2 5 4  4
.'■1 V  i j ll
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Appendix 7. Etiocholan-3p-ol-17-one: MS2 of ion m/z 255; collision energy 30%
3 0 % s t e r o i d 2  1 0 u g _ 0 1 1 1 0 7 1 7 0 0 0 2 # 1 5 - 2 6  RT: 0 . 5 5 - 0 . 6 9  AV: 1 2  S B :  3 9  0 . 0 1 - 0 . 5 0 ,  0 . 9 5 - 1 . 9 6  NL: 2 . 8 6 E 5  
T: + c Full m s 2  2 5 5 . 0 0 @ 3 0 . 0 0  [ 7 0 . 0 0 - 2 5 6 . 0 0 ]
1 9 9 . 2
1 0 0 -
90-
80-
7 0 -
0)0
§  6 0 -*oc
|  5 0 -
1  4 0 -  oc
3 0 -
20-E
1 0 -
1 5 9 2  1 7 3 . 2
1 4 5 . 2
1 3 3 . 2
1 0 5 . 2  121 . 1
8 1 . 3  9 5 . 2
1 6 1 . 2
T—I | I I 
1 6 0  
m / z
1 8 5 . 2
1 8 7 . 2
’ "r ' ' 
1 8 0
2 1 3 . 2
201.2
2 2 7 . 2
2 2 6 , 3
V | 1—Ti  
200 220
1—r
2 5 5 . 3
2 4 0 . 1
i—rn—i—r 
2 4 0
i  i | i r  
8 0 1 0 0 1 2 0 1 4 0
J
Appendix 8 . Etiocholan-3a-ol-17-one: MS of ion m/z 255; collision energy 30%
30% s t e r o i d 1 3  1 0 u g _ 0 1  11 0 8 1 2 0 9 2 9 # 2 6 - 3 5  RT: 0 . 9 2 - 1 . 0 3  AV: 1 0 SB:  3 5  0 . 0 9 - 0 . 7 9 ,  1 . 3 1 - 1 . 9 6  N L : 4 . 4 1 E 5  
T: + c Full m s 2  2 5 5 . 0 0 @ 3 0 . 0 0  [ 7 0 . 0 0 - 2 5 6 . 0 0 ]
1 9 9 . 2
1 0 0 —]
9 0 -
8 0 -
1 7 3 . 2
1 5 9 . 2
7 0 -
6 0 -
<  5 0 -
1 8 5 . 2
1 4 5 . 2
2 1 3 . 14 0 -
1 4 7 . 1
3 0 - 22 7 . 1
1.61.1 187.2
2 0 -
1 3 1 . 2
2 5 5 . 21 0 1? / - 1 121.28 1 . 2 9 5 . 2 2 2 6 . 32 0 .1.1 2 4 0 , 2  2 5 3  ,379,1o- 1
140 160 180 2 0 0 2 2 0 24080 100 120
m/ z
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Appendix 9. Epiandrosterone: MS of ion m/z 255; collision energy 30%
30% s t e r o i d 3  1 0 u g # 1 2 - 2 1  RT: 0 . 4 8 - 0 . 6 1  A V : 1 0  SB:  3 3  0.1 2 - 0 . 5 3 ,  1 . 0 7 - 1 . 8 4  NL: 2 . 7 0 E 5  
T: + c Full m s 2  2 5 5 . 0 0 @ 3 0 . 0 0  [ 7 0 . 0 0 - 2 5 6 . 0 0 ]
1 7 3 . 2
1 0 0 -
9 0 -
8 0 -
7 0 -
§  6 0 -  "O
<  5 0 -
-5 4 0 -  q:
3 0 -
20~
1 0 -
0
1 5 9 . 2
1 4 5 . 2  
1 4 7 . 2
81. 1  9 3 . 2 1 0 5 . 3
121.2 1 3 3 . 2
-r—r  
80
161.2
1 9 9 . 2
1 8 5 . 2  
1 8 7 . 2
2 1 3 . 2
201.1
2 2 7 . 2
2 2 6 , 3
r'"i 'f  l' 
2 2 0
2 4 0 . 2
2 5 5 . 2
1— —i—r 
2 4 0
I r 
1 0 0
-I I I r  
1 2 0
~  r  
1 4 0 1 6 0
m / z
1 8 0 2 0 0
Appendix 10. Androsterone: MS2 of ion m/z 255; collision energy 30%
30% s t e ro i d 7  1 0 u g _ # 1 6 - 2 6  RT: 0 . 5 9 - 0 . 7 4  AV: 11 SB:  3 3  0 . 0 9 - 0 . 5 7 ,  1 . 0 3 - 1 . 8 1  NL: 3 . 4 4 E 5  
T: + c Full m s 2  2 5 5 . 0 0 @ 3 0 . 0 0  [ 7 0 . 0 0 - 2 5 6 . 0 0 ]
1 9 9 . 2
1 0 0 —I
9 0 -
8 0 -
7 0 -
8
1 7 3 . 2S 6 0 -
TJ
C  _
|  50^
.§ =
1  40-5 cc
1 5 9 . 2
1 8 5 . 2
3 0 - 1 4 5 . 2
2 1 3 . 2
2 0 -
1 8 7 . 2 2 2 7 . 216.1.2
1 0 - 1 3 1 . 3
1 0 5 . 2  1 2 1 , 2 2 5 5 . 220 .1.18 1 . 2  9 3 . 2 2 2 6 , 2 2 4 0 . 2o - 1
80 100 140120 160 180 2 0 0 2 20 240
m/ z
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Appendix 11.11-Ketoandrosterone: MS2 of ion m/z 287; collision energy 30%
3 0 % s t e r o i d 2 8  1 0 u g # 2 4 - 3 5  RT: 0 . 9 0 - 1 . 0 5  AV: 1 2 SB:  1 3 0.1 2 - 0 . 6 1  NL: 2 . 3 7 E 5  
T: + C Full m s 2  2 8 7 . 0 0 @ 3 0 . 0 0  [ 7 5 . 0 0 - 2 8 8 . 0 0 ]
2 6 9 . 2i uu—I 2 2 9 . 2
9 0 -
8 0 -
7 0 -
<uo  -
§  6 0 -
T3 _
C  _
|  50^
.2 I
|  40-f a: -
1 4 7 . 2
2 5 1 . 2
1 5 9 . 2
3 0 -
1 6 1 . 2
2 0 - 1 8 7 . 2 2 0 9 . 2
2 4 1 . 2
211.21 6 9 . 2
1 0 - 1 4 5 . 2
93 . 1  1 0 ?-2 1 2 1 2  1.3L1-3 25 9 . 1 2 8 7 . 28 1 , 3
1 0 0 1 2 0 1 4 0 1 6 0 1 8 0 2 4 0 2 6 0 2 8 08 0 2 0 0 2 2 0
m /z
Appendix 12. 11-Ketoandrosterone: MS2 of ion m/z 269; collision energy 30%
3 0 % s t e r o i d 2 8  1 0 u g _ 0 1 1 1 0 8 1 7 5 1 5 0 # 1 9 - 2 6  RT: 0 . 7 5 - 0 . 9 7  AV: 8 SB:  1 3 0 . 1 0 - 0 . 5 9  NL: 3 . 0 5 E 4  
T: + c Full m s 2  2 6 9 . 0 0 @ 3 0 . 0 0  [ 7 0 . 0 0 - 2 7 0 . 0 0 ]
1 4 7 . 2
1 0 0 - 1 2 5 1 . 2
9 0 -
8 0 -
1 5 9 . 2
7 0 -
8
S 6 0 -*D _
C  _
|  50-^
I  =
|  40-5 a:
1 0 5 . 2
1 9 5 . 2
1 6 .1.2
1 8 7 . 2
3 0 - 1 7 5 . 1
2 1 3  2 2 2 7 . 2
1 4 3 , 2 1 6 9 . 22 0 -
2 4 1 . 2 2 6 9 . 31 3 3 . 291.2
1 0 - 1 2 3 . 181.2 9 3 . 2
2 5 3 . 1
o - 1
80 100 120 140 160 180 2 0 0 2 2 0 2 4 0 2 6 0
m Iz
221
Appendix 13. 1 lp-Hydroxyandrosterone: MS2 of ion m/z 271; collision energy 30%
3 0 % s t e r o i d 2 9  1 0 u g _ 0 1 1 1 0 8 1 8 1 0 1 0 # 2 4 - 2 9  RT: 0 . 9 5 - 1 . 1 5  AV: 6 S B :  1 3 0 . 0 9 - 0 . 5 8  N L : 1 . 8 7 E 5  
T: + c Full  m s 2  2 7 1 . 0 0 @ 3 0 . 0 0  [ 7 0 . 0 0 - 2 7 2 . 0 0 ]
1 0 0 —1
9 0 -
8 0 -
7 0
0) -0 -  
§  6 0 -  *o _ c  _
< 50^
5 I
1  4 0 -a:
3 0 -
2 0 -
1 5 9 . 2IQ-
1 9 7 . 2 2 1 3 . 21 7 1 . 21 4 5 . 2 2 2 5 . 2  2 3 8 . 3 2 7 1 . 37 9 . 3  9 5 . 3  10 7 . 1  1 2 1 . 2
80 1 0 0 1 2 0 1 4 0 1 6 0 1 8 0 2 0 0 2 2 0 2 4 0 2 6 0
m /z
Appendix 14. 1 ip-Hydroxyandrosterone: MS2 of ion m/z 253; collision energy 30%
3 0 % s t e r o i d 2 9  1 0 u g _ 0 1  1 1 0 8 1 8 2 1 1 2 # 2 2 - 3 6  RT: 0 . 8 8 - 1 . 2 1  A V : 1 5  SB:  13  0 . 1 1 - 0 . 6 0  NL: 2 . 7 0 E 5  
T: + c Full m s 2  2 5 3 . 0 0 @ 3 0 . 0 0  [ 6 5 . 0 0 - 2 5 4 . 0 0 ]
1 9 7 . 2
1 0 0 —1
9 0 -
8 0 -
7 0 -
§  6 0 -*D
C
|  5 0 -
.5
I  4 0 -  
ir
3 0 -
2 0 -
1 0 -
o - 4
1 5 7 . 2
79,3
I ' ' I I 
8 0
8 1 . 2  9 5 . 3  1 0 7 . 2
"i i"'1 " i—h 
1 0 0
t—r-[ 
1 2 0
1 3 1 . 3
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1 4 3 . 3  
1 4 5 . 2
LL_J
1 |
140
1 7 1 . 2  1 8 3 . 2
1 59 . 2
f - r -Y “ T 
1 8 0
18.5.2
211.2
1 9 9 . 2
i—n - i ' 
2 0 0
2 5 3 . 3
2 2 5 . 2  
224,2
2 3 8 . 2
2 5 1 , 2
r~i—r i i r~T
2401 6 0
m/ z
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Appendix 15. 5a-Androstan-3, 17-dione: MS2 of ion m/z 271; collision energy 32%
3 2% 27 1  s t e r o i d 6 # 2 6 - 3 6  RT: 0 . 5 3 - 0 . 7 4  AV: 11 SB:  1 3 0 . 0 6 - 0 . 3 1  N L : 3 . 5 0 E 4
T: + c Full m s 2 2 7 1 . 5 0 @ 3 2 . 0 0  [ 7 0 . 0 0 - 2 7 2 . 0 0 ]
1 0 0 —i
9 0 -
8 0 -
7 0 -
<  5 0 -
2 1 3 . 2
<o 4 0  —
3 0 -
2 0 -
161 . 1
1 9 7 . 2IQ-
2 7 1 .22 1 5 . 0 2 5 2 , 59 5 , 2  10 7 . 1  121.O
1 6 0 1 8 0 2 0 0 2 2 0 2 4 0 2 6 01 0 0 1 2 0 1 4 08 0
m /z
Appendix 16. 5a-Androstan-3, 17-dione: MS2 of ion m/z 253; collision energy 35%
35% 2 5 3 s t e r o l d 6 # 3 0 - 4  2 RT: 0 . 6 2 - 0 . 8 7  AV: 1 3 SB:  1 3 0 . 0 6 - 0 . 3  1 N L : 2 . 0 2 E 4
T: + c Full m s 2 2 5 3 . 5 0 @ 3 5 . 0 0  [ 6 5 . 0 0 - 2 5 4 . 0 0 ]
9 0 -
8 0 -
7 0 -
£  6 0 -
<  5 0 -
2 1 1 . 2»  4 0 -
3 0 -
2 2 5 . 21 7 1 .2 0 -
1 8 3 . 315 9 . 1 2 5 3 . 4
IQ- 1 4 5 . 2 3 8 . 21.85.1
1 4 3 . 3 2 5 1 , 2207,210 5 . 1 1 2 9 ,8 0 . 9
2 4 02 201 6 0 180 2 0080 100 120 140
m Iz
223
Appendix 17. Androstanediol: MS2 of ion m/z 257; collision energy 33%
3 3 % 2 5 7 s te ro id 2 7 #3  3 -4 1 R T : 0 . 6 7 - 0 . 8 3  AV: 9 S B : 1 3 0 .0 5-0 .3 0 N L : 2 . 2 5 E 5
T: + c Full m s 2  2 5 7 . 5  0 @ 3 3 . 0  0 [ 7 0 . 0  0-2 58 . 0  0]
1 0 0 —|
1 75.1
9 0 -
80
147. 170 —
S 6 0 -
1 35.1
<  50  —
2 0 1  .1
® 4 0  —
14 9.1
3 0 -
1 21 .1
1 8 7 . 22 0 -
13 3,1 229 . 1107 . 1 215 . 1I Q - 9 3 . 1 1 7 3 , 1 1.8 9 .281 .1 1 1 9.1
7 9,0 2 4 2 . 7  2 5 7 . 32 1 3,3 2 2 7,2,
16 0 2 2 0 2 4 080 1 0 0 1 2 0 140 1 80 2 0 0
m Iz
Appendix 18. As-Androstene-3p, 17p-diol: MS2 of ion m/z 273; collision energy 32%
3 2 % 2 7 3 s t e r o i d 2 6 # 2 2 - 2 9  RT: 0 . 4 5 - 0 . 5 9  AV: 8 SB:  13 0 . 0 5 - 0 . 3 0  N L : 1 . 5 7 E 4  
T: + c Full m s 2 2 7 3 . 5 0 @ 3 2 . 0 0  [ 7 5 . 0 0 - 2 7 4 . 0 0 ]
2 5 5 . 2
9 0 -
8 0 -
7 0 -
£ 60  —
<  5 0 -
® 4 0  —
30  —
2 0 -
1 0  —
175 . 1  ias.2 2 0 1 . 2  2 1 6 . 7111.7 1 2 9 r 2 7 3 . 42 4 5 . 2
80 1 0 0 1 2 0 14 0 1 6 0 1 8 0 2 0 0 2 2 0 2 4 0 2 6 0
m /z
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Appendix 19. Androstene-3p, 17p-diol: MS2 of ion m/z 255; collision energy 34%
34% 25  5 s t e r o i d 2 6 # 4  1 -4 8 R T : 0 . 8 4 - 0 . 9 8  AV: 8 SB:  1 3 0 . 0 6 - 0 . 3 0  N L : 7 . 3 6 E 4  
T: + c Full m s 2  2 5 5 . 5 0 @ 3 4 . 0 0  [ 7 0 . 0 0 - 2 5 6 . 0 0 ]
1 0 0 —1
90  —
8 0 -
7 0 -
£  6 0 - 1 9 9 . 2
1 7 3 . 21 4 5 . 2
<  5 0 -
o> 4 0  — 14.7.1
3 0 - 1 8 5 . 2
2 1 3 . 2
2 0 -
227 . 1161. 1
1 33.1
IQ- 10 7 J  121, 1  1 3 1 . 2
81.0 9 3 . 0 2 1 2 , 4 25 3 . 123 7 . 12 2 6 , 2
1 0 0 16 080 1 2 0 14 0 18 0 200 2 2 0 2 4 0
m Iz
Appendix 20. DHEA glucuronide: MS2 of [2M-2H+3Na]+ (m/z 995); collision energy 
32%
32% 9 9 5 s te ro id 1 7 # 2 6 - 4  6 RT: 0 . 6 5 - 1 . 1 6  AV: 21 SB:  1 3 0 . 0 6 - 0 . 3 7  N L : 7 . 2 6 E 3  
T: + c Full m s 2  99  5 . 5 0 @ 3 2 . 0 0  [ 2 7 0 . 0 0 - 9 9 6 . 0 0 ]
5 0 9 . 3
1 0 0 —l
5 4 9 . 4
9 0 -
8 0 -
7 0 -
6 0 -
|  5 0 -
4 0 -
3 0 -
2 0 -
1 0 - 9 7 7 . 4
4 9 1 . 3
6 6 5 . 3  7 0 6 . 73 5 0 . 6 5 8 1 . 4
300 500 600 700400 800 900 1 000
m /z
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Appendix 21. Etiocholan-3a-ol-17-one glucuronide: MS2 of [2M-2H+3Na]+ (m/z 999);
collision energy 32%
32% 9 9 9  s t e ro i d  2 3 # 2  3 -4  4 R T : 0 . 5 8 - 1 . 1 1  AV: 2 2  S B : 1 3 0 . 0  7 -0  .3 7 N L : 2 . 7 6 E 3
T: + c Full  m s 2 9 9 9 . 5  0 @ 3 2 . 0  0 [ 2 7 5 . 0  0 - 1 0 0 0 . 0  0]
1 0 0 —|
9 0  —
8 0 -
7 0  —
6 0  —
|  5 0 -
5 5 1 . 3
4 0  —
3 0 -
2 0  — 9 8 1 . 6
1 0 —
6 0 7 . 0
3 0 0 4 0 0 5 0 0 7 0 06 0 0 8 0 0 9 0 0 1 0 0 0
m /z
Appendix 22. Androsterone glucuronide: MS2 of [M-H+2Na]+ (m/z 511); collision 
energy 34%
34% s t ero i d  1 4 # 3 1  - 50  R T : 0 . 6 8 - 1 . 1 0  AV: 20  SB:  1 3 0 . 0 6 - 0 . 3 2  N L : 1 . 3 7 E 4
T: + c Full m s 2 51 1 . 50@ 3 4 . 0 0  [ 1 4 0 . 0  0 - 5 1 2 . 0  0]
4 9 3 . 2
1 0 0 —|
9 0  —
8 0  —
7 0  —
S 6 0 -
I  5 0 -
® 4 0  —
4 5 1  .2
3 0  —
2 0 -
SI 1 .5
4 3 2 . 13 9 3.7 4 9 CL, 92 21  .01 0 -
14 8.7 4 07  .41 7 9 . 0 261  .9 3 5 3 . 72 4 6 , 5 3 91J_3 2 0 . 3
150 2 0 0 250 300 350 40 0 450 500
m Iz
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Appendix 23. DHEA glucuronide: MS2 of [M-H+2Na]+ (m/z 509); collision energy 35%
35% 5 0 9 s teroid 1 7 # 2  1 -45  RT: 0 . 4 6 - 0 . 9 9  AV: 2 5 
T: + c Full m s 2 5 0 9 . 5  0 @ 3 5 . 0 0  [ 140 . 0  0 - 5 1 0 . 0  0]
1 0 0 —|
9 0  —
SB:  13 0 . 0 6 - 0 . 3 2  N L : 1 . 4 9 E 4
4 9 1 . 2
8 0 -
7 0 -
£  6 0 -
<  50-
o> 4 0 -  OL
3 0 -
20“
1 0 -
4 4 9 . 2
3 5 0 . 8
149. 1 17 9 . 0 2 0 2 . 9  2 3 2 . 0I I I 2 9 3 . 4T l—|—i—r 
2 5 0
I—r 
3 0 0
3 9 0 . 7
—r ~ r
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4 1 5 8  4 4 2 J
. . .  1 . ,1 ll,
4 8 9 , 4
4 8 8 , 3 5 0 9 . 4
it.iilij
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T
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Appendix 24. Etiocholan-3a-ol-17-one glucuronide: MS2 of [M-H+2Na]+ (m/z 511); 
collision energy 35%
35% 51 1 s t e r o i d 2 3 # 2 8 - 4 9  RT: 0 . 6 1 - 1 . 0 8  AV: 22  SB : 1 3 0 . 05-0  . 32 N L : 5 . 1 6 E 3  
T: + c Full m s 2  5 1 1 . 5  0 @ 3 5 . 0  0 [ 1 4 0 . 0  0 - 5 1 2 . 0  0]
4 9 3.3
1 0 0 —i
90  —
8 0 -
7 0 -
8
5 6 0 -  CO —*o _c  _ 4 5 1 . 23
3 5 0 -§
179 . 0
4 0 -
30  —
2 3 9 . 0
3 5 3 . 0
2 0 -- 14 9 - 0 4 1 7 . 6 4 8 6 , 2
2 7 9 . 2221 51 1.5
2 6 1 . 41 0  —
4 0 7 , 2 4 7 5.7203 . 1 4 2 0 . 9
4 5 0 5 0 03 5 0 4 0 0150 2 5 0 3 0 02 0 0
m Iz
2 2 1
Appendix 25. Testosterone glucuronide: MS of [M+Na] (m/z 487); collision energy
27%
27% 4 8 7  s t e ro i d  2 0 #2  8-3  5 R T : 0 . 6 0 - 0 . 7 6  AV: 8 S B : 1 3 0 .0 5 - 0 . 3  2 N L : 1 . 6 3 E 4  
T: + c Full m s 2 4 8 7 . 5  0 @ 2 7 . 0  0 [ 1 3 0 . 0  0-4  8 8 . 0  0]
3 2 8.1
1 0 0 —|
9 0 -
8 0 -
70-
£  6 0  —
<  5 0  —
a* 4 0- oc
3 0 -  
2 0 -Z 
1 0 -
1 4 0 . 0
1 9 8 . 9
1 9 4 . 6
1 50
1  I200
2 1 6 . 6
2 2 4 . 6
230 . 1
3 42 . 1
2 5 0
3 2 7.3
3 2 4 . 8
31 6. 9
3 2 8 . 6
3 4 2 . 7
3 5 0
3 7 0 . 0
4 8 7 . 3
4 1 6 . 2  46 0 . 9 .
4 6 9 . 0
4 0 0 4 5 0
2 “4“Appendix 26. Androsterone glucuronide: MS of [M+Na] (m/z 489); collision energy 
25%
25% 4 8 9  s t ero id 1 4 #2  3-4 5 R T: 0.4 9-0 .9 8 AV: 23  S B : 1 3 0.0 5 -0  .3 2 N L : 7 . 3 0 E 3
T: + C Full m s 2 4 8 9 . 5  0 @ 2 5 . 0  0 [ 1 3 0 . 0  0-4 9 0 . 0  0]
3 3 0 . 5
1 0 0  —I
9 0 -
8 0  —
7 0 -
£ 6 0  —
<  50  —
® 40"oc
30-
2 0 -
1 0 -
19 8.9
1 8 0 . 9
1 6 2 ,8
i—r~
15 0
I1 I V I
21 6.2
J? 1 6 . 8  
2 2 9 . 7
3 2 9 , 7
3 2 8.9
3 2 7, 7  
31 9.1
2 0 0
“i | i i i r 
2 5 0 300
3 4 4 . 5
4 7 1 . 1
3 5 3  3 
I 3 6 5 . 3
350
4 1 4 . 2 4 5 3 . 1
— H —i— i— i— r —i— r
4 8 9 . 0
4 0 0 450
m /z
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Appendix 27. Etiocholan-3a-ol-17-one glucuronide: MS2 of [M+Na]+ (m/z 489);
collision energy 25%
2 5% 4 8 9  s t e r o i d 2 3 # 1  9 - 4 6  RT: 0 . 4 1 - 1 . 0 1  AV: 28  SB:  1 3 0 . 0 6 - 0 . 3 2  N L : 1 . 2 8 E 4  
T: + c FuII m s 2  4 8 9 . 5 0 @ 2 5 . 0 0 [  1 3 0 . 0 0 - 4 9 0 . 0  0]
3 3 0  41 0 0 -
9 0 -
80~
70~
s =£ 60- ■o _ c  _
<  5 0 -
a> 4 0 -  a.
3 0 -
20“
1 0 -
1 9 8 . 9
1 6 2 . 9  1 8 0 . 8
' r
15 0
21 6 .6
ulyH
2 3 0 . 6
2 7 3 . 2
3 2 8 . 9
3 2 7 , 3  
3 2 3 , 7
3 4 4 . 6  
, ,i 3 5 4 . 9
4 8 9 . 2
4 0 3 . 4  4 4 5 . 0
4 71,1
-t- n—i—i—r~ 
4 0 0
I I I i 
4 5 0
t I i r
2 0 0
~ | i i r
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Appendix 28. DHEA glucuronide: MS2 of [M+Na]+ (m/z 487); collision energy 27%
27% 4 87  s te ro id 1 7 #2  5-4 8 R T : 0 . 5 4 - 1 . 0 5  AV: 24  S B : 1 3 0 . 06-0  .32 N L : 4 . 5 7 E 3
T: + c F u  II m s 2  4 8 7 . 5  0 @ 2 7 . 0 0 [ 1 3 0 . 0  0-4 8 8 . 0  0]
1 9 8.9
1 0 0 —1
90  —
80  —
21 6.7
7 0 -
8
S 60  —(D T3 —c  _ 
<  50^
I =ra -  
« 4 0 — O.
3 2 7 . 9
3 2 8 . 7
30  —
2 0  — 3 4 2 . 6
1 6 3 . 0  1 9 2 ■ ‘ 
1 8 0.8
4 8 7.2
1 0 —
3 9 0 . 4 4 6 9 . 22 3 3.6 27 1  .2 4 5 4 . 6
150 2 5 0 3 0 0 3 5 0 4 0 0 4 5 02 0 0
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Appendix 29. 5p-Androstane-l 1, 17-dione-3a-ol glucuronide: MS2 of [MH]+ (m/z 503);
collision energy 25%
2 5 %  5 0 3  s t e r o i d 2 2 _ 0 2 0 8 2 6 1  6 5 4 4 8 # 2  1 -40 RT:  0 . 4 6 - 0 . 8 8  A V : 2 0  S B : 1 3 0 .0 6 -0  .3 2 N L : 3 . 1 8 E 3
T: + c Ful l  m s 2 5 0 3 . 5  0 @ 2 5 . 0  0 | 1 3 5 . 0  0 -5  0 4 . 0  0]
1 9 8 . 9
1 0 0 —1
90  —
8 0  — 2 16. 5
70 —
8 60 —c  CO "O
c
3  50  —
|  =
CD —
c d  4 0 — 
I t
30  —
2 0
1 4 2 . 4 5 0 3 . 3
4 3 0 . 73 3 9.0 3 5 8 . 51 o — 28 5 . 12 3 0 . 0 46  0.1 4 7 4.93 9 2 . 21 80 . 9 2 6 4  81 6 3 . 4 1 8 5
5 0 04 5 02 5 0 3 0 0 3 5 0 4 0 01 50 2 0 0
m /z
Appendix 30. 5a-Androstan-3a, 17p-diol glucuronide: MS2 of [MH]+ (m/z 491); 
collision energy 27%
27% 4 9 1  s t e ro i d 2  5 # 2 4 - 3  8 RT: 0 . 5 3 - 0 . 8 4  AV: 1 5 S B : 1 3 0. 0  7 -0  .3 3 N L : 9 . 0 7 E 3
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Appendix 31. Testosterone glucuronide: MS2 of [2M+Na-2H]' (m/z 949); collision
energy 31%
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Appendix 32. Androsterone glucuronide: MS of [2M+Na-2H]' (m/z 953); collision
energy 32%
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Appendix 33. Etiocholan-3a-ol-17-one glucuronide: MS2 of [2M+Na-2H]' (m/z 953);
collision energy 31%
31 % 2 3 # 2 4 - 3 3  RT: 0 . 6 0 - 0 . 8 2  AV: 1 0 S B :  1 3 0 . 0 7 - 0 . 3 7  N L : 6 . 6 8 E 2  
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Appendix 34. DHEA glucuronide: MS2 of [2M+Na-2H]' (m/z 949); collision energy 32%
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T: - c Full m s 2 9 4 9 .5 0 @ 32 . 0  0 [ 2 6 0 . 0  0-9 5 0 . 0  0]
4 6 3.21 0  0 —
9 0 —
8 0 —
5 61  .37 0 -
m 6 0 -
<  5 0  —
o 4 0 —
3 0  — 9 4 9 . 7
2 0  —
1 o —
3 0 0 4 0 0 6 0 0 7 0 05 0 0 8 0 0 9 0 0
m /z
232
2
Appendix 35. 5p-Androstane-l 1, 17-dione-3a-ol glucuronide sodium salt: MS of
[2M-Na]' (m/z 981); collision energy 31%
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Appendix 36. 5a-Androstan-3a, 17p-diol glucuronide: MS2  of [2M-H]' (m/z 957); 
collision energy 32%
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Appendix 37. 5p-Androstane-l 1, 17-dione-3a-ol glucuronide: MS of [M-Na]
(m/z 479); collision energy 32%
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Appendix 38. 5a-Androstan-3a, 17p-diol glucuronide: MS2 of [M-Na]' (m/z 467); 
collision energy 33%
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